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Summary
Single cell genetic analysis is a necessity in the field of preimplantation 
genetic diagnosis (PGD), non-invasive prenatal diagnosis and can be 
applied to isolated tumour cells in the blood. Current techniques used in 
PGD and non-invasive prenatal diagnosis are mainly based on either the 
polymerase chain reaction (PCR) or fluorescence in situ hybridisation 
(FISH). However, the genetic analysis at a specific locus by PCR has the 
drawback of sacrificing further detection of common chromosomal 
aberrations if there is only one cell available. The limitation of FISH using 
specific probes is that it provides information on only one or a few loci at a 
time.
Comparative genomic hybridisation (CGH), a molecular cytogenetic 
technique, has the advantage over FISH in permitting a comprehensive 
analysis of chromosomal imbalances across the whole genome. 
Combining degenerate oligonucleotide primed polymerase chain reaction 
(DOP-PCR) and CGH techniques, it is possible to study minute quantities 
of DNA prepared from a very few cells. The aim of this project is to verify 
the feasibility of applying these techniques to a single cell and investigate 
the prospect of a novel strategy using whole genome amplification (WGA), 
nested PCR and CGH to increase the scope and capacity of single cell 
genetic analysis.
The work started first to prove the amplification power of DOP-PCR from a 
single cell. Various protocols aiming at whole genome amplification (WGA) 
have different efficiencies in terms of yield and genomic coverage. DOP- 
PCR is superior to primer extension preamplification (PEP) in producing 
more quantity of DNA from a single cell. The amplification power of DOP- 
PCR from a single cell (5 pg) resulted in 10 pg yield with the bulk of DOP- 
PCR products between 200-2000 bp. DOP-PCR is designed to faithfully 
amplify the genome, and provide sufficient DNA template. Thus, numerous 
specific loci and the imbalance of every chromosome can be assessed in 
a single cell.
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To investigate the feasibility of locus detection from WGA products, two 
sets of nested PCR aiming at sex determination or CF AF508 detection 
were optimised and tested on a range of DNA sources. The results 
proved that a strategy of nested PCR could be used to determine the sex 
and CF status on DOP-PCR-amplified DNA derived from single cells. 
Nested PCR was also used in the genetic analysis directly on a single cell. 
In the study of single blastomeres, the sex could be determined in 55.6% 
of cases (10/18) when nested PCR was used directly on single 
blastomeres.
The feasibility of single cell CGH in the diagnosis of major chromosome 
abnormalities such as sex chromosome anomaly, trisomy 18 and 21 was 
established in this study. To produce successful single cell CGH 
experiments, the normal reference DNA could be made from either 
amplified DNA or non-amplified DNA. This study demonstrated that a 
reliable non-amplified reference DNA could increase the success rate of 
single cell CGH and help to identify the underlying causes of failed CGH 
experiments.
For quantitative analysis of CGH experiments, the fluorescence ratio cut­
off value was usually set at 1.2 and 0.8 to represent chromosomal gains 
and chromosomal losses, respectively. However, the fluorescent ratio 
profiles using stringent cut-off values would reduce the false positives with 
the risk of failing to detect the true abnormalities. In this study, the average 
number of false positives was 5 when threshold of 1.2/0.8 was used. Apart 
from the objective quantitative analysis, single cell CGH diagnosis of 
trisomy 21, 18 and sex could also be qualitatively verified from CGH 
images.
After the DOP-PCR/CGH techniques had been proved feasible from a 
single cell, the sensitivity and reliability of CGH was further tested on IQ- 
20 stained cells scraped from slides in order to simulate the current 
strategy used in the non-invasive prenatal diagnosis. This part also 
involved firstly, the correct diagnosis of trisomy 18 and 21 and secondly, 
several coded samples of known sex were tested for the performance of
XXI
single cell CGH. The results showed that chromosomal aberrations such 
as isochromosome X and segmental aneuploidy could be reliably 
detected. However, a small deletion at single band level could not be 
detected by single cell CGH. Thirdly, a manufactured mosaicism designed 
by mixing trisomy 18 male cells with normal female cells was tested to see 
if at 50-70 % mosaic level the trisomy could be detected by single cell 
CGH. The results illustrated that trisomy 18 could not be detected at the 
70% mosaic level using the current protocol. This may illustrate that 
accurate identification of cells of fetal origin is mandatory if current DOP- 
PCR/CGH techniques are to be applied in the field of non-invasive 
prenatal diagnosis.
The final part involved using CGH on blastomeres and tested the 
possibility of employing a shortened protocol for single cell CGH. The 
preliminary results confirm that chromosome abnormalities may be a 
common phenomenon in the early embryonic cells. The success of 
overnight CGH illustrates that further reduction of time is possible. This 
may allow an expansion of its future application in PGD.
Overall, this study demonstrates that DOP-PCR/nested PCR/CGH has the 
potential to serve as a powerful supplement to the present genetic 
analysis from a single cell. Concomitant detailed chromosome analysis 
and specific locus detection may become feasible in the field of PGD and 
non-invasive prenatal diagnosis in the near future.
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Chapter 1
Introduction
1.1 Structure of human genomic DNA
The composition of the human genome is organised in two forms, a 
complex nuclear genome and a simple mitochondrial genome. The 
nuclear genome contributes the great volume of essential genetic 
information, most of which is decoded to specific polypeptides on 
cytoplasmic ribosomes. Mitochondrial DNA is in the form of single circular 
double-stranded DNA, 16569 bp long, which specifies only a very small 
portion of mitochondrial function.
1.1.1 Nuclear genome constitution
The nuclear genome of a human haploid cell contains about 3 x 109 bp of 
DNA. The great majority of the cellular DNA is never transcribed in any cell 
and only about 3% of the human genome is coding DNA (Strachan 1992, 
Figure 1.1).
Nuclear Genome
-3 0 %  „ I - 7 0 %
Genes and gene-related Extragenic DNA
sequence • ......... . •
~ 55% j
-27%
Coding 
DNA
Non-coding DNA
Unique or low 
copy number
T ~ 1 5 %
Moderate to highly 
repetitive
i
Tandemly repeated
Introns
Promoters
Pseudogene
Gene fragments
Interspersed
repeats
Satellite 
Minisatellite 
(Telomeric, Hypervariable) 
Microsatellite
SINEs (Alu family) 
LINEs (Kpn family)
Figure 1.1: Organization o f human nuclear genome (Adapted from Bennett 2000)
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The recent publication of two draft sequences of the human genome is a 
landmark achievement in the history of mankind. Consortium and Celera 
Genomics have completed sequencing 90% of the euchromatic 
chromosomal regions (International Human Genome Sequencing 
Consortium 2001; Venter et al, 2001).
Mapping the genome has located each of approximately 100,000 genes 
on our 24 different chromosomes (Williams and Hayward 2001). In a 400- 
band metaphase karyogram, on this basis, there are about 200 genes per 
band. (Strachan 1992) However, the average gene density is dependent 
on the base composition of the chromosomal region. Chromosomal 
regions with abundant GC (guanine, cytosine) content are thought to be 
rich in genes, while those with rich AT (adenine, thymine) contents are 
deficient in genes. Although on average the human genome has about 
one gene per 30-60 kb of DNA, certain chromosomal regions such as the 
centromeres and telomeres are particularly deficient in genes (Strachan 
1992).
1.1.2 Repeated sequences
The moderately to highly repetitive sequences can be divided into two 
types, depending on whether the individual repeat units are dispersed 
singularly (interspersed repetitive DNA) or clustered together (tandem 
repeat). There are several families of interspersed repetitive DNA 
sequences, and the two largest are known as short and long interspersed 
nuclear elements (SINEs and LINEs, respectively). The most abundant, 
Alu repeat family, which belongs to SINEs, is primate specific and 
accounts for 5% of total human DNA. These tandemly repeated 
sequences may be sub-divided according to the average size of the arrays 
of repeats into satellite DNA, minisatellite DNA and microsatellite DNA 
(Bennett 2000).
Human satellite DNA is found particularly in centromeric heterochromatin, 
which is essential for ensuring disjunction of the chromosomes into 
daughter cells following cell division at meiosis and mitosis. Minisatellites
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can be subdivided into two types: telomeric and hypervariable. Telomeric 
DNA is required for complete replication of the DNA at the chromosome 
termini. Hypervariable minisatellite DNA includes those first discovered 
and termed as ‘DNA fingerprinting’ (Jeffrey et al 1985).
Microsatellites or STRs (short tandem repeats) are ideal genetic markers, 
because they are abundant, highly polymorphic, occur evenly throughout 
the whole human genome, and are small enough to be amplified using 
PCR. Microsatellite-associated applications are very useful in several 
fields: (1) Diagnostic testing for trinucleotide repeat associated diseases 
(2) loss of heterozygous (LOH) analysis (3) linkage analysis (4) paternity 
test (5) forensic science (Bennett 2000).
1.2 Chromosomes
The basic material of chromosomes consists of DNA complexed with 
different DNA-binding proteins, notably histones, and acidic proteins 
(Figure 1.2).
Figure 1.2: From DNA duplex to metaphase chromosome (Human chromosome 
17, G-banded, 550-band preparation. Adapted from Strachan 1992)
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The DNA content of each chromosome is thought to consist of a single 
linear double-stranded DNA molecule and an average size chromosome 
has approximately 130 Mb but can vary between 50 Mb and 250 Mb 
(Table 1.1).
Chromosome Amount of DNA (Mb) Chromosome Amount of DNA (Mb)
1 250 13 110
2 240 14 105
3 190 15 100
4 180 16 85
5 175 17 80
6 165 18 75
7 155 19 70
8 135 20 65
9 130 21 55
10 130 22 60
11 130 X 140
12 120 Y 60
The DNA content is given for a chromosome prior to entering the S (DNA replication) 
phase of cell division
Table 1.1: DNA content o f human chromosome (Adapted from Strachan 1992)
At the metaphase stage, the chromosomes become more condensed and 
can be resolved by optical microscopy as structures which are over 1 pm 
wide and range in length from 2 pm (chromosome 21) to 10 pm 
(chromosome 1). A variety of treatments cause chromosomes in dividing 
cells to become visible as a series of alternating dark and light staining 
bands. The dark bands are generally recognised to contain AT-rich DNA, 
whereas the light bands contain GC-rich DNA. G-banding provides high 
quality chromosome analysis with approximately 400 bands per haploid 
genome, while each of these bands corresponds to around 8 Mb of DNA.
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The bulk of the chromatin is euchromatin which uncoils following cell 
division, becomes light-staining and includes active genes interspersed 
with non-transcribed DNA sequences. However, certain chromosomal 
regions continue to remain condensed throughout the life cycle of the cell. 
They appear as dark-staining areas, termed heterochromatin, and have 
been presumed to be genetically inactive (Strachan and Read 1997).
1.3 Chrom osom e disorders
Chromosomal abnormalities may be present in cells throughout the body, 
or may be present in a small subset of cell or tissues. Chromosome 
abnormalities mostly fall into one of two categories: numerical 
abnormalities and structural abnormalities. Chromosome disorders affect 6 
per 1000 newborn infants and two-thirds of these infants will be disabled, 
and a proportion of the remainder will, in adult life, be at risk of either 
miscarriage or having chromosomally unbalanced offspring (Tolmie 1995).
1.3.1 Numerical abnormalities
Numerical abnormalities involve a change in the number of chromosomes, 
without involving chromosome breakage. Three classes of numerical 
chromosomal abnormalities can be distinguished: polyploidy, aneuploidy, 
and mixoploidy (Figure 1.3).
The most common numerical chromosomal abnormalities are 
demonstrated in Table 1.2. Trisomy 21 is the most common aneuploidy 
found at birth and the majority of cases are the result of non-disjunction 
occurring during maternal meiosis; only 5% are attributable to mitotic error 
(Yoon et al 1996). Similarly X chromosome aneuploidy associated with 
XXX and XXY is mainly the result of maternal meiotic errors, with 9% 
being attributable to mitotic error (MacDonald et al 1994).
5
Numerical chromosomal abnormalities
Polyploidy | Mixoploidy | Aneuploidy
Chimera
Mosaic
Polyploid mosaic | Aneuploid mosaic
Polyploidy: Extra copies of all chromosomes, e.g. triploidy (3n) or tetraploidy (4n)
Aneuploidy: Loss or gain of only certain chromosomes (e.g. trisomy 21 or monosomy X)
Mixoploidy: Two or more cell lines which differ in chromosome number 
Mosaic: The different cell lines derive from a single zygote 
Chimera: The different cell lines originate from different zygotes 
Polyploidy mosaic: e.g. diploidy/triploidy 
Aneuploidy mosaic: e.g.normal/trisomy 21
Figure 1.3: Types of numerical chromosomal abnormality (Adapted from 
Strachan and Reed 1997)
The most common numerical chromosomal aberrations
Trisomy 21 (Down syndrome) 
47.XXX
47.XXY (Klinefelter syndrome) 
47.XYY
Trisomy 18 (Edwards syndrome) 
45,X
Trisomy 13 (Patau syndrome)
Table 1.2: The most common numerical chromosomal aberrations.
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1.3.2 Structural abnormalities
Structural chromosomal abnormalities results from chromosome breakage 
with subsequent reunion in a different configuration and can be balanced, 
if there is no net gain or loss, or unbalanced, if there is net gain or loss 
(Figure 1.4).
Structural chromosomal aberration
one break on 
one chromosome
two breaks on 
one chromosome
Terminal deletion |
Inversion Interstitial deletion
Ring chromosome
two breaks 
on different 
chromosomes
three breaks; at 
least two on one 
chromosome
Reciprocal
translocation
Centric translocation
Interstitial translocation
Terminal deletion: Acentric fragment is lost 
Inversion: region between breakpoints is inverted
Ring chromosome: Region between breakpoints forms a circle by fusion between breakpoints 
Interstitial deletion: Region between breakpoints is discarded: terminal fragments fuse 
Centric translocation: Fusion of centric fragments of two acrocentric chromosomes 
Reciprocal translocation: Balanced exchange of acentric fragments
Insertional translocation: Region between two breakpoints on one chromosome is excised and 
inserts at location of third breakpoint which may be on the same or different chromosome
Figure 1.4: Major types of structural chromosomal aberrations. (Adapted from 
Strachan and Reed 1997)
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In balanced rearrangements, they are usually harmless unless one of the 
breakpoints involves an important functional gene, whereas unbalanced 
rearrangements would cause severe physical or mental disability due to 
the presence of both monosomy and trisomy. If two breaks occur in a 
single chromosome, one of three outcomes is usually observed: a 
chromosome inversion, an interstitial deletion, or a ring chromosome 
(Figure 1.5).
Breaks on the 
same side of 
centromere
Paracentric
inversion
d°
Acentric
fragment
e.d
e.d
Acentric ring chromosome
Ring
chromosome
Interstitial
deletion
Inversion
Breaks on the 
opposite sides of 
centromere
Pericentric
inversion
Centric fragment 
lacks telomere
D Acentric 
fragment
Centric ring 
chromosome
Figure 1.5: Alternative outcomes of two breaks on a single chromosome. 
(Adapted from Strachen and Reed 1997)
If breaks occur on two or more chromosomes, hybrid chromosomes may 
be formed by joining segments originally on different chromosomes 
(chromosome translocation). Three types of translocation are known: a 
reciprocal translocation, a centric (Robersonian) fusion, or an insertional
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translocation. In Robertsonian translocations acrocentric chromosomes 
fuse at their centromeres. Because acrocentric short arms are mainly 
composed of repeated sequences and contain no essential genes, 
balanced carriers are phenotypically normal despite having only 45 
chromosomes. In reciprocal translocations, the rearrangement involves 
two or more chromosomes but the breakpoints are not at their 
centromeres. A carrier of a balanced reciprocal translocation can produce 
unbalanced gametes, resulting in zygotes with partial trisomy and partial 
monosomy for defined chromosomal regions (Figure 1.6).
Gametes
ii
y  v
Meiosis
Zygotes
Normal
Fertilisation {y by normal 
gamete
i i I
Balanced partial trisomy partial monosomy
carrier -•-partial monosomy +partial trisomy
Figure 1.6: Gametogenesis of a balanced reciprocal translocation and the 
possible outcomes. (Adapted from Strachan and Reed 1997)
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1.4 Prenatal diagnosis
The advances in the prenatal diagnosis of birth defects have opened a 
new era in preventive medicine. With the rapid proliferation of newer 
techniques in prenatal diagnosis, the list of disorders that can be 
diagnosed and treated is increasing rapidly. Current practice for detection 
of fetal abnormalities includes ultrasound and maternal serum screening 
for NTD/Down syndrome (e.g. test combining the risk of maternal age, 
AFP, p-HCG, or other markers) (Raghad et al 1999). When genetic 
abnormality is suspected, fetal tissues can be sampled by the employment 
of various invasive procedures such as chorionic villi sampling (CVS), 
amniocentesis, percutaneous umbilical blood sampling (PUBS), or fetal 
biopsy. Fetal cells obtained can be tested directly with various molecular 
techniques or processed by culturing the tissues for karyotyping.
1.5 Principal techniques used in prenatal diagnosis
Apart from conventional cytogenetic analysis, molecular laboratory 
techniques are increasingly important in the evaluation of fetuses at risk of 
single gene disorders or chromosomal abnormalities. New assays or 
techniques such as amplification refractory mutation system PCR, 
fluorescent PCR, heteroduplex analysis and the protein truncation test are 
now applied in prenatal diagnosis (Van den Veyver and Roa 1998). 
Recent advances in molecular cytogenetics such as CGH, primed in situ 
labelling (PRINS), five-colour FISH, the development of new telomeric 
probes and 24-colour FISH are being evaluated for their roles in the 
prenatal diagnosis of chromosomal aberrations (Lapierre et al 1998, 2000; 
Bryndorf et al 1995; Daniely et al 1998, 1999; Divane et al 1994; Lesto et 
al 1999, 2000, Mohaddes et al 1996; Muller-Navia et al 1996).
1.5.1 Conventional cytogenetics
Conventional cytogenetics involves the examination of a dividing 
population of cells by blocking cell division at metaphase with an inhibitor 
of spindle formation (i.e. Colcemid). The development of chromosome
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banding techniques allowed identification of individual chromosome pairs 
and chromosome regions. Human chromosomes are numbered from 1 to 
22, X and Y, the classification being based on the size and arm ratios, and 
banding pattern of the chromosomes.
1.5.1.1 G-banding
The G-banding obtained by digesting the chromosomes with proteolytic 
enzymes are the most widely used technique in clinical cytogenetic 
laboratories for routine chromosomal analysis. This technique is described 
as GTG (G-bands by trypsin using Giemsa). Chromosomes stained by this 
protocol exhibit light- and dark-stained regions (light and dark bands) 
along their lengths. The G-band pattern induced by trypsin is very similar 
to that produced by quinacrine. Although the mechanism of G-banding is 
not yet completely understood, it is hypothesized that the differences 
between positive and negative G-bands may be due to the distribution of 
chromosomal protein and DNA (Verma and Babu 1995).
The G-bands obtained by GTG are far superior in resolution to those using 
fluorochromes. The permanent nature of these preparations facilitates a 
thorough microscopic analysis of metaphases (Verma and Babu 1995).
1.5.2 Molecular cytogenetics
Molecular cytogenetics can be described as the microscopic analysis of 
chromosomes and chromatin in metaphase and interphase using labelled 
DNA probes. Slides of metaphase chromosomes and interphase nuclei 
are prepared from cells that grow in suspension culture, such as 
lymphocyte, or from cells that grow attached to a substrate, such as 
fibroblasts and amniocytes. DNA in the metaphase chromosomes or 
interphase nuclei is then hybridised with a probe labelled either non- 
isotopically with biotin or digoxigenin, or isotopically with 3H. Non-isotopic 
probes are generally detected by fluorescence or an enzymatic method; 
3H-labelled probes are visualised by emulsion autoradiography (Ferguson- 
Smith 1992).
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The emergence of non-isotopic alternatives has greatly improved the 
application of molecular cytogenetics, particularly in prenatal diagnosis, 
because rapid results become possible. The methodology depends on the 
incorporation of a variety of haptens into the nucleotides used for making 
the probes, which can be detected immunologically by binding the reporter 
molecule with specific antibodies (indirect detection). The most widely 
used reporter molecules are biotin and digoxigenin. To build strong 
fluorescent signals, two layers (sandwich amplification) of fluorescently 
labelled antibodies can be applied. However, while the signal intensity 
increases, the background noise also increases. Direct detection involves 
fluorochromes coupled directly to the nucleotides (e.g. FITC-12-dUTP or 
Texas Red) or fluorescently labelled reporter molecules (Figure 1.7).
In situ hybridisation (ISH) can be used to determine the chromosomal map 
and the relative order of genes and DNA sequences within a chromosomal 
band. It can also be used to detect aneuploidy, gene amplification, and 
subtle chromosomal rearrangements. New molecular cytogenetic 
techniques using the same principles as ISH have been developed and 
evaluated in various fields. These include: CGH, PRINS, SKY, micro- 
FISH, Multi-FISH, Fiber FISH, and DNA microarrays (Kallioniemi et al 
1992; Koch et al 1989; Engelen et al 1998; Macville et al 1997; Schrock et 
al 1996, 1997; Speicher et al 1996; Florijn et al 1995; Kraus et al 1997; 
Ried et al 1997; Pinkel et al 1998).
12
Probes Q , ,Q
Denaturation
QJCUUr'YYYV', ooroo nrrrri rV r ^  nrrrri o o
i f  ★ ^  Hybridisation
Target DNA:metaphase chromosome 
or interphase nuclei
indirect detection*— ■
o  o  p  ^
(Sandwich)
C M  One step amplification
★  ★  ★O O O O f
D irect detection
i t  i t i t  i t
a £ 5 g - - & s a
'ey* o  *rr>
*  : F luorochrom e labelled  d N T P  
Q  : reporter m o lecu le  labelled  d N T P
C O ’  F luorochrom e-con jugated  reporter b inding m olecule  
(e.g . avidin, streptavid in  or antibody)
a
U n lab elled  d N T P
: F luorochrom e (e.g . F IT C , T exa s  R ed)
°  : R eporte r m o lecule  (e .g . biotin, d igoxigenin )
Anti body d irected  against reporter b inding m olecule
Figure 1.7: Schematic illustration of the detection of fluorescent signals. For direct 
detection, it uses fluorochrome-conjugated dNTP or fluorescent reporter 
molecule. For indirect detection, it uses one layer of fluorochrome-conjugated 
reporter binding molecule. To amplify the signal, the procedure can be either one 
step or two steps. In the case of two-step amplification, usually the last detection 
reagent is the same as the one used for the primary detection; this procedure is 
therefore also referred as ‘sandwich’ amplification.
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1.5.3 Polymerase chain reaction (PCR)
PCR is an enzyme-catalysed biochemical reaction in which small amounts 
of a specific DNA segment is amplified into large amounts of linear double­
stranded DNA. PCR is a powerful technique which can permit rapid 
amplification of DNA sequence, even when the starting material is from a 
single cell or badly degraded DNA. As a result it has been extensively 
employed in areas such as medicine, evolution studies, and forensic 
science.
In PCR, two primers (short single stranded DNA with 15-30 nucleotides) 
are used that are complementary to opposite strands of the target DNA to 
be amplified. After heat mediated denaturation of the template DNA, the 
primers bind to their respective sequences (annealing) on the template 
DNA and a DNA polymerase synthesizes a complementary strand in the 5’ 
to 3’ direction (extension). Each round of denaturation, annealing, and 
extension is known as a cycle. After 30 cycles, the products of PCR will 
include, in addition to the starting DNA, about 105-106 copies of the 
specific target sequence, an amount which is easily visualised as a 
discrete band of a specific size on agarose gel electrophoresis (Baumforth 
et al 1999).
Like all enzymatic reactions, PCR is not an unlimited process. In most 
applications, after 20-40 cycles, the reaction enters an ‘amplification 
plateau’, a linear phase where additional cycles will not lead to any further 
increase in amplified product. This plateau effect results from the 
exhaustion of reagents such as dNTPs and primers. Another limitation of 
PCR is that it becomes progressively more difficulty to amplify large DNA 
sequences and the method has largely been confined to amplifying small 
DNA regions (generally less than 5 kb).
1.6 Genetic analysis on minute amounts of DNA
Genetic analysis performed on scarce DNA, or even to a single cell level, 
has been used in a number of clinical and research applications. 
Examples include: (1) preimplantation diagnosis (2) non-invasive prenatal
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diagnosis (3) isolated tumor cells from blood or bone marrow (4) forensic 
science (5) investigation of ancient DNA (6) DNA microdissected from 
various cytogenetic preparations (Handyside et al 1997; Sekizawa et al 
1996; Ohshima et al 1999; Pantel et al 1999; Racila et al 1998; Hummel et 
al 1999; Viesbach et al 1994; Engelen et al 1998).
1.6.1 Micromanipulation techniques
A number of techniques have been described to retrieve single cells from 
cell suspensions or slides. A microscope fitted with hydraulic 
micromanipulators is necessary for preimplantation diagnosis or 
chromosome microdissection (Cui et al 1994; Hozier et al 1996). 
Microdissection has become a very popular method for making both 
whole-chromosome and region-specific painting probes (Meltzer 1992; 
Guan et al 1994). For genetic analysis of tumour samples, cell 
heterogeneity is one major problem, as a large variety of cell types usually 
present in these specimens can mask cell-specific genetic alterations 
associated with disease. Although cells of interest can now be retrieved by 
microdissection techniques, it is difficult to isolate single cells from a tissue 
section without the risk of contamination by the neighbouring cells. 
However, this can now be overcome by a new laser-assisted 
microdissection technique (Becker et al 1996, 1997; Aubele et al 1998). 
The development of laser microbeam based, contamination-free 
preparation of one single or a few homogeneous cells out of a 
heterogeneous cell population is an important step towards highly precise 
molecular analysis of genetic defects, underlying cancer, infection or 
disease (Schiitze et al 1997)
1.6.2 Preimplantation genetic diagnosis (PGD)
PGD is a very early form of prenatal diagnosis aimed at identifying 
embryos carrying serious genetic diseases before implantation. In current 
prenatal diagnosis, fetuses at risk are tested on samples of chorionic villi 
obtained at 10 weeks’ gestation, or fetal cells obtained by amniocentesis
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at 16 weeks’ gestation. It can be as late as 18-22 weeks’ gestation when a 
definite diagnosis is made and this can leave families confronting the 
social and religious dilemmas regarding termination of pregnancy.
PGD was first developed to diagnose genetic diseases such as sex-linked 
or autosomal inherited diseases. However, the scope of PGD has been 
greatly widened and the indications for diagnosis now may include: 
carriers of balanced translocations, couples with recurrent abortions, 
aneuploidy screening in aged women, in ICSI (intracytoplasmic sperm 
injection) candidates with a severe oligoospermia and /or the presence of 
meiotic anomalies, in patients with recurrent artificial reproductive 
technique (ART) failures, and in patients in whom a gonadal mosaicism is 
suspected (Handyside et al 1998).
The clinical application of PGD uses the methods of super-ovulation and in 
vitro fertilisation (IVF) established for the treatment of infertile couples. 
Human embryo biopsy has been successfully carried out at the cleavage 
stages on day 3 post-insemination, at the six- or eight-cell stage, or at the 
blastocyst stage on days 5 or 6. However, very few embryos reach 
blastocyst stage and to date there have been no reports on blastocyst 
biopsy for clinical PGD cycles (Harper and Wells 1999).
In PGD, the time required for genetic analysis is kept to a minimum 
because the prolonged culture of human embryos tends to reduce viability 
and the resulting pregnancy rates decline. In most cases, the aim is to 
diagnose the status of the embryos and transfer a maximum of two 
unaffected embryos later on the same day as embryo biopsy. Recent 
advances in the culture of human embryos to the blastocyst stage would 
allow an additional 2-3 days to perform some more lengthy diagnostic 
procedures (Gardner et al 1998; Gianaroli et al 1998; Veigh et al 1999).
1.6.2.1 Early cell cleavage and mosaicism
The application of the FISH technique to spare, untransferred embryos 
after IVF cycles has led to the most interesting findings that 30% of 
normally developing cleavage stage embryos are chromosomally mosaic
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(Delhanty et al 1993, 1997). Using conventional cytogenetic analysis, 
karyotyping was possible in 39.8% of embryo preparations. The data also 
show that 30% of apparently normally fertilized embryos carry a major 
chromosome anomaly including aneuploides, mosaicism, structural 
anomalies and undetected abnormality of ploidy. (Jamieson et al 1994) 
More recently a comprehensive analysis of early embryos using CGH 
technique have demonstrated around 75% chromosomal aberrations in 
early embryo cells (Voullaire et al 2000, Wells et al 2000).
All blastomeres of monospermic embryos will be abnormal when the 
chromosome abnormality occurs during the first embryonic division. 
Mosaicism occurring at the second cleavage in one of the two cells will 
result in an embryo in which half of the cells are abnormal. Mosaicism 
occurring at the third cleavage in one of the four cells will result in one 
fourth of the cells being abnormal (Munne et al 1994a; Figure 1.8).
In most dividing cells, a series of checkpoints act to ensure that each 
phase of the cell cycle is completed before progression to the next. 
Absence of this checkpoint has been shown in murine oocytes (Le Maire- 
Adkins et al 1997). It is likely that deficiency of the metaphase-anaphase 
checkpoint could also be responsible for the chromosome malsegregation 
seen in human embryos (Wells et al 2000).
The influence of mosaicism needs to be examined, because it could lead 
to incorrect results in PGD (Munne et al 1994b, Katagiri et al 1996).
The consequences of chromosomal mosaicism for early human embryonic 
development are unknown. The frequent occurrence of chromosomal 
mosaicism may be a contributing factor to the relatively low success rate 
of IVF (Katagiri et al 1996).
1.6.3 Non-invasive prenatal diagnosis
The possible resources for noninvasive prenatal diagnosis include fetal 
DNA in maternal plasma, exfoliated trophoblasts through cervical canal 
and fetal cells in maternal blood (Adinolfi 1995; Bianchi 1995; Lo et al 
1997, 1999).
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Figure 1.8: Onset of mosaicism in monospermic human embryos. This is 
exemplified in the figure by a non-disjunction of sex chromosomes occurring at 
different cleavage stages (Adapted from Munne et al 1994a).
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1.6.3.1 Fetal DNA in maternal plasma and serum
Free DNA has been demonstrated in serum in cancer, autoimmune 
diseases and in pregnancy (Mulcahy et al 1996; Bianchi et al 2000). There 
are similarities between a growing fetus and a neoplasm because both are 
immunologically foreign to, and have an extensive vascular interface with, 
their hosts. Prompted by such reports, Lo demonstrated that fetal DNA is 
present in maternal plasma and serum. Detection of fetal DNA sequence 
was possible, in 80% and 70% of cases, with just 10 pi of boiled plasma 
and serum, respectively (Lo et al 1997). The underlying processes that 
cause free DNA to be released into the maternal circulation have yet to be 
explained. Possible mechanisms include cell lysis resulting from 
immunological and physical damage, and developmentally regulated 
apotosis of certain fetal tissues (Sekizawa et al 2000).
As well as sex-linked disorders, techniques for fetal-DNA detection in 
maternal plasma or serum can also be used to detect many paternally 
inherited DNA sequences that differ from their maternal counterpart (Lo et 
al 1997). More recently, a proportion of such DNA has been seen in intact 
fetal cells within maternal plasma and trisomy 21 has been diagnosed 
using FISH (Poon et al 2000).
1.6.3.2 Fetal cells in maternal circulation
The candidate fetal cells in maternal blood may include trophoblasts, 
lymphocytes, granulocytes and NRBCs (nucleated red blood cells). 
Lymphocytes are poor candidates because these cells are known to 
persist from previous pregnancies. It has also been reported that fetal cells 
may persist in maternal blood for as decades (Bianchi et al 1996). 
Granulocytes are largely unexplored as candidate cells. Trophoblasts 
remain theoretically attractive, but unequivocal proof of a specific 
monoclonal antibody is still lacking. Moreover, the multinucleated nature 
can complicate FISH analysis and the phenomenon of confined placental 
mosaicism is another drawback for its candidacy (Bianchi et al 1996). 
Despite these limitations, some investigators have successfully detected Y
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chromosome sequences by PCR and FISH techniques in trophoblast 
sprouts physically isolated from maternal blood (Mueller et al 1990, 
Durrant et al 1996, Mavrou et al 1998).
There are several reasons why NRBCs are the best candidate cells to be 
used in noninvasive prenatal diagnosis: fetal erythroblasts are nucleated 
and larger in size when compared with maternal red blood cells. This 
distinctive morphological difference is used in the separation of fetal 
nucleated cells from maternal components. Second, the DNA contained by 
these cells makes it possible to do direct genetic analysis once the cells 
are isolated. Third, NRBCs possess various cell surface markers, which 
can be used for isolation. Lastly, NRBCs have a definite life span in the 
maternal blood (Bianchi et al 1996).
NRBCs are present from at least 10-18 weeks’ gestation, with no obvious 
diminution in their frequency after 16 weeks. It has been estimated that 
30% of erythroblasts in maternal blood are of fetal origin, with the 
frequency of these cells varying through gestation (Shulman et al 1998; 
Troeger et al 1999). By using a density gradient purification method from 
10 ml of maternal blood, 7-95 erythroblasts could be identified between 
15-24 weeks gestation (Kuo et al 1999). Based on flow cytometry data, the 
ratio of fetal NRBCs to maternal blood cells is 1:1x107 to 1:1x108. The 
separation of fetal NRBCs from maternal blood relies on differences in cell 
size, volume, and DNA content. Based on these characteristics, fetal cells 
can be isolated with density gradient centrifugation or lysis of the non­
nucleated maternal erythrocytes. The remaining cells can then be purified 
further using fluorescent activated cell sorting (FACS), magnetic activated 
cell sorting (MACS), or other techniques (Herzenberg et al 1979; Bianchi 
1995).
The presence of fetal cells in maternal blood has been termed as 
‘microchimerism’, and is associated with a number of maternal diseases 
such as scleroderma (Bianchi 2000).
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1.7 Technical developments for single cell genetic analysis
1.7.1 Conventional cytogenetic study of blastomeres
Human embryo cells remain in interphase for most of their 16-hour cell 
cycle. Only a small proportion of blastomeres, isolated at random from 
such embryos, can be expected to enter metaphase during the short 
period available for analysis. Even after overnight culture of isolated 
blastomeres in the presence of colcemid, only one-third of the cells 
produce metaphases suitable for karyotyping (Santalo et al 1995). The 
proportion of successfully karyotyped embryos was reported to be 
between 23.9-76% (Angell et al 1986; Rougier et al 1993; Jamieson et al 
1994; Kalousek et al 1995).
In general, a complete analysis of blastomeres from human embryos 
between the 2-cell to the blastocyst stage by conventional karyotyping 
studies is very labour intensive if possible to obtain at all. The main 
reasons for analytical failure are, lack of chromosomes, cell loss and over­
spreading of individual metaphase plates (Jamieson et al 1994). Detailed 
chromosome analysis is usually not feasible due to sub-optimal 
metaphase morphology and inconsistent chromosome banding.
1.7.2 Nuclear conversion for blastomere karyotyping
The possibility of applying nuclear transplantation techniques for 
karyotyping a single blastomere from preimplantation human embryos has 
been reported recently. In this ‘nuclear conversion’ technique, human 
oocytes or abnormally fertilised zygotes were enucleated and the 
blastomere was injected into the perivitalline space. The results of human 
blastomeres fusion with enucleated human zygotes showed that 87% of 
the nuclei could be transformed into analysable chromosomes. If 
blastomeres were fused with human oocytes, the figure for analysable 
chromosomes was 55% (Evsikov et al 1999).
When cryopreserved in vitro matured bovine oocytes were fused with 
human blastomeres, the transferred human nuclei were ‘forced’ into
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metaphase within a few hours (Willadsen et al 1999). In 87 of the hybrid 
cells, 21 had no trace of human chromatin, while 64 of the remaining 66 
(73%) displayed chromosomes suitable for analysis. Furthermore, a 
relatively simplified and efficient method for obtaining metaphase 
chromosomes was also proposed, and chromosome plates could be 
obtained in 91% when human blastomeres were fused with commercial 
available frozen mouse zygotes (Verlinsky et al 1999).
Interphase nuclei conversion may be of particular help for translocation 
patients and age related aneuploidy screening. In cases of complicated 
rearrangements, recent advance in multi-colour FISH such as SKY or 
mutliplex-FISH could be applied to the metaphase spreads produced from 
these converted nuclei (Speicher et al 1996; Schrock et al 1996, 1997; 
Marquez et al 1998).
1.7.3 Single cell molecular diagnosis
The amount of DNA in a single cell is estimated to be around 5 pg 
(Schaaff et al 1996). Conventional PCR, which applies around 25-30 
cycles for amplification, is unable to amplify a single cell to a detectable 
level on ethidium bromide-stained agarose gel. Two stages of PCR 
amplification (e.g. nested PCR) involving 55-60 cycles are required for 
specific locus detection from a single cell. Various researchers for single 
cell genetic analysis are now focusing on new methods such as 
fluorescent PCR, multiplex PCR, and whole genome amplification. These 
methods are being developed in order to speed up the diagnosis, to 
increase the sensitivity, or to expand the range of diseases that can be 
detected at the single cell level (Blake et al 1999; Findlay et al 1995, 1998; 
Kristjansson et al 1994; Harper and Wells, 1999).
To shorten the time for PGD, one stage PCR involving 35-40 cycles is 
possible if a sensitive detection method is applied. Fluorescent PCR, 
performed as conventional PCR, is labelled with fluorophores so that they 
can be detected after excitation by a laser during electrophoresis (Findlay 
et al 1995). Fluorescent PCR products are 1000 times more detectable
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than those achieved using conventional non-radioactive methods (Harper 
et al 1999; Scherlock et al 1998).
Unlike nested PCR, however, detection of fluorescent PCR products 
requires the use of an automated sequencer and has high running costs 
(Findlay et al 1995). With only one cell available, the diagnostic spectrum 
is usually limited and repeat tests are impossible. The development of 
multiplex PCR and whole genome amplification has the potential to 
overcome these disadvantages and maximize information gained from a 
single cell (Wells et al 1998).
1.7.3.1 Nested PCR
Conventional gel analysis from a single cell is not attainable from one step 
of 30 cycles of PCR amplification, whereas this could be overcome by 
using a strategy of nested PCR (Handyside et al 1992). In nested PCR, 
two sequential amplifications are used. The first one uses a set of primers 
that yield a large product, which is then used as a template for the second 
amplification. The second set of primers anneal to the sequences within 
the initial product. Nested PCR may enhance the specificity and reduce 
the risk of carry-over contamination. Sensitivity is also increased because 
two sets of amplification, both in the order of 25-30 cycles, are used 
(Figure 1.9).
The first clinical application of PGD using a nested PCR strategy for sex 
determination was reported in a case of a male X-linked disorder 
(Handyside et al 1990). Using a similar strategy, the first single gene 
defect to be successfully screened was the common 3 bp AF508 deletion 
in exon 10 of the cystic fibrosis transmembrane regulator (CFTR) gene 
causing CF and was achieved by heteroduplex analysis (Handyside et al 
1992).
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Figure 1.9: Principle of nested PCR. In nested PCR, two separate reactions were 
applied. The first uses a pair of outer primers yielding a large product, which is 
then used as a template for second amplification. The second pair o f primers 
anneals to sequences within the initial product, producing a second small 
product.
1.7.3.2 Multiplex PCR
Multiplex PCR makes use of two or more primer sets within the same 
reaction mix. This system is useful for the simultaneous detection of a 
number of different sequences. As interaction between unrelated primers 
and PCR products may occur, each multiplex PCR system may need 
tedious optimisation processes.
A quantitative multiplex fluorescent PCR system has been enhanced 
simultaneously to diagnose sex and cystic fibrosis and determine a reliable 
and accurate DNA fingerprint in a single cell. Simultaneous diagnosis of 
Down syndrome and sex could be completed in five hours if a rapid 
fluorescent PCR system is used (Findlay et al 1995, 1998).
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1.7.3.3 Quantitative fluorescent PCR
Fluorescent-based DNA detection technology, first developed for 
automated sequencing, has been adapted for PCR fragment analysis and 
applied for genetic screening. Incorporation of fluorescently labelled 
primers into PCR products enables a laser excitation/detection system to 
register the DNA fragments as excitation peaks. This detection system is 
more sensitive than standard gel electrophoresis. The signal intensities of 
the fluorescent peaks can be compared and used for quantitative PCR 
analysis. This allows accurate genotyping of samples in which one allele 
has been dramatically over-amplified relatively to the other (Findlay et al 
1995). Such results may resemble allele drop-out (ADO) using less 
sensitive detection method. The superior sensitivity of fluorescent PCR 
means that fewer copies of the template are necessary for the product to 
be detected and fewer cycles are needed. This has the effect of speeding 
up the diagnosis while reducing the threat of contamination by PCR 
products. As a consequence of increased sensitivity, a low ADO rate (4%) 
has been reported due to an ability to distinguish true ADO from 
preferential amplification of one allele over the other (Findlay et al 1995).
1.7.3.4 Whole genome amplification (WGA)
The term of ‘WGA’ is used to indicate a PCR method that is aiming to 
generate a non-specific amplification of whole genomic sequences from a 
minute quantity of starting DNA. WGA represents a more flexible 
alternative to multiplex PCR and aims to amplify the entire genome in an 
unbiased way. Several versions of WGA (e.g. primer extension 
preamplification (PEP), degenerate oligonucleotide primed PCR (DOP- 
PCR), Alu-PCR, tagged PCR, and ligation-mediated PCR) have been 
presented over the past decade for various research purposes: single 
sperm genotyping, simultaneous linkage and mutation analysis, 
genotyping for multiple disease genes, identification of genetic changes in 
small lesions (Zhang et al 1992; Telenius et al 1992a, 1992b; Baldini et al 
1991; Grothues et al 1993; Vincent et al 1994; Sanchez-Cespedes et al
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1998; Aubele et al 1998; Kallioniemi et al 1996; Klein et al 1999).
PEP uses random pentadecanucleotides as primers and is able to amplify 
about 80% of a cell’s genome to a minimum 30 copies from a single sperm 
(Zhang et al 1992). This method produces a sufficient number of DNA 
copies from a single cell to perform multiple loci genetic analysis, or to 
verify molecular findings by repeat analysis. PEP has been applied 
successfully in the analysis of sex (ZFX/ZFY), cystic fibrosis (AF508), two 
major mutations responsible for Tay-Sachs disease and a common 
restriction polymorphism in the gene responsible for haemophilia A 
(Snabes et al 1994).
Kristjansson applied PEP technology for single-cell analysis of the five 
most commonly deleted exons of the dystrophin gene in conjunction with 
ZFX/ZFY analysis (Kristjansson et al 1994). Ao et al also applied PEP for 
preimplantation genetic diagnosis of familial adenomatous polyposis coli 
(Ao et al 1998).
Another method of WGA is DOP-PCR which uses primers defining 
sequences at the 5’ end and the 3’ end. Between these regions is a 
random hexamer sequence (Telenius et al 1992a). PCR is performed 
under low-stringency conditions during the first 5 cycles followed by 28-35 
cycles with a more stringent temperature. It has been shown that DOP- 
PCR produces sufficient DNA for over 100 independent PCR 
amplifications. These amplified templates have been successfully used in 
the analysis of CFTR, APC, p-globin and DNA markers at chromosome 21 
and 18 (Wells et al 1999).
Using DOP-PCR, efficient amplification was achieved from the genome of 
all species. This PCR technique had important applications to genome 
mapping, including chromosome painting and chromosome-specific 
marker generation (Telenius et al 1992b).
1.7.3.5 Problems related to single cell PCR
For single cell PCR, the principal problems encountered are amplification 
failure, ADO and contamination. Amplification failure occurred in about
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10% of isolated blastomeres, and may have resulted from transfer failure 
or incomplete lysis (Wells et al 1998).
ADO is a phenomenon where only one of the two alleles present in a cell 
is amplified to a detectable level. It affects a significant proportion of single 
cell amplifications and is a problem that is yet to be understood (Avner et 
al 1994; Rechitsky et al 1996). Improving the lysis method or increasing 
PCR denaturing temperature may reduce the occurrence of ADO, 
although such modifications cannot entirely eliminate it (Ray et al 1996; El- 
Hashemite et al 1997).
Although the exact cause of ADO is not known, it is believed that it may be 
due to sub-optimal PCR conditions or degradation of target DNA 
molecules. For genetic analysis, ADO will cause serious misdiagnosis 
particularly in autosomal dominant conditions or in autosomal recessive 
compound heterozygotes. Failure to amplify the mutant allele (PCR failure 
or loss of the chromosome) will lead to transfer of an affected embryo.
PCR is also highly prone to sources of error due to its sensitivity, 
particularly when the starting DNA is from a single molecule. For this 
reason, stringent precautions must be taken in order to avoid 
contamination in PGD. In IVF, many sperm may be embedded in the zona 
pellucida and may be accidentally transferred along with the blastomeres 
during embryo biopsy. Maternal cumulus cells are another potential source 
of contamination. Contamination might also be of laboratory origin (e.g. 
previously amplified DNA) or external in origin (e.g. operator DNA).
1.7.4 Single cell FISH
In PGD, sexing by PCR has now largely been abandoned in favour of a 
FISH technique due to the risk of misdiagnosis by PCR (Griffin et al 1994; 
Munne et al 1994). FISH has an advantage over PCR for sexing in that it 
detects the X and the Y chromosomes simultaneously, as a result of which 
not only the sex of the embryo can be determined but also whether there 
is aneuploidy of the sex chromosomes (Harper et al 1995). An additional 
advantage is that the risk of contamination with irrelevant cellular matter is
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minimal with FISH, as the nucleus is viewed at all stages of the process, 
from initial spreading to final analysis.
Most PGD have been performed for age-related aneuploidy, with most 
groups using FISH probes to detect chromosomes X, Y, 18, 13 and 21 
which together account for 95 % of all postnatal chromosome 
abnormalities. More recently this approach has been questioned and 
modified to include a re-probing stage with additional probes for 
chromosomal 14,15 and 22 (Munne et al 1998; Bahce et al 1999). 
Interphase FISH is not as efficient as metaphase FISH and the addition of 
every extra probe and re-probing step decreases the hybridisation 
efficiency further. Therefore FISH is a compromise between the number of 
chromosomes examined and the efficiency of the FISH procedure. 
Overlapping signals and hybridisation failure can affect all FISH protocols 
and so strict criteria have to be followed (Bischoff et al 1998).
1.7.5 Five-colour FISH for single cells
FISH with 5 fluorescent DNA probes has been reported for analysis of five 
chromosomes in a single blastomere or fetal cells isolated from maternal 
blood (Munne et al 1996; Bischoff et al 1998). However, simultaneous 
analysis of more than the 5 chromosomes is limited by several causes:
(1) lack of alpha-satellite specific probes for some chromosomes
(2) limited number of fluorochromes or fluorophore-labelled probes for 
visual detection with spectrally well-separated emissions
(3) lack of excitation and emission filters for visualising both primary and 
mixed colours concurrently
(4) difficulties in counting resulting from spatial relationships when 
assessing more than 8 hybridisation signals in a single cell.
Because of the limited number of fluorescent colours of DNA probes, the 
number of chromosomes that can be examined simultaneously in each 
blastomere is limited to a maximum of five (Bischoff et al 1998).
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1.7.6 Repeated FISH on the same blastomere
In order to increase the number of chromosomes examined in each 
blastomere, some reported a repeated FISH procedure in which six or 
more chromosomes can be analysed per blastomere of an embryo. Based 
on the initial number of nuclei, the percentages of nuclear loss and 
presence of signals were 3 and 92% after the first FISH; the percentages 
were 7 and 87% respectively after the second FISH, and were 13 and 
78% respectively after the third FISH (Liu et al 1998). The rate of nuclei 
with signals decreased in the second and third FISH procedures. This 
might be due to repeated washing and denaturation procedures, which 
would affect the hybridisation between DNA probes and target sequences. 
The loss of blastomere nuclei might also occur in the FISH or repeated 
FISH procedures (Liu et al 1998).
1.7.7 Primed in situ labelling (PRINS)
The PRINS method is an alternative to conventional FISH for 
chromosomal detection based on the use of chromosome-specific 
oligonucleotide primers. In this method, chromosomal identification is 
performed by primer extension by Taq DNA polymerase in the presence of 
labelled nucleotides (Koch et al 1989, 1996). Pellestor has however 
defined specific primers for several chromosomes and established a dual­
colour PRINS protocol (Pellestor et al 1996 a, b). The PRINS reaction is 
performed on a programmable temperature cycler, with specific labelling 
obtained in less than 2 hours.
It has been demonstrated that the PRINS technique is more specific and 
considerably faster than classical FISH using alpha-satellite DNA 
sequences for chromosome identification (Gosden et al 1994). Diagnostic 
use of centromeric repeat probes is hampered by the lack of specificity as 
there is a high degree of homology between certain chromosomes in their 
satellite DNA sequences (Ried et al 1992).
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1.7.8 Multicolour FISH for single cells
A genome-wide screening for chromosomal aberrations has become 
possible with the recent developments of colour karyotyping. This has led 
to the development of 24-colour FISH, a process which allows the 
visualisation of the 22 human autosomes and the 2 sex chromosomes in a 
single hybridisation. The ability to conduct FISH experiments in multiple 
colours permits complex chromosomal abnormalities to be analysed in a 
single hybridisation.
Two strategies are available for producing 24-colour chromosome paint. In 
ratio labelling, paints may be generated from a number of fluorochromes 
mixed together in different proportions. Due to difficulties in accurately 
recreating the dye ratios of the paint, this strategy is unsuitable for mass 
production. Combinatorial labeling, however involves the construction of a 
multiple-coloured probe set through mixing, in equal proportions, of 
differentially labelled chromosome specific paints. The number of 
permutations following this strategy is given by the formula 2n-1 where n 
represents the number of dyes. Paint sets can easily be reproduced and 
software programmed to automatically classify the resultant FISH signals, 
making combinatorial labelling the method of choice for reproduction of the 
24-colour chromosome paint (Verma and Babu 1995).
Two systems currently in use for the imaging of 24-colour FISH slides are 
multiplex-FISH (M-FISH) and spectral karyotyping (SKY) (Speicher et al 
1997; Schrock et al 1996). The M-FISH system is based on a series of 
narrow bandpass filters selected to correspond with excitation and 
emission characteristics of the incorporated fluorochromes of the paint. 
SKY utilises a Sagnac scanning interferometer to measure the spectra of 
the emitted fluorescent signals of the hybridised probe. It employs 24 
chromosome-specific painting probes. Each probe is labelled with different 
proportions of five separate fluorochromes and observed by spectral 
imaging, providing a different colour for each human chromosome.
SKY FISH has already been employed to examine chromosomes from 
oocytes and polar bodies. However, a significant number of metaphases
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will be unsuitable for analysis due to poor chromosome morphology, 
extensively overlapping chromosomes, and loss of chromosomes from the 
spread (Fung et al 1998; Marquez et al 1998).
1.7.9 DNA microarrays
A rapidly evolving technique for molecular analysis is the DNA chip which 
provides the potential to simultaneously detect thousands of possible 
sequence variants in previously defined genes (Solinas-Toldo et al 1997; 
Pinkel et al 1998, Snijders et al 2000). This technique accommodates high 
throughput, integrated data acquisition and computation. Microchip 
technology is mainly suited for large-scale screening including single base 
polymorphism, gene expression and pathogen detection, but may become 
relevant also in preimplantation genetic diagnosis (Harper et al 1999, 
Bredbacka 2001).
1.8 Concomitant molecular/cytogenetic diagnosis for single 
cells
The information provided from single cell genetic analysis is usually limited 
due to the scarcity of cells available. To increase the scope of single cell 
analysis, techniques have been refined to the demand of certain clinical 
conditions which require multi-purpose diagnosis at both molecular and 
cytogenetic level. These include: cell recycling and WGA/CGH.
1.8.1 Cell recycling
A ‘cell recycling’ procedure combines the two powerful techniques of PCR 
and FISH on a single fixed cell (Thornhill et al 1996). In this procedure, the 
initial PCR analysis takes place on a single cell fixed to a miniature glass 
slide, thus allowing subsequent FISH analysis of that cell (Rchitschy et al 
1996; Figure 1.10).
Using single blastomeres from mouse embryos as a model system, cell 
cycling procedures detected a single-copy mouse beta-hemoglobin gene 
sequence at efficiency of 70% and sex constitution at an efficiency of 74%
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in the same single cell (Thornhill et al 1994). Theoretically, the number of 
detected genes can be further increased if WGA is to be coupled with 
multiplex PCR (He et al 1999).
PCR FISH
Figure 1.10: Schematic illustration of cell recycling on a single cell. A  single cell is 
fixed and marked on a m iniature glass slide in a PCR tube. A fter PCR 
amplification reaction, this single cell is analysed by FISH in order to reveal more 
information.
1.8.2 WGA and CGH
The study of combining WGA and CGH for diverse diagnostic purposes 
from a single cell was first reported in 1999 (Wells et al 1999). Using this 
strategy allows the possibility of analysing a variety of mutations from 
amplified DOP-PCR products. Meanwhile, fluorescent labelling of DOP- 
PCR products could be applied for CGH for detailed chromosome 
analysis.
Apart from DOP-PCR/CGH, Klein used the strategy of ligation-mediated 
PCR/CGH to detect the LOH and mutations from a micrometastatic cancer 
cell in the bone marrow (Klein et al 1999).
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1.9 Comparative genomic hybridisation (CGH)
CGH is a molecular cytogenetic approach with the potential of detecting 
chromosomal imbalances in previously inaccessible specimens as only 
DNA (and not dividing cells) is required for the procedure. Therefore, the 
study of genetic alterations in tumour tissues was greatly enhanced as 
previously the cytogenetic analysis of solid tumour was usually hampered 
by the difficulties involved with cell culturing and interpretation (Kallioniemi 
et al 1992).
CGH allows the detection of chromosomal gains and losses across the 
entire genome and provides a relatively rapid screening method that can 
point at specific chromosomal regions. This may help to understand the 
pathogenesis or progression of the tumors. With more specific molecular 
biological techniques such as FISH, LOH analysis and sequencing, the 
information revealed by the results of CGH can lead to the identification of 
oncogenes or tumor suppressor genes in these regions (Forozan et al 
1997).
1.10 Principles of the CGH technique
In CGH, the green-labelled genomic DNA from tissue samples (test DNA) 
is simultaneously co-hybridised with red-labelled DNA from normal tissue 
(control DNA) on to normal metaphase slides. The green and red labelled 
DNA fragments compete for hybridisation to their locus of origin on the 
metaphase chromosomes. As a result, a general background staining of 
two colours over all the chromosomes is obtained. Chromosomal 
sequences present in additional copies within the test DNA will result in a 
higher green staining at the corresponding chromosomal targeted 
sequences, as compared with the control DNA, while losses of 
chromosomal sequences will result in higher red staining of the 
corresponding target chromosomes. Using dedicated computer software 
for quantitative analysis, the green to red fluorescence ratio is measured 
along the chromosomal axis and represents gain (ratio>1) or loss (ratio<1) 
of the test sample DNA at that specific locus (Figure 1.11).
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Test DNA (Green: FITC)
Normal reference DNA (Red: Rhodamine) 
Human Cot-1 DNA
Comparative genomic 
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Figure 1.11: Schematic illustration of CGH. Green labelled test DNA, red labelled 
normal reference DNA and human Cot-1 DNA are co-hybridised to a normal 
metaphase slide. Images of fluorescence signals are captured and the green to 
red ratio are digitally quantified for each chromosomal locus along the 
chromosomal axis.
1.10.1 Metaphase slides for CGH
Metaphase slides are prepared according to standard protocols using 
PHA-stimulated peripheral blood from normal individuals. The selection of 
high-quality slides is crucial for CGH experiments. Ideal preparations 
should have little cytoplasm, minimal overlapping, low cell density coupled 
with a high mitotic index. Furthermore, the chromosomes should be of 
adequate length and contain no separated chromatids. Under phase 
microscope, these chromosomes should appear relatively dark, because 
shiny and faded chromosomes would result in poor hybridisation 
(Kallioniemi et al 1996).
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It is recommended that several batches of slides are prepared at a time, 
and slides should be tested with known positive and negative control DNA 
samples that have previously worked well in CGH experiments 
(Kallioniemi et al 1994). Despite careful selection, the only certain criterion 
for slide quality is an actual CGH experiment (Kallioniemi et al 1996).
1.10.2 Extraction of DNA for CGH
It is most important to prepare high quality DNA from specimens to be 
tested. DNA extracted from fresh or frozen tissues is usually of high 
molecular weight and will be of the best quality for labelling purposes. In 
the case of tumour specimens, contamination of the tumour DNA with 
normal stromal and inflammatory cells is an inevitable problem. 
Chromosomal aberrations could go undetected if the proportion of 
malignant cells were less than 50%.
DNA from archived, formalin-fixed samples is almost always degraded and 
cross-linked. During the labelling processes by nick translation, the DNA 
becomes even shorter and might be too small for optimal CGH results. 
Recently, improved methods for extracting DNA from formalin fixation and 
paraffin-embedded tissues have been described; however, fresh samples 
are always preferable, because some archival tissues never yield DNA 
that is suitable for CGH analysis (Weiss et al 1999).
1.10.3 Labelling of probes
The labelling of genomic DNA for CGH analysis falls into two categories. 
One involves a flurochrome-conjugated molecule such as FITC-dUTP or 
rhodamine-dUTP for direct detection after hybridisation. Another involves a 
hapten biotin-14-dUTP or digoxingenin-11-dUTP and is detected with 
avidin-FITC or anti-digoxigenin rhodamine. Compared with the indirect 
method, directly conjugated DNA probes provide improved hybridisation 
quality and speed, although the signals are weaker.
Nick translation is the most popular method used to incorporate biotin, 
digoxigenin or flurochromes into probe DNA. This enzyme-mediated
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reaction involves DNase I and DNA polymerase I in the presence of 
dNTPs, with the dTTP being partially reduced by hapten-labelled (or 
flurochromes-labelled) dUTP. The DNase I produces single strand nicks 
in the double-stranded DNA of the probe to expose a free 3’-OH. The 5’ to 
3’ exonuclease activity of DNA polymerase I deletes a mononucleotide at 
the 5’ side of the nick, and catalyses the incorporation of new dNTPs at 
3’OH end of nick. By manipulating the DNase I concentration and reaction 
time, optimal probe size can be achieved, which is important in relation to 
the accessibility of the probe to the target sequences. The digested 
fragments of both test and reference DNA should be in the same range of 
lengths and within the limits of 500-2000 bp. The size distribution can be 
checked by electrophoresis on agarose gels stained with ethidium bromide 
(Weiss et al 1999).
1.10.4 Blocking
When interspersed repetitive sequences (IRS) are present in high- 
complexity probes, these will hybridise to the ubiquitous complementary 
sequences throughout the genome. Signals caused by IRS within a given 
probe can be suppressed effectively by preannealing with unlabelled 
genomic or Cot-1 DNA to the labelled probe before hybridising the probe 
to the target DNA (Lichter et al 1988). This permits only the unique probe 
sequences to bind to their complementary target during the subsequent 
ISH proceedings.
Short repetitive sequences occur throughout the whole genome, but are 
particularly abundant at all centromeres, telomeres, and some specific 
regions such as chromosome arms 1 p, 16p, and chromosomes 19, 22 
(Weiss et al 1999). The lengths of these regions are very variable between 
individuals and this can interfere with CGH analysis. Therefore, unlabelled 
human Cot-1 DNA is added to suppress the binding of labelled repetitive 
sequences from the genome of both the test and reference probes to the 
centromeric and repetitive regions of the chromosomes (Weiss et al 1999). 
Cot-1 DNA is prepared from human placental DNA which, with a size from
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50-100 bp, is rich in repetitive DNA sequences. In CGH analysis, true 
variations in the fluorescence signals in the regions of interest can only be 
analysed after the repeated sequences are blocked. Inadequate 
suppression of the repetitive sequences can interfere with the true signal 
intensity, and lead to a reduced amplitude of the fluorescence ratio; hence 
true chromosomal gains and losses may go undetected (Weiss et al 
1999).
1.10.5 Pre-hybridisation
The CGH protocol is similar to the method described for FISH with painting 
probes. Equal amounts of test and reference DNA (100ng-1pg) are 
pooled together with 100 times the same amount of human Cot-1 DNA, 
precipitated, and re-suspended in hybridisation. Formamide, in the buffer 
solution, decreases the melting temperature of the DNA, while dextran 
sulfate increases the effective probe concentration (Weiss et al 1999).
In practice, opposite sex test and reference DNAs are used. The resulting 
uneven fluorescence ratio for the X chromosome functions as an extra 
control of the quality of the CGH experiments. However, additional sex 
matching should be taken into consideration when analysing the X 
chromosome (Weiss et al 1999).
1.10.6 Denaturation of metaphase slides and probes
Hybridisation between single-stranded DNA molecules forms the basis of 
the use of DNA probes to detect specific sequences in tissue samples. 
The specificity of the annealing reaction can be adjusted by altering the 
temperature and/or pH. In CGH, the chromosomes require sufficient 
denaturation to permit accessibility of labelled probes, while still retaining 
the chromosomal morphology for identification purposes. The probe and 
the normal metaphase slides are denatured separately, and this is carried 
out at 70-76°C for 2-10 minutes in 70% formamide/2XSSC solution. To 
produce optimal CGH results, it is important to test each slide batch at 
various denaturation conditions (Weiss et al 1999).
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1.10.7 In situ hybridisation and DAPI staining
The hybridisation takes place under a coverslip in a humid incubator at 37- 
40 °C for 2-4 days. The exact time of hybridisation is not critical for optimal 
results. Hybridisation over 3 days is acceptable as long as the 
hybridisation mix does not dry out. Overnight hybridisation has been found 
not to be as homogeneous as when carried out for 2-3 days. After 
hybridisation, the slides are washed and counterstained with DAPI in an 
antifade solution. DAPI staining provides a banding pattern similar to that 
of quinacrine banding for chromosomal identification and karyotyping. The 
optimal concentration of DAPI in antifade may vary with slide batches or 
with the microscope used. Staining should be bright enough to permit easy 
band detection but not so bright as to obscure the bands (Weiss et al 
1999).
1.10.8 Hardware and software requirements for CGH anaylsis
To complete both qualitative and quantitative analysis of CGH 
experiments, hardware for image acquisition and software for fluorescence 
ratio measurement are required (Du Manoir et al 1995a; Piper et al 1995).
1.10.8.1 Image capture
Fluorescent molecules absorb light and release energy in the form of light 
and heat. Because some energy is lost as heat, the average wavelength 
of emitted fluorescence is longer than the average excitation wavelength 
for any given fluorochrome.
Visualisation of fluorescence signals is carried out with a fluorescence 
microscope equipped with a mercury lamp, appropriate excitation and 
emission filter sets and camera. The acquisition of images is carried out 
firstly by scanning the entire slide for the best metaphase spreads. The 
metaphases are selected based on the following criteria: homogeneous 
hybridisation signals across each chromosome, similar chromosome 
length, low background noise, adequate suppression over centromeres
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and heterochromatic regions, proper DAPI banding for chromosome 
identification. For each sample, around ten metaphases are captured for 
digital processing.
Selection of proper filters is important since cross-talk between different 
fluorochromes can occur which will bias CGH ratio measurements. Filter 
sets for the often used DAPI/TRITC/FITC fluorochromes combination are 
commercially available now, and optical shift becomes negligible if either a 
computer-controlled filter wheel or microscopes with an automatic filter 
change are used for image acquisition. CGH images are captured by a 
cooled CCD (charged coupled device) camera, which although not 
necessary, has advantages including digital readout, high spatial 
resolution, high sensitivity, low noise and high dynamic range (Du Manoir 
S et al 1995b). Some CGH systems used a simpler and cheaper video­
rated camera which is sufficient for CGH analysis (Du Manoir et al 1995a).
1.10.8.2 Image processing
Visual analysis of CGH is limited by the subjectivity and poor sensitivity of 
the human eye in detecting small colour intensity or intensity ratio 
differences. In practice, only high-level amplification can be reliably 
evaluated without digital processing. For detailed CGH copy-number 
karyogram analysis, the captured images must be software-processed. 
Current dedicated CGH software should enable the following steps to be 
carried out (Piper et al 1995):
(1) background removal
(2) segmentation and removal of non-chromosomal objects
(3) normalization of the FITC: rhodamine ratio for the whole metaphase
(4) interactive karyotyping
(5) interactively position the centromeres correctly and scale the 
chromosomes to a standard length.
After processing, the total fluorescence for green and red is measured for 
each separate image and equalised to a fluorescent ratio (FR) of 1.0. This 
allows subsequent integration of data from several different metaphase
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images and identification of chromosomal regions showing abnormal FR 
for that test sample. The average FR of several selected metaphases are 
depicted along the idiograms of corresponding chromosomes, presenting 
chromosomes that are more green (chromosome gains) or red (losses)
The interpretation of the ratio profiles, at a locus or an entire chromosome 
arm, can be done using fixed or statistical thresholds. Fixed limits of 1.15- 
1.25 and 0.75-0.85 can be used to identify chromosome gains and losses 
respectively, while others use the 95% confidence interval (Cl) limits of the 
ratio profile. In the latter, deviations from normal are interpreted when the 
95% Cl of the fluorescence ratio does not contain 1.0. Fixed thresholds do 
not take account the variation of ratio values between different 
experiments, different metaphases of the same slide and even different 
chromosome regions. Calculation of statistical confidence limits may 
improve the interpretation of CGFI profiles (Moore et al 1997; Kirchhoff et 
al 1998).
Idiogram Ratio value 1.0 line
(Fig 1.12).
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Figure 1.12: Ratio profile with selected displayed options
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1.10.9 Limitations of CGH
There are varying estimates regarding the smallest size of low-copy- 
number gains or losses that can be detected reliably by CGH. According to 
simulation experiments, the total amount of DNA of increased or 
decreased copy number smaller than 2Mb is considered as unlikely to be 
detected (Piper et al 1995; Parente et al 1997). Based on CGH 
experiments, this technique can detect genetic imbalances with estimated 
size of 10-20 Mb (Kalliomiemi et al 1994; Bentz et al 1995).
CGH cannot however detect the following genetic aberrations (Kalliomiemi 
et al 1994): (1) balanced structural aberrations such as balanced 
translocations, inversions (2) small intragenic rearrangements and point 
mutations (3) ploidy changes (4) pericentromeric and heterochromatic 
regions (5) low level mosaicism (>50% normal cell contamination).
1.11 Applications of CGH
1.11.1 Application for cancer cytogenetics
By using techniques such as microdissection and whole genome 
amplification, CGH can be applied to minute quantities of DNA. This has 
allowed studies using archival formalin fixed and paraffin-embedded 
materials whereas previously only DNA from fresh and frozen tumors 
materials could be used (Hermsen et al 1996; Kuukasjarvi et al 1997; 
Ozcan et al 2000).
CGH is a powerful tool to identify chromosomal aberrations in 
precancerous conditions and to study tumour progression and clonal 
evolution (Forozan et al 1997). The interpretation of CGH could also be 
used as a supplement to tumour staging and prognosis prediction 
(Forozan et al 1997; Yutaka et al 2000). Heselmeyer et al found that gain 
of 3q was consistently detected when severely dysplastic uterine cervical 
cells progressed into invasive cancer (Heselmeyer et al 1996).
Combining laser capture microdissection and DOP-PCR/CGH, small 
samples (consisting 3-40 cells) out of routinely processed and 
Papanicolaou-stained cervical smears could be accurately analysed
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(Aubele et al 1998). This may help in the understanding of the progression 
of cervical cancer, especially for low grade lesions, and lead to future 
revised classification of high and low grade cervical intraepithelial 
neoplasm (CIN) lesions (Aubele et al 1998).
1.11.2 Application for early embryo development
Although a high incidence of mosaicism is acknowledged in early embryo 
cells using a FISH technique, the comprehensive study of every 
chromosome requires the use of CGH or multicolour FISH (Delhanty et al 
1997). Using DNA amplified from a single blastomere, CGH is able to 
provide comprehensive analysis of the diploid set of human chromosomes. 
This will shed light on the mechanisms underlying the unprecedented 
levels of chromosomal mosacisms reported in human embryos at the 
cleavage stage (Wells et al 1998).
Recently, two WGA methods (i.e. DOP-PCR and ligation-mediated PCR) 
used in three different centres have reported reliable single cell CGH 
(Wells et al 1999, 2000; Vollaire et al 1999, 2000). The data demonstrate 
75% chromosomal aberrations in early embryo cells (Voullaire et al 2000; 
Wells et al 2000).
1.11.3 Application for clinical cytogenetics
CGH was developed initially for cancer studies; however, it has been used 
as a supplementary diagnostic tool more recently for a number of clinical 
cytogenetic applications such as detection of euchromatic involvement in 
marker chromosomes, characterization of complicated unbalanced 
chromosome rearrangements, cryptic telomeric translocation screening 
and studies of aneuploidies in spontaneous abortion and stillbirth (Du 
Manoir et al 1993; Bryndorf et al 1995; Ghaffari et al 1998a, 1998b; 
Daniely et al 1998, 1999).
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1.12 Aims of the project
The overall aim of the present study was to develop the genetic analytical 
techniques using nested PCR, whole genome amplification (WGA) and 
comparative genomic hybridisation (CGH) on a single cell. Specific aims 
included:
1. Optimisation of two sets of nested PCR for the diagnosis of sex and 
cystic fibrosis.
2. Establishment of a single cell manipulative model and of 
contamination control.
3. Whole genome amplification from a single cell.
4. Optimisation of single cell CGH.
5. Application of single cell CGH on 10-20 stained cells.
6. Application of the DOP-PCR/CGH technique on coded samples.
7. Investigation of the potential of multiple-purpose diagnosis using 
nested PCR/DOP-PCR/CGH.
8. Investigation of the feasibility of a short protocol for single cell CGH.
9. Application of nested PCR and CGH on single blastomeres.
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Chapter 2
Materials and Methods
2.1 Samples
The single cells used in this study included amniocytes, buccal cells, and 
lymphocytes. Amniocytes was supplied by the Clinical Cytogenetics 
Laboratory of the Medical Genetics Department, Yorkhill, NHS Trust. 
Cultured amniocytes had been treated with trypsin and the cell 
suspensions were used for retrieval of a single cell. The remaining cells 
were stored in a tube and frozen in a -60°C freezer. Frozen cells might be 
thawed and retrieved again, if the initial experiment failed. The karyotypes 
of amniocytes included: normal males, females, and common aneuploidies 
(e.g. trisomy 18, 21 and sex chromosome aberrations).
At an early stage of this study involving the single cell retrieval technique, 
buccal cells prepared from mouthwashes were used. These cells received 
several washes in PBS solution in order to remove the debris. 
Lymphocytes, which had been treated with fixative (i.e. 3 methanol/1 
acetic acid), were also used for the retrieval of a single cell. These cells 
were stored in the fixative at 4°C for periods of one week to several weeks. 
The sources of stained cells were from both amniocytes and lymphocytes. 
These cells were microdissected from G-banded slides. After the 
procedure, the slides were stored in a sealed box in a -60°C freezer for 
recycling use if further experiments were indicated. The karyotypes of 
these samples included: normal males, females, and common numerical 
aneuploidies (e.g. trisomy 18, 21) To test the reliability of CGH, a number 
of samples were coded for use in ‘blind’ testing.
Blastomeres were supplied by in vitro fertilisation unit of Glasgow Royal 
Infirmary. These samples were received frozen and subsequent 
experiments were carried out within 1-4 week(s). Each PCR tube (250 pi) 
contained 1-5 blastomeres in 10 pi lysis buffer. Some tubes contained only 
Tyrode acid solution or water and were used as negative controls.
2.2 Single cell manipulation
The micropipettes were hand-prepared from Pasteur pipettes using a 
burner. By applying proper forces, the micropipettes were produced with
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appropriate shape and diameter. For single cell transfer, 30-50 
micropipettes were made each time.
Before a single cell manipulation, several droplets containing 50 pi of PBS 
solution were put on a sterilised Petri-dish to perform serial dilution of the 
amniocytes and wash off any lysed DNA (Figure 2.1). Single cell 
suspension was then transferred to a sterilised Petri-dish by using heat- 
pulled glass micropipettes which were newly prepared. For each transfer, 
a new micropipette was employed to prevent the residual cells or lysed 
DNA coating the walls of the micropipettes and carrying over into the next 
manoeuvre.
The presence of a single amniocyte could be confirmed under an inverted 
microscope. To eliminate any lysed DNA, this single cell received a further 
wash. It was then transferred to a PCR tube (250 pi) containing 10 pi lysis 
buffer. Two pi of the final washing solution was used as a negative control 
to ensure that there was no extraneous DNA contamination.
2.3 Microdissection of stained cells
G-banded slides, which had never been covered and sealed, were used 
for microdissection. Clusters of 10-20 stained interphase cells were 
scraped using a sterile needle (Microlance®, 23G, Becton Dickinson, 
Spain). The scraped cell clumps were checked under a microscope and 
then carefully transferred to a PCR tube containing 10 pi of lysis buffer. 
The tip of the needle was inspected again to make sure there were no 
remaining cells. To increase the success rate, 2-3 transfers were carried 
out for each case with a change to a new needle for each transfer. By 
using a new needle to touch an area without cells, a sham microdissection 
was used as a negative control.
To test the tolerance of cell contamination in single cell CGH, a series of 
manufactured mosaicism (50-70%) was made. For a manufactured mosaic 
at the 70% level, the stained cells were prepared from 14 male trisomy 18 
cells and 6 normal female cells.
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Figure 2.1: Schematic illustration of single cell retrieval technique. A series 
of washes were carried out to remove the lysed DNA and decrease the 
number of cells. Single cell retrieval was eventually confirmed under 
inverted microscope. After retrieval of a single cell, the remaining PBS 
washing solution was used as a negative control to demonstrate the 
absence of extraneous DNA.
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2.4 Lysis methods for single cells
Reagents:
For single amniocyte
20 mM Tris-HCI, pH 9.3 
3 mM MgCI2 
100 mM KCI, pH 8.3
0.5 mg/ml proteinase K
For stained cells
100 mM Tris-HCI, pH 7.5 
1 mg/ml of proteinase K
Procedure:
1. In the case of fresh cells, incubate at 55°C for 1 hour in a PCR 
cycler (OMN-E, Hybaid). For stained cells, the time is increased to 
1-2 days.
2. Incubate at 95 °C for 10 minutes to inactivate proteinase K.
2.5 Primer synthesis and de-protection
The primers were synthesised by a Synthesizer PCR-MATE (Applied
Biosystem) and required de-protection processes:
1. Connect a polypropylene syringe containing 1 ml of ammonium 
hydroxide (40 mM) to the end of the column (primer).
2. Attach an empty syringe to the other end.
3. Gently push the ammonium hydroxide through the column; 
consequently the barrel of the syringe was displaced.
4. Push ammonium hydroxide back and forth through the column, 2-3 
times, for 2-3 hours. The column should be filled with liquid, which 
will decolourise from yellow to white.
5. Withdraw the ammonium hydroxide and transfer into a small Nunc 
tube.
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6. Add ammonium hydroxide up to 2 ml, tighten the cap and incubate 
in a 55°C water bath overnight.
7. Store at -70°C.
To work with primers, 200 pi of primer stock was transferred to a 500 pi 
PCR tube and left in a fume hood overnight.
2.6 Extraction of genomic DNA
Reagents:
RBC lysis solution
155 mM Ammonium Chloride 
10 mM Potassium Hydrogen Carbonate 
1 mM EDTA 
Cell lysis solution
25 mM EDTA 
2% SDS
Proteinase K (20 mg/ml, Gibco BRL)
Protein precipitation
10 M Ammonium Acetate 
Isopropranol 
Ethanol (70% v/v)
TE buffer
10 mM Tris-HCI pH 8.0 
1 mM EDTA
Procedure:
1. Add 3 volumes cold RBC lysis solution to one volume of whole 
blood.
2. Invert the sample several times to mix and keep at room 
temperature for 20 minutes before centrifuging at 2000 g for 7 
minutes.
3. Discard the supernatant, leaving visible white cell pellet and 10-20
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|j| of residual fluid.
4. Re-suspend cell pellet by vortexing. Add one volume of cell lysis 
solution, and vortex again.
5. Add 1/3 volume of protein precipitation solution. Vortex and 
centrifuge at 3000 g for 20 minutes.
6. Transfer supernatant to clean tube containing 1 volume isopropanol 
and mix thoroughly to form DNA precipitate.
7. Spool out DNA using sealed Pasteur pipette and wash in 70% 
ethanol.
8. Dry the DNA pellet and dissolve in an appropriate volume of TE 
buffer or distilled water.
2.6.1 Measurement of DNA concentration
The concentration of the DNA was measured by optic density at A260 nm in 
a spectrophotometer. 5 pi of DNA were added to a tube containing 995 pi 
dH20, and mixed well by vortexing. The concentration was measured by 
following the formula below:
Concentration = OD A260 x 200 (dilution factor) x 50 ng/pl
50: a constant corresponding to 50 pg DNA per ml at 260 nm per 1 unit
OD.
Once the concentration of DNA was determined by spectrophotometry, a 
series of DNA dilutions were prepared by adding distilled water to the 
extracted genomic DNA. The diluting process was repeated to a single cell 
level which was estimated to be around 2-7 pg. Instead of using a single 
cell, the diluted DNA was applied in order to test and optimise the PCR 
protocols. The concentration of diluted DNA, together with the sex and 
other information, were noted and the samples stored in separate 
containers from other reagents at -60°C.
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2.7 Primer extension preamplification (PEP)
Reagents:
10X PCR buffer (Boehringer Mannheim)
25 mM MgCI2 
500 mM KCI
100 mM Tris HCI (pH 8.3)
1 mg/ml Gelatin
10X nucleotide mixture (Boehringer Mannheim)
2 mM of each dNTP (dATP, dGTP, dCTP, dTTP) 
10X primer (4 mM): random 15-mer oligonucleotides 
Distilled water
Taq polymerase (5 U/pl, Boehringer Mannheim)
Procedure:
PEP on individually isolated cells was carried out as the method described 
previously (Zhang et al 1992).
Thermal cycling conditions:
50 cycles 92°C 1 minute
37°C 2 minutes
(37°C-55°C transition at rate of 10 sec/°C)
55°C 4 minutes
A short PEP protocol was carried out as the method described by Sermon 
(Sermon et al 1996):
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Thermal cycling conditions:
50 cycles 92°C 15 seconds
37°C 30 seconds
(37°C-55°C transition at rate of 6.6 sec/°C)
55°C 2 minutes
2.8 DOP-PCR
DOP-PCR on individually isolated cells was performed as previously 
reported (Telenius et al 1992a). The master mix of the PCR reaction was 
added to a final volume of 50 pi in a tube containing 2 pM of degenerate 
primer, 0.2 mM dNTPs, 1.5 mM MgCI2, 50 mM KCI, 10 mM Tris-HCI, pH 
8.3, 2.5 U Taq enzyme (Boehringer Mannheim) and overlaid with 50 pi 
mineral oil.
Reagents:
10X PCR buffer with 15 mM MgCI2 (Boehringer Mannheim) 
10X nucleotide mixture (Boehringer Mannheim)
10X 6MW primer 20 pM
5’-CCGACTCGAGNNNNNNATGTGG-3’
DNA polymerase 1 U/pl (Boehringer Mannheim)
Distilled water
E x p a n d e d ™  High Fidelity (EHF) PCR System
Polymerase mix 0.8 pi (2.7U/pl, Boehringer Mannheim)
10X EHF buffer (15-40 mM MgCI2)
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Procedure:
The amount of reagents added was as follows:
DNA samples (single cell in lysis buffer) 12 pi
10X PCR buffer 5 pi
10X dNTP 5 pi
DOP primer 5 pi
Taq polymerase 2.5 pi
Distilled water 20.5 pi
Thermal cycling conditions:
1 cycle 95 °C 5 minutes
8 cycles 94 °C 1 minute
30 °C
30°C-72°C transition in 3 minutes
1 minute
72°C 3 minutes
28 cycles 94 °C 1 minute
56 °C 1 minute
72 °C (with an increment of 1 sec/cycle) 3 minutes
1 cycle 72°C 10 minutes
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2.8.1 PCR labelling
To prepare probes for CGH, 5 pi of the first DOP-PCR amplified DNA was 
transferred to a second tube where a PCR identical to the first except for 
reduction of the dTTP concentration to 0.15 mM, 4 mM MgCI2 and 
inclusion of 2 pi of Flurorescent-11-dUTP (Amersham) was carried out.
Thermal cycling conditions:
20 cycles 95°C 
56°C 
72°C
1 cycle 72°C
2.9 Nested PCR for sex determination 
Reagents
10X PCR buffer with 15 mM MgCI2 (Boehringer Mannheim) 
10X nucleotide mixture (Boehringer Mannheim)
10X first round PCR primer sequences (1 pM)
AMG 3: 5 -CTT CCC AGT TTA AGC TCT GAT G-3 
AMG 4: 5 -CCT TGC TCA TAT TAT ACT TGA C-3 
Second round PCR primer sequences (4 pM)
AMG 5: 5 -CTC AGG GAG GTT CCA TGA-3 
AMG 6: 5 -TGA GAA AAC CAG GGT TCC-3 
Distilled water
1 minute 
1.5 minutes 
3 minutes 
10 minutes
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Procedure:
1. Nested PCR was performed as previously reported (Schaaff et al 
1996). For the first round of PCR amplification, the master mix of 
the reaction was added to a final volume of 25 pi in a tube 
containing 0.1 pM of first round PCR primer, 0.2 mM dNTPs, 1.5 
mM MgCI2, 50 mM KCI, 10 mM Tris-HCI, pH 8.3, 1.5 U Taq enzyme 
(Boehringer Mannheim).
2. Both first and second round PCR were carried out in an oil-free 
environment, which required a hot-lid thermal cycler (OMN-E, 
Hybaid). Alternately, commercial Ready-To-Go™ PCR Bead 
(Amersham phamacia biotech) could be used for the PCR 
amplification. In this method, the final volume was 25 pi and only 
primers and template DNA were added as the beads contained all 
other reagents which were required in a PCR reaction.
The reagents used in a Ready-To-Go™ PCR tube contained:
DNA template 5 pi (first round)
1 pi (second round)
Primers 2.5 pi
Distilled water 17.5 pi (first round)
21.5 pi (second round)
Ready-To-Go™ PCR Bead 1 tube
The amount of reagents added in the first round of nested PCR:
DNA samples (DOP-PCR products) 5 pi
10x PCR buffer 2.5 pi
10xdNTP 2.5 pi
First round PCR primer 2.5 pi
Taq polymerase 1.5 pi
Distilled water 11 pi
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Thermal cycling conditions of first round PCR:
1 cycle 95°C 5 minutes
25 cycles 94 °C 30 seconds
52 °C 1 minute
72°C 1 minute
1 cycle 72°C 10 minutes
The amount of reagents added in the second round of nested PCR:
DNA template (first round PCR product)
10X PCR buffer 
10X dNTPs
Second round PCR primers 
Taq polymerase 
Distilled water
Thermal cycling conditions of second PCR:
1 cycle 95 °C 5 minutes
30 cycles 94 °C 30 seconds
56 °C 30 seconds
72 °C 1 minute
1 cycle 72°C 10 minutes
2.10 CF AF508 mutation detection
For detection of CF mutation AF508, 5pl of DOP-PCR products were 
added to two different AF508 mutation detection methods.
The first one was modified from a method used in the Clinical Molecular 
Genetic Laboratory in Yorkhill NHS Trust.
1 pi
2.5 pi
2.5 pi
2.5 pi
1.5 pi 
15 pi
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Reagents:
2 mM dNTPs 2.5 pi
10X PCR buffer (25 mM MgCI2) 2.5 pi
Primer 1 (10 pM) 1.5 pi
5 -GTTTTCCTGGATTATGCCTGGCAC-3 
Primer 2 (10 pM) 1.5 pi
5 -GTTGGC ATGCTTT GAT G ACGCTT C-3 
Template DNA 5 pi
Taq polymerase (1 U/pl) 1.5 pi
Distilled water Up to 25 pi
Thermal cycling conditions:
1 cycle 94 °C 2 minutes 30 seconds
58 °C 30 seconds
72°C 30 seconds
40 cycles CO o o 30 seconds
58 °C 30 seconds
72°C 30 seconds
1 cycle 72°C 10 minutes
A strategy of nested PCR was used as an alternative approach, which had 
been described previously (Scobie et al 1996).
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Reagents
2 mM dNTPs
10X PCR buffer with 15 mM MgCI2 
Taq polymerase (1 U/pl)
10X first round PCR primer sequences (1 pM)
Primer for Exon 10
5 -AAGT GAATCCT GAGCGT GATTT GATAAT GA -3 
5 -CACAGTAGCTTACCCATAGAGGAAACATAA-3 
10X second round PCR primer sequences (4 pM)
Common: 5 -G ACTT CACTT CTAAT GAT GATTATGGG AG A-3 
Normal: 5 -GTATCTATATTCATCATAGGAAACACCAC-3 
Mutated: 5 -GTATCTATATT CAT CATAG G AAAC AC C ATT -3 
Tube N: contained common and normal primers 
Tube M: contained common and mutant primers 
Distilled water
Procedure:
1. For detection of AF508, 5 pi of DOP-PCR product was added to a 
PCR bead tube containing 0.1 pM external primers (Exon 10).
2. For secondary PCR, 1 pi of first PCR product was transferred to 
tube N (containing a pair of common primer and normal primer, 
each at 0.1 pM) and tube M (containing a pair of common and 
mutant primer, each at 0.4 pM).
Thermal cycling conditions of first round PCR:
25 cycles 94 °C 1 minute
55 °C 30 seconds
72°C 30 seconds
One cycle 72°C 10 minutes
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Thermal cycling conditions of second round PCR:
30 cycles 94 °C 
60 °C 
72°C
1 minute
30 seconds
30 seconds
2.11 Prevention and monitoring of contamination
A number of guidelines were employed to monitor and prevent
contamination:
1. All reagents and PCR tubes were sterilised.
2. Ultraviolet irradiation of the master mix for 15-20 minutes prior to PCR 
amplification.
3. Used barrier tips throughout whole experiments (except analysing 
PCR products) to prevent aerosol contamination
4. Master mix was made with a new set of micropipettes which were 
never in contact with genomic DNA.
5. The PCR products were analysed with separate micropipettes in a 
separate location.
6. The master mix was prepared in a safety cabinet and the working area 
was cleaned with 70% ethanol before preparation. If contamination 
was suspected, the whole batch of master mix for PCR was discarded.
7. The DNA samples and reagents were kept in separate places.
8. Lab coat, gloves, and mask were worn whenever single cells were 
manipulated.
i*
2.12 Purification of PCR products
To remove the excess of degenerate primers, dNTPs, and salts, further
purification of DOP-PCR products was carried out by using a ‘High Pure
PCR Product purification Kit’ (Boehringer Mannheim).
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Reagents:
Binding buffer
3 M guanidine-thiocyanate 
10 mM Tris-HCI
5% ethanol (v/v), pH 6.6 (25 °C)
Wash buffer
20 mM NaCI
2 mM Tris-HCI, pH 7.5 (25 °C)
Elution buffer
10 mM Tris-HCI 
1 mM EDTA, pH 8.5 (25 °C)
High Pure Filter tube 
Collection tube
Procedure:
1. Add 500 pi binding buffer to a 50 pi PCR reaction and mix well.
2. Combine the High Pure filter tube and the collection tube and 
transfer sample to the upper reservoir.
3. Centrifuge for 30 seconds at maximum speed.
4. Discard the flow through and combine the filter tube again with the 
same collection tube.
5. Add 500 pi wash buffer to the upper reservoir and centrifuge for 30 
seconds at maximum speed.
6. Discard the wash buffer flow through and combine the filter tube 
again with the same collection tube. Add 200 pi wash buffer, and 
centrifuge as step 3.
7. Discard the collection tube and insert the filter tube in a clean 1.5 ml 
reaction tube.
8. Use 25-50 pi elution buffer or redistilled water for the elution of 
DNA. Add elution buffer or water to the filter tube and centrifuge at 
maximum speed for 30 seconds.
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2.13 Analysis of PCR products
2.13.1 Agarose gel analysis
Reagents
Loading mix
0.25% bromophenol blue
0.25% xylene cyanol 
40% sucrose
Agarose gel
1.5% (0.75 g/50 ml TBE buffer)
10XTBE buffer (pH 8.3)
108 g Tris 
55 g boric acid
9.3 g EDTA
Up to 1000 ml distilled water 
Ethidium bromide (10 mg/ml)
Procedure:
1. Weigh out 0.75 g of agarose and add to 50 pi TBE buffer.
2. Dissolve by heating in a microwave oven.
3. Allow to cool to 70°C, then add 1 pi of ethidium bromide to the 
dissolved agarose solution inside the fume hood.
4. Pour the gel onto the gel-casting unit.
5. Mix 5 pi of reaction products with 1 pi loading mix and load on the 
gel.
6. Run the gel at 15 V/cm for 30 minutes and take photographs under 
ultraviolet illumination (UVP Imagestor 5000).
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2.13.2 Polyacrylamide gel analysis
Reagents:
Distilled water 
40% stock acrylamide
30 ml
12.5 ml
7.5 ml 
250 Ml 
50 pi
5XTBE
10% APS (Ammonium persulphate) 
Temed
Procedure:
1. Assemble the glass plates and spacers (1mm) for pouring the gel 
on gel forming tray. The glass plate must be free of grease spots to 
prevent air bubbles from forming in the gel.
2. Prepare gel mix.
3. Add the mixture to gel set-up and immediately insert the 
appropriate comb.
4. Allow the acrylamide to polymerise for 60 minutes at room 
temperature.
5. Carefully remove the comb. Immediately rinse out the wells with 
water.
6. Attach the gel to the gel tank. The notch plate should face inward 
toward the buffer reservoir.
7. Fill the reservoirs of gel tank with 1XTBE.
8. Add 2 pi of loading mix to each sample. Load 8 pi of each sample 
and a molecular weight marker
9. Run the gel until the marker dyes have migrated the desired 
distance.
10. Gently dismantle the gel and submerge the gel in ethidium bromide 
solution for 30-45 minutes. Photograph the gel under ultraviolet 
illumination.
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2.13.3 Silver staining of polyacrylamide gels 
Reagents:
Solution 1: 10% ethanol + 0.5% acetic acid 
Solution 2: 0.1% silver nitrate 
Solution 3: 1.5% NaOH + 0.1% formaldehyde 
Solution 4: 0.75% Na2C03
Procedure:
1. Assemble a mini-polyacrylamide gel cast (1 mm thick) using a 
modified RunOne system (Embi Tec, San Diego, USA).
2. Pour the mixture (10% polyacrylamide gel was made by adding 3 
ml 40% acrylamide, 8.9 ml 1XTBE buffer, 12 pi Temed and 120 pi 
APS) into the cast.
3. Allow the acrylamide to polymerise for 60 minutes at room 
temperature.
4. Add 2 pi of loading mix to each sample. Load 5 pi of each sample 
and a molecular weight marker.
5. Run the gel until the marker dyes have migrated the desired 
distance.
6. Submerge the gel in solution 1 for 5 minutes on a shaker.
7. Repeat step 6.
8. Submerge the gel in solution 2 for 15 minutes.
9. Remove the gel and rinse quickly with two changes of distilled 
water.
10. Submerge the gel in solution 3 for 20 minutes.
11. Submerge the gel in solution 4 for 10 minutes.
12. Remove the gel and seal in a plastic bag. Photograph the gel 
immediately.
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2.14 Culture techniques and chromosome preparation from 
peripheral blood
2.14.1 Peripheral blood culture 
Reagents:
Iscoves medium (Imperial Lab Prod.)
Heparin (5000 units/ml, LEO Laboratory)
Glutamine (Gibco BRL)
PHA (Gibco BRL)
Penicillin/Streptomycin
(100 U/ml and 100 pg/ml, respectively, Gibco 
BRL)
Procedure:
1. Add 0.5 ml of heparinised whole blood to 4.5 ml of culture medium 
using aseptic technique.
2. Mix the contents of each culture tube by gently inverting several 
times.
3. Incubate for 72 hours with tubes tilted at 45 degree in a humidified 
37°C incubator.
2.14.2 Harvesting 
Reagents:
Colcemid (Gibco BRL)
Hypotonic solution 
Fixative solution
Procedure:
1. Initiate harvest by adding 0.1 ml Colcemid. Mix by gently shaking 
the tube and incubate at 37°C for 45 minutes.
10 pg/ml 
75 mM KCI
3 methanol/1 acetic acid
100 ml 
1 ml
1 ml
2 ml 
1 ml
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2. Centrifuge the tube at 1200 rpm for 7 minutes. Discard the 
supernatant using pipette into a container of 10% Chloros.
3. Add 10 ml of 75 mM KCI (pre-warmed at 37°C) and gently re­
suspend pellet.
4. Incubate the tube at 37°C for 10 minutes.
5. Centrifuge the tube at 1200 rpm for 7 minutes. Then discard the 
supernatant into a container of 10% Chloros.
6. Re-suspend the pellet by adding 10 ml of fresh fixative.
7. Centrifuge the tubes at 1200 rpm for 7 minutes and remove the 
supernatant.
8. Re-suspend the pellet in 10 ml of fixative. Centrifuge the tube at 
1200 rpm for 7 minutes and remove the supernatant.
9. Re-suspend the pellet by adding 5 ml of fresh fixative and place the 
tube in the freezer (+4°C) for a minimum 30 minutes.
10. Centrifuge the tube at 1200 rpm fro 7 minutes and remove the 
supernatant.
11. Re-suspended the pellet in 1 ml of fresh, cold fixative to produce a 
light milky suspension.
12. Prepare slides and analyse chromosome spreads
2.14.3 Slide preparation
1. Clean microscope slides by soaking in Decon® overnight and 
rinsing with running water for at least 2 hours. Store the clean slides 
in 70% ethanol.
2. Remove the slides from ethanol and rinse with running water until 
the ethanol has gone and a thin, uniform film of water covers the 
slides. Keep the slides in water at +4°C at least for 30 minutes.
3. Centrifuge the tubes containing the cell suspension at 1200 rpm for 
8 minutes and discard the supernatant, re-suspend the pellets in
0.5-1 ml of fresh cold fixative solution. Place 3-4 drops of the cell 
suspension onto cold grease-free, wet slides.
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4. For G-banding, place the slides on a hotplate to dry and evaluate 
under a light microscope (phase contrast). For CGH, allow the 
slides to air dry.
2.14.4 G-banding 
Reagents:
Trypsin solution
Difco trypsin (1:250) 1 . 2  g
Sorenson’s Buffer 1 0 0 0  ml
Sorenson’s Buffer
Distilled water 1 liter
Disodium dihydrogen phosphate 9.48 g
Potassium dihydrogen phosphate 9.08 g
Staining solution
Leishmans powder 3g
Methanol Up to 2 liters
Filter this solution before use. For staining
purpose dilute this solution with buffer (pH
6 .8 ) in the ratio 1 part stain to 3 parts buffer.
Procedure:
1. Age the slides by placing them in a dry oven at 80°C for two hours.
2. Immerse the slides in trypsin solution for 10-15 seconds.
3. Rinse with saline and stain with Leishmans solution for two minutes.
4. Place the slides on the hotplate to dry.
2.15 Comparative Genomic Hybridisation
To validate the feasibility of CGH in analysing a single cell, the CGH 
experiments were first carried out by using samples from single 
amniocytes of numerical aneuploidy (e.g. trisomy 18 and trisomy 2 1 ) while 
the reference DNA was from normal individuals of the opposite sex. 
Further experiments were carried using 10-20 stained cells scraped from
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G-banded slides. To test the sensitivity and reliability of single cell CGH, a 
number of samples were coded in order to be analysed blind (the sex was 
known).
To rule out the metaphase factor, two hybridisation reactions were 
performed simultaneously on the same slide. On one area the CGH was 
carried out using probes which had previously worked well. To test the 
efficiency of probes prepared from single cells, some experiments used 
one-colour hybridisation prior to the real 2-colour CGH experiment. 
Throughout the study period, CGH experiments were carried out using 
various sources of test and reference DNA. The test and reference DNAs 
were prepared from either non-amplified DNA (i.e. total extracted DNA) or 
amplified DNA (i.e. whole genome amplification from single cells) (Table 
2 .1).
Test DNA Labelling method Reference DNA Labelling method
4Total genomic DNA Nick translation Total genomic DNA Nick translation
Total genomic DNA Vysis Total genomic DNA Vysis
*MPE 600 Vysis Total genomic DNA Vysis
Amplified DNA PCR or Amplified DNA PCR or
(1 cell) nick translation (one cell) nick translation
Amplified DNA PCR Amplified DNA PCR
(1 cell) (10-20 cells)
Amplified DNA PCR Total genomic DNA Vysis
(1 cell)
Amplified DNA PCR Amplified DNA PCR
(10-20 stained cells) (10-20 cells)
Amplified DNA PCR Total genomic DNA Vysis
(10-20 stained cells)
Amplified DNA PCR Total genomic DNA Vysis
(1 blastomere)
Table 2.1: The combination of test and reference DNA used in CGH experiments. 
Labelling methods were noted to the right of the test DNA and reference DNA 
respectively.
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The painting probes were labelled by either the method of nick translation 
or PCR. Commercial kits were also employed as positive or negative 
controls. The SpectrumGreen MPE 600 (Vysis) was used as a positive 
CGH control to verify the hybridisation conditions. Negative controls were 
from SpectrumGreen-labelled or SpectrumRed-labelled normal human 
genomic DNA. The majority of the metaphases were prepared using 
commercial slides except during the early stages of the study.
2.15.1 Metaphase slides
Metaphase spreads were made as described in 2.14.3. Wet slides were 
left at room temperature to dry and then aged for 2 days. These slides 
were stored at -70°C if not used immediately. Usually, 60-100 metaphase 
slides were made at a time and several slides from each batch were 
checked for the hybridisation quality of metaphases. If the quality of the 
slides was not suitable, the entire batch was discarded. Commercial slides 
(Vysis, Downers Grove, Illinois) were also employed in this study. These 
slides were kept at room temperature during transportation; however, they 
were stored at -60°C once they were received from a supplier. Because of 
the laborious nature of testing and selecting suitable metaphases, 
homemade metaphase slides were gradually substituted with commercial 
slides. These commercial slides were prepared using standard cytogenetic 
slide preparation methods and have been optimised for use in CGH 
experiments. They were manufactured from phytohemagglutinin (PHA) 
stimulated lymphocytes derived from a karyotypically normal male donor. 
The chromosome length was estimated to be at the 400-550-band level. 
Both homemade and commercial slides required detailed scrutiny and the 
criteria for inclusion included: high mitotic index, minimal overlapping of 
the chromosomes, and little evidence of cellular debris around the nuclei.
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2.15.2 Pre-treatment of slides for CGH
In the early stage of this study, the metaphase slides were pre-treated by 
washing in PBS solution for five minutes at room temperature, followed by 
dehydration through an ethanol series (70%, 90%, 100% for 5 minutes 
each) and then air-drying. The slides were then treated with 100 pg/ml 
RNase in 2XSSC and incubated for 1 hour at 37°C in a humidified 
chamber. The RNase was eliminated with two washes in 2XSSC at room 
temperature, each lasting 5 minutes. Slides were then washed in 
proteinase K buffer (10X proteinase K buffer: 20 mM CaCI2; 200 mM Tris- 
HCI, pH 7.5) at 37 °C for 5 minutes, before a 5 minute treatment again at 
37 °C with proteinase K (50 ng/ml in proteinase K buffer). Following a brief 
immersion in PBS/1 % MgCI2, the slides were fixed with paraformaldehyde 
(1% paraformaldehyde; 1% w/v MgCI2 in PBS) for 10 minutes at room 
temperature. After this the slides were washed in PBS, followed by 
dehydration through an ethanol series as before, and then air-drying. 
Pre-treatment of slides was not necessary if the slides had little cytoplasm 
remaining on them.
2.15.3 Nick translation 
Reagents:
1 pg of DNA in 36 pi distilled water
5 pi 10X A4 mixture (0.2 mM dATP, dGTP, dCTP in 500 mM Tris- 
HCI, 50 mM MgCI2, 100 mM p-mercaptoethanol, 100 pg/ml bovine 
serum albumin)
2 pi Texas Red-5-dUTP (Dupont, Boston, MA) or Rhodamine-4- 
dUTP (Amersham) for reference DNA
2 pi FITC-12-dUTP (Dupont, Boston, MA) or Fluorescein-11-dUTP 
(Amersham) for test DNA
5 pi DNA Polymerase/DNase (Gibco BRL, Gaithersburgh, MD)
1 pi DNA Polymerase I (Promega, Madison, Wl)
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Procedure:
1. Mix all the reagents (50 |jl) in a 1.5 ml micro-centrifuge tube.
2. Incubate 50 minutes-3 hours at 15°C.
3. Stop the reaction by 10 minutes incubation at 75°C. The distribution 
of probe size is checked on a 1 % agarose gel, and the incubation 
time and DNase concentration are adjusted in order to obtain the 
ideal size of probes (500-2000 bp).
2.15.4 Preparation for Hybridisation 
Materials and Reagents
Metaphase slides 
Labelled test DNA
Labelled reference DNA or 1 pi SpectrumRed total human 
genomic DNA (200 ng/pl, Vysis)
Human Cot-1 DNA (1 pg/pl, BRL Life Science)
3M sodium acetate (pH 5.2)
1 0 0 % cold ethanol
Ethanol series (70%, 90%, 100%)
Deionised formamide
Hybridisation buffer (50% formamide, 10% dextran sulfate) 
Denaturation solution (70% formamide, 2XSSC pH 7.0) 
Coplin jars 
Rubber cement 
Water bath
Procedure:
Preparation of target metaphase slides:
1. Check the areas of the slides under phase contrast microscope.
2. Mark the appropriate areas with a diamond pen.
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3. Denature metaphase slides for 3-5 minutes at 72-75 °C in a 
denaturation solution (70% formamide/2XSSC).
4. Submerge slides into 70% ice-cold ethanol.
5. Dehydrate slides in a series of ethanol (70%, 90%, 100%), one
minute each.
6 . Allow slides to air dry.
Preparation of reaction mix for comparative genomic hybridisation:
1. Mix 10 pi of PCR labelled test DNA, 200-800 ng reference DNA (or 
1 pi SpectrumRed total human genomic DNA), 10 pg Human Cot-1 
DNA (Gibco BRL) in a 1.5 ml reaction tube.
2. Add 1/10 volume of 3 M sodium acetate (pH 5.2), mixed, then add
2.5 volume of 100% ethanol for precipitation of DNA.
3. Centrifuge for 30 minutes at maximum speed.
4. Discard the supernatant and vacuum dry for 15-25 minutes.
5. Re-suspend the pellet in 10 pi hybridisation buffer.
6 . Denature the probe mix for 5 minutes at 75°C immediately before 
use.
7. Apply the probe mix on denatured slides.
8 . Cover with a glass coverslip (22x22 mm). The edges are sealed 
with rubber cement to prevent evaporation.
9. Incubate for 48-72 hours in a 37°C moist chamber.
2.15.5 Post-hybridisation wash
Reagents
Washing solution (50% formamide/2XSSC)
2XSSC
4XSSCT (4XSSC containing 0.05% Tween 20) 
4,6-diamidino-2-phenylindole-dihydrochloride (DAPI)
Antifade (Citifluor, Chem. Lab., Canterbury, U.K.)
Ethanol series (70%, 90%, 100%)
50 ml 
50 ml 
50 ml 
1 pg/ml
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Procedure:
1. Pre-warm washing solution in a glass Coplin jar at 45 ° C.
2. Remove the coverslip carefully.
3. Immerse the slides in pre-warm 50% formamide/2XSSC for 5
minutes.
4. Immerse the slides in pre-warm 2XSSC for 5 minutes.
5. Repeat step 4.
6 . Immerse the slides in pre-warm 4XSSCT for 5 minutes.
7. Dehydrate the slides through a series of ethanol (70%, 90%,
1 0 0 %), one minute each.
8 . Allow the slides to air dry in darkness.
9. Apply 10 pi of the antifade solution containing 0.2 pM DAPI. Cover
with a glass coverslip and seal with nail polish.
10. Evaluate slides with an epifluorescence microscope.
2.15.6 Chromosome identification with DAPI
Quips CGH/Karyotyper allowed automatic classification and pairing of 
metaphase chromosomes to generate a karyotype with 80-90% accuracy. 
The DAPI counterstain could be enhanced to bring out the band structure 
and thus help in identification of the chromosomes. The DAPI 
chromosome identification was based on that posted at website 
http://amba.charite.de (Institute of pathology, University Hospital Charite, 
Berlin) In general, the chromosome identification was made by following 
categories and characteristics:
Chromosome 1-3: easy to identify
*Chromosome 1: end of p arm lighter than the rest of the chromosome, 
centromeric heterochromatin like an isosceles triangle with the base 
directed towards the q arm.
*Chromosome 2: 2nd largest chromosome, submetacentric.
*Chromosome 3: 3rd largest chromosome, metacentric.
Chromosome 4-5: same size, difficult to identify 
*Chromosome 4: darker than 5.
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*Chromosome 5: with light area at the end of the q arm.
Chromosome 6 , 7. X: difficult to identify
*Chromosome 6 : darker q arm, lighter p arm with band/dots at the end . 
*Chromosome 7: distinct band visible, one at the p arm, two at the q arm 
slightly pronounced centromere.
*Chromosome X: particularly difficult to distinguish from chromosome 7, X 
chromosome usually showed less intense fluorescence signal in the FITC 
image if the test DNA was from a male (two chromosome 7 compared to 
one X chromosome).
Chromosome 8-12: are more or less of the same size, difficult to identify. 
*Chromosome 9: easy to identify, (look for suppression in the FITC 
image); Intense centromeric heterochromatin; p arm of chromosome 9 is 
longer than that of chromosome 8  and 1 0 .
*Chromosome 8 : particularly difficult to distinguish from chromosome 10, 
chromosome 8  usually darker than chromosome 1 0 .
*Chromosome 10: shows three bands on the q arm, in particular a 
subcentromeric band on the long arm compared to 2  bands on the q arm 
of chromosome 8 .
*Chromosome 11: showed two bright dark bands on the q arm and p arm. 
*Chromosome 12: shows only a distinct dark band on the q arm. The p 
arm is shorter than that of chromosome 1 1 .
Chromosome 13-15: same size, difficult to identify.
*Chromosome 13: dark zone covering about 2/3 of the q arm. 
*Chromosome 14: has a distinct band on the q arm followed by a light 
zone before telomeric end (chromosome 15 may have a band too; 
however, there is usually no light zone distinguishable before the telomeric 
end)
*Chromosome 15 shows a more prominent centromere (look for 
suppression in the FITC image), the dark zone of chromosome 15 extends 
more telomeric than that on chromosome 14 
Chromosome 16-18: usually easy to identify.
*Chromosome 16: distinct centromeric heterochromatin
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*Chromosome 17: p arm is longer than that of chromosome 18, distinct 
band visible on the q arm and mostly on the q arm.
*Chromosome 18:darker than chromosome 17. There are usually two 
distinct bands visible on the q arm.
Chromosome 19-20: difficult to identify.
*Chromosome 19: more pronounced centromeric heterochromatin (look 
for suppression in the FITC image)
*Chromosome 20: has a dark band on the p arm 
Chromosome 21-22: difficult to differentiate.
*Chromosome 21: has a more pronounced dark band on the q arm 
compared to chromosome 22. The band takes the shape of a triangle 
compared to more distinct, rectangular-shaped staining pattern for 
chromosome 2 2
Chromosome Y: easy to identify. Carries a lot of heterochromatin.
2.15.7 A short CGH protocol
The procedures of the short protocol were the same as previously 
described in the CGH method except for the hybridisation time and the 
amount of probe. For overnight CGH, 20-40 pi of amplified DNA was used, 
while the hybridisation time was around 12 hours. The CGH experiments 
were performed in the late afternoon, and hybridisation was carried out 
overnight. Post-hybridisation wash was performed the next morning and 
CGH analysis could be completed before noon.
2.15.8 Digital image analysis
CGH results were viewed through an epifluorescence microscope (Zeiss, 
Axioplan, Germany) equipped with a 50-100 Watt mercury lamp. 
Metaphases spreads were examined with 100X oil-immersion lens and 
appropriate filter set for the fluorochromes used. Differences in relative 
intensity of the two fluorochromes could be visualised by using a dual­
band-pass filter that transmitted red and green fluorescence 
simultaneously, along with a filter for the DAPI counterstain.
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For image acquisition, separate digitised grey level images of red, green, 
and blue were captured with a CCD camera (Photometries) controlled by 
SmartCapture™ version 2.1 software (Digital Scientific, Cambridge, U.K.) 
and analysed with Quips CGH software (Vysis) on a computer 
(Macintosh). Average green to red fluorescence ratios along the length of 
each chromosome were calculated from 5-10 metaphase spreads with 
high intensity and uniform hybridisation. Chromosome regions with 
fluorescence ratio (FR, green-to-red ratio) above 1.2 were considered to 
be over-represented (gains), whereas regions with a ratio less than 0 . 8  
were considered to be under-represented (losses) These values could be 
manipulated using various thresholds depending on the internal control of 
X chromosomes in each experiment.
2.15.9 Quips CGH analysis system
The Quips CGH analysis software system is a suite of programmes, which 
provides comprehensive patient management and semi-automatic image 
analysis for CGH studies. Each programme in the suite can be used 
independently. In this system, usually the Quips CGH/Karyotyper and 
Quips Interpreter are employed. Quips CGH/Karyotyper programme is 
used to edit and analyse a metaphase image to generate a karyotype and 
CGH ratio profiles. Quips Interpreter is used to edit and analyse ratio 
profile data from several metaphases in a CGH experiment. Quips CGH 
analysis system contains features of Quips Karyotyping and uses 
multicolour images from the microscope obtained from Quips 
SmartCapture FISH. The sequence of analysis and features of this system 
are presented as follows:
1 . Correct background automatically.
2 . Normalise fluorescent intensity automatically.
3. Enhance DAPI banding automatically.
4. Display metaphase as individual colour plane or composite colour.
5. Display karyotype as individual colour plane or composite colour.
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6 . Compute chromosome symmetry axis and CGH ratio profiles
automatically.
7. Optionally include chromosomes in karyotype but not in profile
analysis.
8 . Display ideograms with karyotype and ratio profiles.
9. Display individual or average ratio profiles.
1 0 . Compute regions of DNA copy number gains or losses.
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Chapter 3
Results
3.1 Single cell manipulation
Retrieving a single amniocyte required a series of cell dilution processes 
using a PBS solution. Under inverted microscopy, it was extremely difficult 
and unreliable to isolate a single cell without first using this cell dilution 
process. For each cell manoeuvre, frequent changes of the micropipette 
were mandatory as this would prevent any cell carry-over. A single cell 
could be secured when it was seen to pass over the tip of the 
micropipette. After a single cell was transferred, the remaining PBS 
solution was used as a negative control to ensure that no DNA remained 
in the washing solution. During the study period, several cell types 
including fresh, or frozen amniocytes, fixative-treated lymphocytes and 
buccal cells were manipulated. The characteristic features of various cell 
types are listed in Table 3.1.
Fresh amniocytes Frozen amniocytes Fixative-treated
lymphocytes
Buccal ceils
Cell debris Mild Moderate Mild Much
Cell identification Relatively Relatively Relatively Easy
easy difficult difficult
Cell size Medium Medium Small Large
Cell division Common No No No
Stored solution Trypsin-treated Trypsin-treated 3 methanol Water
culture medium culture medium /1 acetic acid
Cell number Numerous Few Numerous Numerous
Cell manipulation Relatively Difficult Difficult Relatively
Difficult easy
Table 3.1: Various cell types and their characteristic features under 100X 
inverted microscope.
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Fresh samples proved the best candidates for single cell manipulation, 
whereas micropipetting a single cell from fixative-treated lymphocytes was 
technically more difficult. Fixative interfered with surface tension of the 
PBS solution and made single cell manipulation difficult. In addition, the 
presence of any remaining fixative was detrimental to the PCR reaction. 
After several failed PCR amplifications, single cell manipulation of fixative- 
treated lymphocytes was abandoned.
Amniocytes from patients with a chromosome abnormality were frozen in 
cases when cell transfer or PCR amplification failed. The frozen sample 
was subsequently thawed at room temperature and used for cell recovery 
when repeat experimentation was indicated. However, cell number 
noticeably decreased and an increase in debris was noted after the 
freezing and thawing processes. Debris might mimic amniocytes under 
microscopy, and thus careful differentiation was required.
Fresh amniocytes had a reflective surface and particles in the cytoplasm, 
while nuclei were less obvious under inverted microscopy. Debris usually 
manifested with an irregular surface and could be differentiated by careful 
adjustment of focus. Amniocytes had the tendency to adhere to the Petri- 
dish surface if manipulative procedures were lengthened. Under such 
circumstances, cell manipulation became difficult because amniocytes 
which adhered to surface were resistant to aspiration by micropipettes. 
Buccal cells were relatively larger in size. Besides the characteristic 
features of a large cytoplasm to nucleus ratio the clear nucleus made cell 
identification easier. However, the disadvantage of using mouthwashes 
was their plentiful cell debris, which might increase the chance of 
contamination for PCR amplification. It was also difficult to obtain 
mouthwash samples from certain chromosome abnormalities such as 
trisomy 18. Consequently single buccal cell isolation was abandoned when 
experiments were carried out to test the reliability of single cell CGH in 
predicting various chromosome anomalies.
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To increase the success rate of single cell transfer, two to four single cells 
were transferred each time because single cells might be lost or might 
adhere to the PCR tubes during cell transfer (Figure 3.1).
Figure 3.1: DOP-PCR amplification from single cells. Lanes 1-3: single 
amniocyte transfers. Lane 4: transfer failure. P: from around 20 cells. N: 
No DNA control. The smear strength may show a discrepancy among 
single cells after 30 cycles of DOP-PCR. M: 100 bp DNA ladder.
3.2 The problems of contamination
At the beginning of this study when PCR amplification was carried out to 
determine the sex of samples, the reaction employed 1pg DNA. The 
experiments used routine laboratory techniques, and the results did not 
show any predilection for contamination. Flowever, this situation was
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greatly challenged when the whole genome amplification protocol was 
used. In DOP-PCR experiments, it was not uncommon to see a negative 
control in which only distilled water was added resulting in a smear 
following agarose gel analysis. An increased rate of contamination was 
also noted when the number of DOP-PCR cycles was more than 40 
(Figure 3.2). The condition was exacerbated when two stages of DOP- 
PCR involving 70 cycles were adopted. For two stages of DOP-PCR, 5 pi 
of the first DOP-PCR product was added to the secondary DOP-PCR 
amplification. All experiments using two stages of DOP-PCR amplification 
resulted in false amplifications from negative controls. The smear strength 
of negative control was indistinguishable from that of minute DNA (Figure 
3.3).
Figure 3.2: DOP-PCR amplification from a series of diluted genomic DNA. 
PCR cycles including 5 cycles of low stringency and 40 cycles of high 
stringency were used. Lane 1: 190 pg, Lane 2: 94 pg, Lane 3: 38 pg, Lane 
4: 19 pg, Lane 5: 9 pg, Lane N: negative control. M: 1 kb DNA ladder.
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bFigure 3.3: Two-stage DOP-PCR protocol, a: The robust DOP-PCR 
protocol could amplify diluted DNA down to femtogram level, which was 
equivalent to one chromosome band. In lanes 1-3, template DNA was 
from 1.6 pg, 950 fg, and 475 fg, respectively. Lane N: negative control. 
Lane 3 and N were unable to produce smear from the first round DOP- 
PCR. b: Two-stage DOP-PCR protocol showed a strong smear on lane 3’ 
and N’ derived from lane 3 and lane N, respectively. In cases of similar 
smear strength, it is not possible to differentiate true amplification of 
minute DNA from contamination. M: 1 kb DNA ladder
To avoid false amplification, the longer DOP-PCR protocol (> 40 cycles) 
was abandoned and stringent precautions against contamination were 
adopted. All containers, water, PCR tubes, pipettes were contaminated to 
some degree with DNA. These were autoclaved and UV-irradiated before 
they were used to make a PCR reaction mix. Old pipettes were plagued 
with aerosol contamination because numerous DNA analyses had been
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carried out previously. Dismantling these pipettes and cleaning the interior 
sides of barrels with 1 0 0 % ethanol still did not completely eliminate the 
contamination.
Contamination was only reliably avoided when a series of new pipettes, 
which would measure 1-1000 pi, were utilised and frequently UV- 
irradiated/or autoclaved before preparing the reagents. These pipettes 
were strictly employed only for reagent preparation and never contacted 
solutions, which might contain DNA. Laboratory autoclaved yellow tips 
were not suitable for single cell DOP-PCR as the results showed high 
rates of contamination. Tips with barriers could effectively decrease the 
aerosol contamination. This would prevent the PCR preparation and the 
interior of the pipettes from carry-over contamination. Another set of 
pipettes for PCR products analysis were prepared and kept entirely 
separate from DNA-free pipettes. These pipettes were also used for 
preparing CGH mixtures, which contained DNA.
Despite all these precautions, contamination would still occur. However, 
this could be kept to a minimal degree and carefully monitored through the 
use of negative controls. When each single cell was transferred, a 
respective negative control from the last 50 pi droplet of PBS washing 
solution afforded the best indicator for monitoring contamination. 
Successful transfers of single cells were revealed by the apparent 
discrepancy of smear strength between single cell transfers and negative 
controls. (Figure 3.4).
3.3 Microdissection of stained cells from slides
Cell clusters of 10-20 stained cells, not in metaphase, could be easily 
demarcated under the inverted microscope. Areas containing greatly 
scattered cells were avoided, as this would require more manoeuvres and 
the genuine number of cells retrieved might be in doubt. Compared to 
single cell manipulation from cultured amniocytes, this procedure was 
relatively easy and less labour-intensive. A ‘sham’ microdissection, which 
was performed by placing the needle to an area without any cells, was
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used as a negative control for each slide. Results of DOP-PCR from 
stained cells usually revealed a similar smear strength to those obtained 
from a single cell. However, the size distribution was usually smaller than 
those obtained from a single cell (Figure 3.5).
Figure 3.4: The distribution of single cell DOP-PCR products (lanes 1, 2, 3, 
4) and the respective negative controls (lanes 1N, 2N, 3N, 4N). M: 100 bp 
DNA ladder.
82
Figure 3.5: DOP-PCR products from microdissected stained cells. The 
majority of DOP-PCR fragments were less than 800 bp. In lanes 3-4, the 
smear was very faint and could not be differentiated from the negative 
control. M: 100 bp DNA ladder.
3.4 Optimisation of whole genome amplification (WGA)
Two WGA protocols (i.e. PEP and DOP-PCR) were tested in this study 
(Zhang et al 1992; Telenius et al 1992). For DOP-PCR amplification, the 
work started by testing several parameters including 2-10 pM primer, 1.25- 
4 U Taq polymerase per 25-50 pi reaction volume, and 2-4 mM MgCI2 on 
diluted DNA. The PCR conditions included 5-8 cycles of low stringent 
annealing temperature, and 28-40 cycles of high annealing temperature. 
The purpose of DOP-PCR optimisation was to obtain a rapid and effective 
protocol, which would amplify sufficient template from a single cell. The 
results showed that an obvious smear could be obtained by using any 
combination of these parameters. Nevertheless, the lower concentration
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was preferred in order to avoid the high remaining concentration of 
degenerate primer which could interfere with subsequent specific locus 
detection.
PEP, another PCR technique aimed at whole genome amplification, 
applied 37°C and 10 s/°C ramp temperature to 55°C as the annealing 
temperature. With this slow ramp rate, it took 10 hours to complete 50 
cycles of PEP protocol. A short protocol took around 5-6 hours to 
complete (Sermon et al 1996). Both PEP protocols did not produce 
apparent smear on agarose gel analysis after 50 cycles.
3.4.1 Primary DOP-PCR
A series of extracted DNA, which was diluted to picogram level, was tested 
to validate the performance of DOP-PCR from minute DNA quantities. The 
results showed that, with diminution of DNA concentration, the smear 
strength of DOP-PCR products also correspondingly decreased (Figure 
3.6). For DOP-PCR cycling conditions, a combination of low stringency 
(i.e. 5-8 cycles) and high stringency (i.e. 28-40 cycles) was tested for its 
performance in amplifying minute DNA. All forms of recombinant cycling 
conditions could produce a visible smear on agarose gel analysis despite 
the increased tendency for contamination with prolonged cycles. Low 
stringency conditions were empirically set at 5-8 cycles in order to 
increase random-priming sites throughout the whole genome. To prevent 
a lengthy process, high stringency conditions were set at 28-30 cycles. 
The time requirement for this protocol would then be around 4 hours and 
15 minutes.
Preferential amplification occurred occasionally in the DOP-PCR reaction 
(Figure 3.7). This phenomenon was manifested by the presence of one or 
more bands amongst the background smear. However, subsequent CGH 
experiments were not precluded in this case, because it did not 
necessarily represent contamination. Successful single cell CGH 
experiments were achieved from these DOP-PCR products and the results 
did not show over-representation of certain chromosomal regions.
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Figure 3.6: DOP-PCR from a series of diluted genomic DNA. Lane 1:760 pg, 
Lane 2: 500 pg, Lane 3: 380 pg, Lane 4: 250 pg, Lane 5:190 pg, Lane N: 
negative control. M: 1 kb DNA ladder.
Figure 3.7: Preferential amplification of DOP-PCR from single cells. Lanes 1-3: 
This phenomenon was manifested by the presence of one or more bands 
amongst the background smear (indicated by arrows). M: 100 bp DNA ladder.
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The low stringency annealing temperature of 30°C is the characteristic 
feature of DOP-PCR. The PCR conditions included a ‘ramp’ (i.e. 3 min 
transition from 30°C to 70°C) for lower stringency conditions while 
‘increment’ (i.e. addition of 1 sec/cycle for elongation step) was applied in 
high stringency conditions (Telenius et al 1992b). Various experiments 
revealed that DOP-PCR without ramp and increment could still efficiently 
produce a smear, whereas the time requirement was decreased by half an 
hour. It took 6  hours and 42 minutes to complete 48 cycles of DOP-PCR; 
however, the time requirement was decreased to 4 hours and 20 minutes 
for 35 cycles of DOP-PCR (Table 3.2).
DOP-PCR DOP-PCR PEP* Short PEP**
Cycle 35 48
Low stringent 5 8
Cycle
High stringent 30 40
Cycle
Total Time 4 h 20 m 6 h 42 m
* Zhang et al 1992
** Sermon et al 1996
Table 3.2: Time requirements for various protocols of whole genome 
amplification.
The oil-free cycler, which used a hot lid to prevent evaporation of PCR 
mix, caused another problem in the DOP-PCR reaction. The heat 
accumulated by the hot lid would decrease the efficiency of the cooling 
system of the PCR cycler, particularly in a warm room where there was 
heat or on a hot summer day. The temperature would then be raised to 
several degrees above 30°C. Failure to lower the temperature to 30°C
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would ruin the DOP-PCR reaction. Moving the cycler into a cold room 
(4°C) or avoiding using the hot lid solved this problem. An oil-free PCR 
reaction was a better choice for PCR labelling because further 
comparative genomic hybridisation might be interfered with by the 
presence of mineral oil.
Repeated DOP-PCR experiments using 5 cycles of low stringency 
conditions and 30 cycles of high stringency conditions produced an 
obvious smear from diluted DNA at the picogram level. This protocol was 
then adopted to test on single cells in order to avoid two-stage DOP-PCR 
or extended DOP-PCR cycles (i.e. over 40 cycles).
3.4.2 DOP-PCR reaction from single cells and stained cells
The size distribution of DOP-PCR products from a single cell was usually 
smaller than those amplified from diluted DNA; however, variation did 
occur. The majority of DOP-PCR results usually ranged from 200-2000 bp, 
with the bulk of the smear less than 1500 bp. Nevertheless, wide-range 
amplification products, with the size of products more than 2 0 0 0  bp, could 
occur. DOP-PCR products from stained cells usually resulted in shorter 
fragments, with the majority of the smear less than 1000 bp (Figure 3.8). 
DOP-PCR tended to amplify shorter sequences more efficiently than 
longer ones. The majority of the DOP-PCR smear concentrated distally 
rather than proximally on agarose gel analysis. Occasionally, the 
distribution of DOP-PCR fragments was less than 1000 bp. Further CGH 
experiments would not be considered if the distribution of fragments were 
less than 600 bp. Short DOP-PCR fragments were very unlikely to 
produce optimal CGH results. DOP-PCR amplification from a single cell 
would yield 10 pg template in 50 pi reaction volume. This was similar to 
the results from a positive control from 1 ng diluted DNA.
The Expand™ High Fidelity PCR system, using mix of Taq polymerase 
and Pwo polymerase, is especially optimised to amplify DNA fragments up 
to 5-12 Kb from human genomic DNA. However, this PCR system did not 
produce a wide fragment distribution if compared with conventional Taq
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polymerase throughout the study period. Moreover, the yield appeared to 
diminish when Expand™ Fidelity PCR system was used for DOP-PCR 
amplification from single cells (Figure 3.9).
Figure 3.8: The variation of DOP-PCR amplification from single cells, a-b 
DOP-PCR from microdissected single cells. The fragment distribution was 
less than 1000 bp with the majority of products less than 800 bp. c-d The 
DOP-PCR from a single cell. The majority of fragments ranged from 200 
bp to 2000 bp. P: positive control from 10-20 cells. N: Negative control. M: 
100 bp DNA ladder.
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M 1 2 3 4 N
Figure 3.9: Comparison of DOP-PCR using Taq enzyme and Expand™ 
High Fidelity PCR system on single cells. Lanes 1, 3: DOP-PCR 
amplification from 20 cells by Taq polymerase. Lanes 2, 4: by Expand™ 
High Fidelity PCR system. N: negative control. M: 100 bp ladder.
3.4.3 Secondary DOP-PCR for probe labelling
After primary DOP-PCR from a single cell, 5 pi of the product was 
transferred into a secondary DOP-PCR amplification for probe labelling. 
Twenty cycles of PCR labelling would yield 5-10 pg of painting probe. The 
size distribution usually ranged from 200 to 1500 bp. However, the 
majority of the fluorochrome was not incorporated into the probe and 
accumulated distally in a free form over the smear trail (Figure 3.10). The 
molecular size of Fluorescein-11-dUTP (Green) is smaller than that of 
Rhodamine-4-dUTP (Red), because green fluorescent dye ran further than 
its red counterpart. Expand™ High Fidelity PCR system could increase 
probe size distribution; however, Taq polymerase also had similar effects if 
4 mM magnesium concentration was used (Figure 3.11). Fluorescence- 
conjugated nucleotides ranging from 1-2.5 pi were investigated for efficient 
labelling. The results demonstrated that 2 pi of fluorescence-conjugated
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nucleotides could produce consistent and reliable CGH results. A higher 
concentration would cause waste while lower amounts failed to generate 
consistent results.
Figure 3.10: Probe labelled by secondary DOP-PCR. Lanes 1, 2, 4: 
labelled with fluorescein-11-dUTP (green). Lane 3: labelled with 
rhodamine-4-dUTP (red). The size distribution was usually less than 1500 
bp. The molecular size of fluorescein-11-dUTP was less than rhodamine- 
4-dUTP. M: 100 bp DNA ladder.
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Figure 3.11: Size distribution of the probes made using Expand™ High 
Fidelity PCR system and Taq polymerase. Lanes 1-2: labelled using Taq 
polymerase and 4 mM MgCI2 Lanes 3-4: labelled with Expand™ High 
Fidelity PCR system. M: 100 bp DNA ladder.
3.5 Optimisation of nested PCR for sex determination
The primers designed for sex determination led to primary amplification of 
555 and 371 bp for the X and Y chromosomes, respectively (Schaaf et al 
1996). The second amplification resulted in one 323 bp band for female 
cases, and two bands of 323 bp and 142 bp for male cases (Figure 3.12).
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<First round PCR>
X  (555bp) -------- ► --------
AMG3 AMG4
Y  (371 bp)  ► 1 7 7  bp deletion --------
<Second round PCR>
X  (323 bp) . -------► , , -------.
AMG5 AMG6
Y (1 4 2 bP) •-------► 177 bp deletion  •
Figure 3.12: Nested PCR strategy for sex determination. Homologous 
primers for both sex chromosomes were designed by simultaneous 
amplification of AMGX and AMGY. Both pairs of primers were aligned to 
encompass a 177-bp deletion in AMGY. Fragments of different sizes for X 
and Y (323 bp and 142 bp, respectively) could be resolved by simple 
agarose gel analysis.
A series of diluted DNAs was tested in order to determine the lowest 
concentration, which could yield detectable products on agarose gel after 
25 cycles of the first round PCR. The outer primers flanking the 555 bp 
sequence could be amplified from 1 pg, and 100 ng DNA template but not 
10 ng DNA (Figure 3.13). At first the primer concentration for nested PCR 
of the amelogenin locus was performed as in the original protocol. When 
both outer and inner primer concentrations were set at 400 nM, the results 
demonstrated some extra bands on agarose gel analysis. These 
unwanted bands were located at the position of 400+ bp and 200+bp 
(Figure 3.14).
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Figure 3.13: Minimal DNA requirements for the first round PCR in sex 
determination. The reaction was tested with a series of female diluted 
DNA. Lane 1: 1 |jg, iane 2: 100 ng, lane 3: 10 ng. M: 100 bp DNA ladder.
*200 bp
323 bp
142 bp
Figure 3.14: Extra bands produced in the nested PCR. Sex was 
determined by the presence of an X band (323 bp) and a Y band (142 bp). 
Unwanted bands (*) were noted when 400 nM outer primer was used. 
Lane 1: Male with unwanted bands at the position of 400+ bp and 200+ 
bp. Lane 2: Female band at 323 bp. M: 100 bp DNA marker.
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To achieve final products of 323 bp for AMGX and 142 bp for AMGY, 
various concentrations of the outer primer were tested, while the inner 
primer concentration was set at 400 nM. The results showed that, with 
decreasing outer primer concentration, the targeted final products of 323 
bp for AMGX became more obvious (Fig 3.15). In other experiments, the 
annealing temperature of the second round PCR was elevated from 56°C 
to 60-62°C; however, this did not completely prevent the occurrence of 
unwanted bands.
Figure 3.15: The effects of various concentrations of outer primer in the 
nested PCR reaction. From lane 1 to lane 4, the concentration of outer 
primer was gradually diluted from 2 pM to 200 nM. The targeted fragment 
became evident when lower concentration of outer primer was used. M: 
100 bp DNA ladder.
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To determine the optimal primer concentrations for the nested PCR 
reaction, subsequent experiments applied a series of outer and inner 
primer concentrations in testing the template DNA at the picogram level. 
The experiments set the concentration of outer primer concentration at 2 
pM, 400 nM, 200 nM, 133 nM, and 100 nM, respectively. The inner primer 
concentration was set at 400 nM, and 800 nM. The results showed that 
targeted band patterns (i.e. 323 bp for AMGX and 142 bp for AMGY) could 
be obtained when AMG-3/AMG-4 primers were set at 100 nM. The inner 
primer, when set at 400, or 800 nM, had similar results (Figure 3.16). It 
was therefore decided that 100 nM and 400 nM were the optimal 
concentration for outer and inner primers, respectively.
M 1
* • '
je-323 bp 
•<—142 bp
*
Figure 3.16: Optimisation of nested PCR at the amelogenin locus using 
various concentrations of outer and inner primers. From lanes 1-5, the 
outer primer concentration was progressively diluted to 100 nM. Lane 4 
showed failed amplification. Unwanted bands were apparent when primer 
concentration was high (lane 1). Extra band at 400+ bp became less 
obvious from lane 2 to lane 5. M: 100 bp DNA ladder.
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Throughout the study period, it was a general finding that the Y band was 
usually fainter than X band. For those band patterns recognised as male, 
some extra bands might occur: a dim band slightly above 323 bp, a band 
of 200+ bp, or extra bands above 400 bp. Occasionally male cases would 
manifest as a single Y band of 142 bp (Figure 3.17). Apart from 323 bp for 
AMGX, some dim extra bands were simultaneously amplified, at the 
position of 400+ bp, for recognised female cases. Flowever, sex could not 
be determined for some band patterns as they lacked apparent targeted 
bands. A pattern, which involved simultaneous amplification of a band of 
200+ bp and 323 bp, was equivocal because both males and females 
could display a similar pattern.
a
M 1 2 3 4 5  6 7 8  P N
1 2 3 4 5 6  7 8
300 -
200 -
band 300.
Y band
-X band
Figure 3.17: The phenomenon of a single Y band. Sex determination from DOP- 
PCR products derived from 10-20 microdissected stained cells, a: In lane 2 and 
5, only a single Y band was amplified. The X band was not simultaneously 
amplified. P: positive control from 5 ng male diluted DNA. N: negative control. 
This phenomenon may be due to DNA damage, preferential amplification or 
incomplete lysis, b: Various band patterns from male cases. The Y band was 
usually fainter than X band. Flowever, it may be similar to X band (lane 8). Some 
extra bands were noted in lane 5-8. In lanes 1-2, only Y bands were produced. 
M:100 bp DNA ladder.
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3.6 Sex determination for DOP-PCR-derived DNA from a 
single cell
To validate the feasibility of sex determination for DOP-PCR-amplified 
DNA, 60 single cells were DOP-PCR amplified and subsequently 
investigated with nested PCR on the amelogenin locus. The distribution of 
band patterns from both sexes was depicted in figures 3.18-3.19.
Of 60 cases, 26 (43.3%, 26/60) failed to produce PCR products, while five 
cases resulted in band patterns, which could not be recognised. 
Identifiable patterns at the amelogenin locus for DOP-PCR-amplified DNA 
was seen in 48.3% (29/60). However, one male cell was interpreted to be 
female while another female cell was interpreted to be male, and resulted 
in a 6.9% (2/29) misdiagnosis rate among those identifiable band patterns. 
Among 9 single male cells, which had distinguishable band patterns, 4 
produced only Y bands. Contamination occurred when a female cell was 
diagnosed as a male and this represented 3.4% (1/29) among those with 
recognisable band patterns.
Unrecognised
M  Identifiable
Misdiagnosis
  X:323 bp
Y:142 bp 
100---------
Number: 4 1 4 3 1
Failed amplification: 17
Total number: 30
Figure 3.18: The distribution of male band patterns when sexing on DOP- 
PCR-derived DNA prepared from a single cell.
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300
200
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M Identifiable
Unrecognised
600 ——  Misdiagnosis
500____
400--------
300...........     X:323 bp
200--------
Y:142 bp
100---------
Number: 13 1 4 2 1
Failed amplification: 9 
Total number: 30
Figure 3.19: The distribution of female band patterns when sexing on 
DOP-PCR-derived DNA prepared from a single cell.
3.7 Sex determination for DOP-PCR-derived DNA from 
multiple single cells
Forty-nine cases of DOP-PCR-derived DNA, which were amplified from 
starting DNA templates of 2-100 cells, were also tested by nested PCR on 
the amelogenin locus. Fifteen cases were from males and 34 cases were 
from females. Six cases (12%, 6/49) showed no band on agarose gel 
analysis, while eight cases produced bands which could not be identified. 
43 cases displayed clear bands (71.4%, 35/49). The distribution of band 
patterns from each sex was shown respectively in figures 3.20-3.21. 
Thirty-three cases (94%, 33/35) resulted in a correct diagnosis, while two 
cases (6 %, 2/35) were misdiagnosed.
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MX:323 bp 
Y: 142 bp
Number: 5 1 2  1 1 2
Failed amplification: 3 
Total number: 15
Figure 3.20: The distribution of band patterns when sexing on DOP-PCR- 
derived DNA prepared from 2-100 male cells.
M
600 Identifiable Unrecognised patterns
500_____
400--------
300-------------------------------------   —
200--------
100--------
Number: 19 3 2 2 1 3 1
Failed amplification: 3 
Total number: 34
Figure 3.21: The distribution of band patterns when sexing on DOP-PCR- 
derived DNA prepared from 2-100 female cells.
X:323 bp 
Y:142 bp
Identifiable
600____ Misdiagnosis
Unrecognised
4 0 0 --------------- nattorn
300-------------------------------------------p -------
200---------
100---------
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3.8 Sex determination for blastomeres by nested PCR
Three batches of blastomeres, which contained 1-6 cells in 200 |jl PCR 
tubes, were analysed with the above-mentioned strategy for sex 
determination. Among 28 cases for sex determination, 18 cases involved 
nested PCR directly on blastomeres, while 10 cases involved nested PCR 
on DOP-PCR-derived DNA from single blastomeres. Sex could be 
determined in 55.6% (10/18) of cases involving nested PCR directly on 
blastomeres. For sex determination of a single blastomere, 30% (3/10) of 
cases could be determined.
For another group involving nested PCR on DOP-PCR-derived DNA, sex 
could be determined in 40% (4/10) of cases. For sex determination of a 
single blastomere, 37.5% (3/8) of cases could be determined; however, 
this include 3 cases resulting in only a single Y band (Table 3.3; Figure 
3.22).
-* ■* **
Figure 3.22: Sex determination of a single blastomere. Lane 1: shows a male 
embryo. Lanes 2, 3, and 5: failed to determine the sex. Lane 4: shows a female 
embryo. Lane P: positive control from 5 ng male DNA. Lane N: negative control. 
M: 50 bp DNA ladder.
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DOP-PCR Sexing on DOP-PCR-derived 
DNA
Sexing on single 
Cells
Embryo 1-13
1 cell X
1 cell X
1 cell X
1 cell X
Embryo 1-9
1 cell X X
5 cell X X
Embryo 1-11
1 cell Female
1 cell X
Rest of embryo 11 Female
Embryo 1-12
1 cell X
1 cell X
Embryo 1-6
1 cell
Rest of embryo 6 + Female
Embryo II-1 1
1 cell + A Y band only
1 cell A Y band only
6 cells Male
Embryo II-6
1 cell - A Y band only
Rest of embryo 6 Male
Embryo II-5
1 cell Male
1 cell +- X
2 cells X
4 cells Male
Embryo 11-10
1 cell X
1 cell ++ X
1 cell Female
1 cell +- X
1 cell +- X
Embryo III-3
5 cells Male
Embryo III-5
5 cells Female
Embryo III-4
3 cells Male
x: no PCR products, +-: faint DOP-PCR smear, +: moderate DOP-PCR smear, ++: strong DOP- 
PCR smear
Table 3.3: Results of sex determination from single blastomeres. Nested PCR for 
simultaneous amplification of AMGX and AMGY was applied on single 
blastomeres, or DOP-PCR-amplified DNA derived from single blastomeres.
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3.9 Cystic fibrosis diagnosis for DOP-PCR-derived DNA 
from single cells
To investigate AF508 mutation for DOP-PCR-derived DNA from single 
amniocytes, two protocols were employed. One involved 40 cycles of PCR 
on DOP-PCR-amplified DNA, and the results were analysed on a 10% 
polyacrylamide gel. A normal individual would result in an 88 bp band; an 
affected individual would display an 85 bp band, while a heterozygous 
individual would reveal 85 and 88 bp bands plus a heteroduplex doublet. 
For 10 cases involving 1-20 single amniocytes, clear bands were 
produced (Figure 3.23).
Apart from analysis on a standard polyacrylamide gel, the results could 
also be analysed on a simplified polyacrylamide gel (5x8x0.1 cm). This 
simplified gel was relatively easy to prepare and analysis time was 
shortened to 2 hour, compared to 4 % hours for a standard polyacrylamide 
gel (Figure 3.24).
M
100 bp-
8
Fleteroduplex formation
,
-85 bp
88 bp
Figure 3.23: Mutation detection of AF508 from DOP-PCR-amplified DNA. 
The normal pattern was shown as an 88 bp band (lane 9). The 
heterozygous patterns were shown as 85 bp, and 88 bp bands, and a 
heteroduplex formation (lanes 1, 2, 3, 5, and 8). The homozygous affected 
individuals were shown as an 85 bp band (lanes 4, 6, and 7).
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Figure 3.24: Mutation detection of AF508 by a simplified polyacrylamide 
gel. The normal pattern was shown in lane 5. The heterozygous pattern 
was shown in lanes 1 and 4. The affected pattern was shown in lanes 2 
and 3. M: 100 bp DNA ladder.
3.10 Cystic fibrosis detection for stained cells
Another protocol using nested PCR for detecting the AF508 mutation was 
subsequently tested on DOP-PCR-derived DNA from stained cells. The 
first round PCR aimed to amplify fragments of 380 bp of CFTR exon 10. 
For normal cases, the second round PCR would produce 160 bp from N 
tube containing normal primers. For affected cases, the second round 
PCR would produce 157 bp from M tube containing mutant primers. 
Fleterozygous cases would produce 160 bp from N tube and 157 bp from 
M tube, respectively (Figures 3.25-3.26).
Of 18 samples analysed, 10 cases (55.5%) revealed a normal pattern; 3 
cases displayed a heterozygous pattern (16.7%) while 5 cases (27.8%) 
were without bands (Figure 3.27). Consequently for the DOP-PCR- 
amplified DNA derived from stained cells, the coverage rate for CFTR 
detection was 72%.
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First round PCR: amplification of 380 bp within exon 10 
Second round PCR:
N tube: contains common 
primer and 
normal primer
M tube: contains common 
primer and 
mutant primer
Figure 3.25: Strategy for AF508 mutation detection by nested PCR.
DNA
Marker
600_____
500_____
400--------
300--------
   Normal: 160 bp
Mutant: 157 bp
N  M  N  M  n  M
Figure 3.26: Band patterns for AF508 mutation detection using nested 
PCR. Normal individual will display one 160 bp band in N (Normal) tube. 
Affected case will have one 157 bp band in M (Mutant) tube. 
Heterozygous carrier will have one 160 bp band in N tube and one 157 
band in M tube.
200
Normal Affected Carrier
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350
150 160 bp (N) 157 bp (M)
Figure 3.27: Nested PCR for AF508 mutation detection. Cases 1-2: DOP- 
PCR-amplified DNA from stained cells. Both displayed normal pattern. 
Case 3: normal control. Case 4: affected control. Case 5: Heterozygous 
carrier control. Case 6: Negative control. M: 50 bp DNA ladder.
3.11 CGH technique
3.11.1 Preparation of genomic DNA for CGH
Reference DNA was prepared from peripheral blood of both a normal male 
and a normal female. High molecular weight total genomic DNA (>4 kb) 
was required for successful CGH. The purity of the DNA was not critical, 
but degraded DNA was avoided because it would yield probes that were 
too small on nick translation, thereby resulting in poor CGH quality.
3.11.2 Labelling of genomic DNA by nick translation
Painting probes were directly labelled with fluorochrome-conjugated 
nucleotides. Test DNA was labelled with Fluorescein-12-dUTP and 
reference DNA was labelled with Rhodamine-5-dUTP. CGH experiments 
were initially carried out according to the previous report (Kallioniemi et al 
1994). However, the protocol required further modification in order to 
generate consistent and reliable CGH images. Instead of using 200 ng for 
both test and reference DNA, the amount of test DNA ranged from 400 ng
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to 1 |jg, while reference DNA ranged from 200-600 ng. Instead of using 1 
|j|, the amount of fluorochrome-conjugated nucleotides was increased to 2  
|j| (1 mM). Heterochromatic regions were relatively less stained with 
green/red by adding 10 |jg of human Cot-1 DNA. This represented 
effective in situ suppression of repetitive sequence in these areas. The 
probe size was adjusted by varying both the concentration of DNase and 
the reaction time. To obtain optimal probe size, it usually took 2-3 hours 
for the nick translation reaction. An increased concentration of DNase and 
reaction time would decrease the size of probes.
3.11.3 Labelling of DOP-PCR-derived DNA
Labelling of DOP-PCR-derived DNA was carried out by either nick 
translation or the PCR method. When 1 pg of DOP-PCR-derived DNA was 
used in the nick translation reaction for one hour, the resulting probes did 
not show uniform hybridisation on metaphases. The results demonstrated 
that the current nick translation protocol used for labelling total genomic 
DNA was not suitable for labelling DOP-PCR-derived DNA because 
optimal probe size distribution was difficult to obtain. The size distribution 
was usually too small under such conditions.
In comparison, probes prepared by the PCR method were efficient and the 
process could be automated. The PCR labelling method generated 
reliable and consistent painting probes for CGH experiments from 5 pi of 
primary DOP-PCR products. Since only one fifth of the probe was used 
for each of the CGH experiments, the remaining probe could be used for 
additional experiments if there was any uncertainty from the primary CGH 
result.
3.11.4 Preparation of metaphase slides for CGH
A batch of 50-100 metaphase slides was prepared at a time, and the 
morphology of metaphase chromosomes was evaluated using a phase 
contrast microscope. Slides, which did not reach the acceptance criteria, 
were abandoned. Each batch preparation required a further test to
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determine the proper temperature and time requirement for denaturation. 
Optimal metaphase denaturation was usually achieved at 73-75°C for 2.5- 
5 minutes. The temperature of the water bath and denaturation solution 
was carefully monitored. The ideal denaturation time was the one where 
morphology was maintained for chromosome identification, whist sufficient 
denaturation had occurred to allow proper hybridisation.
The quality of the slides that passed the morphological check was also 
evaluated by a rapid denaturation test. The batch of the slides would be 
discarded if the appearance of C-banding patterns were revealed. Despite 
the efforts to screen appropriate batches of slides, the only reliable criteria 
to judge the quality of metaphase spreads was through a real CGH 
experiment.
Metaphase slides were also commercially available, although these slides 
required the same scrutinizing criteria to select proper area for 
hybridisation. Commercial metaphase slides might avoid laborious 
metaphase preparation and selection procedures; however, it did not 
guarantee the successful performance of CGH experiments. Despite the 
recommended temperature of 75°C for 5 minutes according to the 
manufacturer’s protocol, the denaturation time occasionally required 
adjustment in order to yield optimal CGH images. Compared to 
homemade slides, commercial slides resulted in more successful CGH 
results during the initial stage of CGH optimisation. Therefore, commercial 
slides were employed to test the reliability of single cell CGH.
3.12 Assessment of CGH image quality
Before quantitative analysis, all the images were checked in order to 
ascertain whether their quality was adequate for ratio profile analysis. Only 
high-quality images were utilised as accurate interpretation could not be 
made if hybridisation was not uniform along the majority of the 
chromosomes (Figure 3.28). During image acquisition and analysis, a 
number of quality indicators could be estimated in order to accept or reject
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for further analysis. The criteria for assessing the quality of hybridisation
included (Kallioniemi et al 1996):
(1) Relatively low intensity of fluorescence for both the test and reference 
DNA probes in the pericentromeric and heterochromatic regions of 
chromosomes 1, 9, and 16 indicated adequate suppression of the 
repeated sequences.
(2 ) All chromosomes showed uniform and smooth high-intensity 
hybridisation. Metaphase spreads with granular patterns and 
fluorescent spots were excluded.
(3) Relatively straight chromosomes should be selected to reduce the 
artefacts that result from bending. Crossover and crowded 
chromosomes were avoided.
(4) Green and red hybridisation patterns are uniform between the two 
chromatids of a chromosome, the two homologous chromosomes in 
each metaphase, and in different metaphases.
(5) Chromosomes showed intense DAPI staining with visible bands.
(6 ) Background noise should be minimal.
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Figure 3.28: Qualitative assessment for CGH experiments. (A) Test DNA labelled 
with FITC. Using an appropriate single band-pass filter, a CCD image of only 
FITC staining was obtained. This grey-scale image was then digitally 
pseudocoloured in green. (B) Reference DNA labelled with rhodamine. The 
image was psuedocoloured with red. (C) CCD image of a normal metaphase 
spread counterstained with DAPI. (D) Digital inversion of image shown in C. This 
procedure provides a banding pattern resembling G-banding. (E) Mixed-colour 
image obtained by digital overlaying of the images shown in A, B, C. This CGH 
image was from a female trisomy 18 amniocyte co-hybridised with normal male 
DNA.
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3.13 Chromosome identification with DAPI staining
Chromosomes stained by DAPI alone displayed Q-band-like fluorescence 
bands along their lengths with prominent staining at the pericentromeric 
regions of chromosome 1, 9, 16 and the distal long arm of the Y 
chromosome. Acrocentric chromosomes and pericentromeric regions of 
chromosome 4, 7, 10, 19 might show fluorescence of variable intensity. 
The Q-band-like pattern of DAPI staining in CGH experiments, following 
denaturation and washes, was less obvious than the chromosomes 
stained directly with DAPI alone.
For quantitative analysis, CGH software would automatically classify the 
chromosomes by size or by banding-specific classifier. However, errors 
might occur and part of the chromosomes could not be identified due to 
similar size and/or poor banding. Further correction could be reached by 
manually classifying these chromosomes. For successful CGH 
experiments, DAPI staining usually displayed adequate and clean signals 
over both interphase cells and chromosomes. Over or poor DAPI staining 
usually accompanied poor CGH results. However, optimal CGH 
experiments did not always result in optimal Q-banding pattern of DAPI 
staining.
3.14 Troubleshooting hybridisation with CGH kits
Unsatisfactory CGH results could be due to poor hybridisation (dim or no 
signals), granular hybridisation, poor metaphase morphology, and/or 
background noise. The underlying causes were varied and were relatively 
difficult and tedious to resolve. To produce ideal CGH images, all 
parameters including test/reference DNA, metaphase slides, labelling 
procedures, denaturation, and DAPI staining must be optimal. Since 
various factors were involved, it was not uncommon to have difficulty in 
identifying the causes of failed CGH experiments.
Commercial products offer a control to assess and troubleshoot the 
performance of CGH experiments. These kits contain differently-labelled 
normal DNA from both sexes, and a positive control from SpectrumGreen
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MPE 600, which was extracted from an immortal female breast cancer cell 
line containing well characterized genetic abnormalities. The confirmed 
selected chromosome abnormalities included: (1 ) small deletion near 
1pter; gain of 1q (2) loss of 9p (3) distal deletion on 11q (4) loss of 16q.
In troubleshooting CGH experiments, two hybridisation areas were 
simultaneously tested on the same metaphase slide. Under the same 
experimental conditions, metaphase quality could be determined. The 
factor of metaphase quality could be ruled out if the area of controlled 
CGH experiment demonstrated good hybridisation, whilst single cell CGH 
displayed poor results. The underlying causes of failed CGH might, 
therefore, point to the preparation of the test DNA. If both areas showed 
poor hybridisation, then CGH experiments were repeated with a new batch 
of slides. However, other factors such as denaturation should be taken 
into consideration. A reliable reference DNA could help to identify the 
underlying cause of problems with single cell CGH (Table 3.4).
Test DNA Reference DNA Possible causes and solutions
Poor hybridisation Good hybridisation 1. Failed single cell PCR
(e.g. incomplete lysis, contamination)
Poor hybridisation Poor hybridisation
2. Labelling errors.
1.Poor metaphase quality. Change
with another batch of slides.
2. Improper denaturation.
Good hybridisation Poor hybridisation 1.Unmatched probe size. Verify the 
probe size.
2. Out-of-date reference DNA.
Table 3.4: Troubleshooting single cell CGH based on a reliable reference DNA
Using commercial reagents for positive and negative controls, the 
quantitative CGH analysis also displayed fluctuation. Several extra 
abnormalities of MPE 600 were noted when cut-off value of 1.2 and 0.8 
was selected to represent chromosome gains and losses, respectively 
(Figures 3.29, 3.30).
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Figure 3.29: CGH karyotyping from SpectrumGreen MPE 600. Test DNA was 
from immortal female breast cancer cell line and co-hybridised with normal male 
DNA. CGH image demonstrated greenish colour over chromosome 1 q, and X 
and reddish colour over chromosome 9p, 11 q, 16q, 17p and Y.
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Figure 3.30: Fluorescence ratio profile from breast cancer cell line co­
hybridised with normal male DNA. Chromosome gains were noted over 
chromosome 1q and X, and chromosome losses were noted over 
chromosome 9p, 11 q, 16q, 17p and Y when the threshold value was set at
1 . 2 / 0 . 8 .
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3.15 Optimisation of single cell CGH
During the optimisation of single cell CGH, the normal reference DNA 
used was from either amplified DNA (e.g. matched number of single cells 
or 1-10 ng diluted genomic DNA) or non-amplified DNA. Theoretically, 
reference DNA for single cell CGH should be from a matched number of 
single cells. However, this approach usually produced inconsistent results 
and a high failure rate perhaps because of difficulties involved in single cell 
manipulation and single cell PCR.
During the initial stage, it was common to have results showing good 
hybridisation of test DNA, but not the reference DNA, or vice versa. It was 
also not uncommon to have results showing poor signals from both test 
and reference DNA, which might result from failure of single cell PCR, 
poor-quality metaphase slides, or inappropriate denaturation conditions. 
Success rates of single cell CGH increased only when as many variables 
were kept relatively constant.
DOP-PCR-derived DNA from a single cell was further labelled either by 
nick translation or PCR. PCR labelling was more convenient and efficient 
than nick translation, because the former method could be performed 
using an automated PCR machine, while the latter one required 
adjustment of reaction temperature, time, and DNase concentration in 
order to result in optimal probe size. PCR labelling with 20-25 cycles 
yielded 10-20 pg of test DNA in a 50 pi reaction volume. A series of test 
DNA ranging from 5 pi to 40 pi was tested in order to yield optimal CGH 
images. The results demonstrated that 10 pi (2 pg) was the smallest 
amount required to produce consistent and reliable hybridisation in CGH 
experiments.
To validate the effectiveness of labelling from a single cell, a one-colour 
hybridisation could be applied as a pre-CGH test before the real two- 
colour CGH experiments. The procedure was similar to CGH, while only 
one labelled DNA was used on any metaphase slide. If amplification and 
labelling were successful from a single cell, the hybridisation signals would 
appear homogeneous and intense. Failed hybridisation usually presented
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with background noise or coarse granularity over the metaphase 
chromosomes. One-colour hybridisation was used to evaluate the 
efficiency of the test probes in order to prevent lengthy, uninformative 
CGH experiments. No further CGH experiment would be carried out if one- 
colour hybridisation appeared dim or produced no signal. A poor one- 
colour hybridisation test might indicate single cell PCR failure, which might 
result from cell loss, contamination or inefficient labelling.
3.16 CGH from a single amniocyte
To prove the feasibility of single cell CGH and its performance in predicting 
chromosome aberrations, a single cell with a known numerical 
chromosomal abnormality was retrieved from cultured amniocytes. For 
visual assessment of colour change over designated chromosomes, 
trisomy 18 was a preferred candidate over chromosome 2 1 , because the 
size of the chromosome 18 was relatively easier to identify than 
chromosome 21. Test DNA was firstly co-hybridised with normal genomic 
DNA from opposite sex DNA. Subsequent experiments used amplified 
reference DNA with same sex.
3.16.1 Trisomy 18
Test DNA probe was prepared from a single trisomy 18 female cell, while 
normal reference DNA was from SpectrumRed male total human genomic 
DNA. The CGH displayed uniform hybridisation for both test and reference 
DNA. The fluorescent intensity of sex chromosomes could be viewed as a 
qualitative internal control for optimal CGH results. In this case, the X 
chromosomes displayed more green while Y chromosomes displayed 
more red over upper part of the Y chromosomes (heterochomatic region 
was suppressed with Cot-1 DNA and stained with DAPI). Chromosome 18 
homologues also displayed more green than other chromosomes (Figure 
3.31). Similar findings were noted over the majority of CGH images, and 
these were then utilised for quantitative analysis.
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Global analysis demonstrated green colour over chromosome 18 and X 
chromosome, while the Y chromosome was painted with red (Figure 3.32). 
Ratio profiles analysis using 0.8 and 1.2 to represent chromosomal losses 
and gains demonstrated chromosome gains over X and chromosome 18, 
while Y chromosome displayed losses (Figure 3.33). The quantitative ratio 
profiles findings were concordant with the preliminary visual assessment of 
the CGH images. Since reference DNA was from a normal male, the 
presence of chromosomal gains over chromosome X, 18 and 
chromosomal losses over Y chromosome indicated that test DNA was 
from female DNA with extra copy of chromosome 18. In this single cell 
CGH experiment, test DNA was prepared from amplified DNA, whereas 
reference DNA was prepared from total genomic DNA. The results showed 
that heterochromatic regions of chromosome 1, 9 and acrocentric 
chromosomes displayed more red than green. The euchromatic region of 
Y chromosome displayed red while the heterochromatic region was 
painted with blue.
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Figure 3.31: CGH karyotyping from a female trisomy 18 amniocyte. By 
computer software, karyotyping was carried out automatically with manual 
correction. Five to ten metaphases were required for objective quantitative 
fluorescent ratio profile analysis. Since normal male DNA was used for co­
hybridisation, the X chromosome showed a greenish colour (2X/1X) while 
the Y chromosome showed a reddish colour (0Y/1Y). Chromosome 18 
also showed a greenish colour (3/2).
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Figure 3.32: Single cell CGH of female trisomy 18 co-hybridised with normal male 
DNA. Left column: CGH images. Right column: global analysis derived from 
respective CGH images on the left. In global analysis, a three-colour lookup table 
in ratio image indicates chromosomal gains and losses. Gains are indicated in 
green, losses are indicated in red, and normal chromosomal complements are 
indicated in white.
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Figure 3.33: Quantitative fluorescence ratio profile from a female trisomy 
18 amniocyte co-hybridised with normal male DNA. Test DNA was from 
amplified DNA while reference DNA was from total genomic DNA. 
Quantitative CGH analysis used a fluorescence ratio of 1.2 (green line) to 
represent chromosome gains and 0.8 (red line) to represent chromosome 
losses. Chromosome gains were noted over chromosomes 18 and X and 
were represented as green bars to the right of idiogram. The red bar to the 
left of Y idiogram represented reference DNA was from a male. 
Heterochromatic and telomeric regions were excluded from analysis.
119
3.16.2 Trisomy 21
Test DNA probe was prepared from a single, trisomy 21, female cell, while 
normal reference DNA was from SpectrumRed male total human genomic 
DNA. Qualitative CGH images displayed more green over chromosome X 
and 21, while chromosome Y showed a red colour (Figure 3.34). Global 
analysis showed chromosome gains over the majority of the chromosome 
21 homologue. False positives were noted over other chromosomal 
regions; however, these false chromosome gains did not involve 
chromosome homologues in a single CGH image. Unlike universal gains 
over chromosome 2 1 , false positives involving other chromosomes were 
usually episodic and not consistent. For ratio profile assessment, the 
number of false positives was 17 when cut-off value was set at 0 . 8  and 1 . 2  
to represent chromosomal losses and gains, respectively (Figure 3.35). 
However, false positives were reduced to minimum if a more stringent cut­
off value was employed (Figure 3.36). The experiment was repeated, and 
the results still showed 8  false positives when a low stringency cut-off 
value was applied.
Another experiment involving female trisomy 21 was carried out by using 
reference DNA from amplified DNA (e.g. 10 ng female diluted DNA). 
Despite some false positives, the majority of chromosome 21 homologues 
demonstrated more green when global analysis was applied (Figure 3.37). 
Since both test and reference DNA were from a female, the Y 
chromosome did not display obvious green or red as was seen in 
experiments employing mismatched sex DNA. The X chromosome 
showed no gain or loss and was depicted in white colour in global 
analysis. Centromeric and heterchromatic regions were mainly stained 
with DAPI (Figure 3.38). The ratio profile showed 6  false positives when 
low stringent cut-off value was applied (Figure 3.39). However, the number 
of false positives was reduced to one chromosome region when more 
stringent value was applied (Figure 3.40).
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Figure 3.34: CGH karyotyping from a female trisomy 21 amniocyte. Test 
DNA was from amplified DNA and co-hybridised with total genomic DNA 
from a normal male. The intersected picture of global analysis 
demonstrated chromosomal gains over chromosome X and 21, while the 
Y chromosome was painted with a red colour.
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Figure 3.35: Fluorescence ratio profile from a female trisomy 21 amniocyte 
co-hybridised with normal male DNA. Numerous false positives were 
noted when the threshold value was set at 1.2 and 0.8. Chromosome 
gains over the X chromosome and losses over the Y chromosome show 
that test DNA was from a female. (2X/1X, 0Y/1Y)
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Figure 3.36: False positives were reduced by using a more stringent 
threshold value. Detection of chromosome 21 was achieved and internal 
control of chromosome X (from mismatched sex) was still maintained. 
Compared to figure 3.38, false positives were eliminated when the cut-off 
values were set at 1.4 and 0.6 to represent chromosomal gains and 
losses, respectively.
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Figure 3.37: CGH images of amplified test DNA vs. amplified reference DNA. 
Test DNA was from a female trisomy 21 amniocyte while reference DNA was 
from 1ng female DNA. The Y chromosome was painted with DAPI (blue) in 
qualitative CGH images (left column). Global analysis (right column) showed a 
greenish colour over chromosome 21 homologue (3/2). The X chromosome was 
balanced (white, 2X/2X). Over-representation of other chromosomal regions was 
noted. However, they did not manifest in both chromosomal homologues.
. . V t - V
T , „
% V
>  \
§
I I
1 0  11 12
13 14
19 20
15 16 17 18
• »
21 22
Figure 3.38: CGFI karyotyping from a female trisomy 21 amniocyte. Test 
DNA was from amplified DNA and was co-hybridised with amplified DNA 
prepared from 1 ng female DNA. The intersected CGH image 
demonstrated that both chromosome 21 homologues are greenish. The X 
chromosome was balanced and the Y chromosome was painted with blue.
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Figure 3.39: Fluorescence ratio profile from a female trisomy 21 amniocyte 
co-hybridised with amplified normal female DNA. False positives were 
noted over chromosomes 2, 3, 4, 5, 6, and 11 when the threshold values 
were set at 1.2 and 0.8. No chromosome gain or loss was seen over the X 
chromosome (2X/2X).
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Figure 3.40: Fluorescence ratio profile using stringent cut-off values. The 
number of false positives was reduced to one chromosomal region on 
chromosome 4q when the cut-off values were set at 1.4 and 0.6. 
Heterochromatic and telomeric regions were excluded from ratio profile 
analysis.
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3.17 CGH for microdissected stained cells
To test the sensitivity and reliability of CGH from minute quantities of DNA, 
archived slides afforded a range of specimens for CGH experiments. The 
size distribution of PCR products from archived fixative-treated stained 
cells was usually smaller than those prepared from fresh cells. DOP-PCR- 
CGH procedure was similar except for the lysis conditions. Compared to a 
one-hour lysis for single amniocytes, stained cells required lengthy 
incubation in order to achieve cell lysis. DOP-PCR-CGH experiments 
failed when a one-hour lysis protocol was applied, whereas it improved 
substantially when a longer lysis time was adopted (e.g. 1-3 days).
3.17.1 Trisomy 18
Stained cells from a male trisomy 18 were co-hybridised with 
SpectrumRed female total genomic DNA. The CGH results displayed that 
the X chromosomes were stained with red while euchromatic parts of the 
Y chromosomes were stained with green (Figure 3.41). Heterochromatic 
regions of chromosomes 1, 9, 16, and acrocenric chromosomes showed 
more red than green. The majority of chromosome 18 homologues also 
displayed more green than other chromosomes. Global analysis revealed 
chromosome gains over chromosome 18 and Y while chromosome loss 
was noted over the X chromosome. Although false positives were noted 
over other chromosomal regions, these were sporadic and did not show 
universal pattern as chromosomes X, 18 and Y (Figure 3.42). Ratio profile 
analysis displayed 6  false positives over other chromosomal regions when 
cut-off values were set at 1.2 / 0.8. However, a correct diagnosis was 
made if more stringent values of 1.4 / 0 . 6  were set (Figure 3.43).
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Fig 3.41: CGH karyotyping from male trisomy 18 stained cells. Test DNA 
was from amplified DNA and co-hybridised with normal female total 
genomic DNA. The intersected CGH image demonstrated that both 
chromosome 18 homologue and euchromatic parts of the Y chromosome 
are painted with a greenish colour, while the X chromosome was reddish.
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Figure 3.42: Global analysis for trisomy 18 from stained cells. Over­
representation of chromosome regions was painted with green, while a red 
colour represented chromosome losses. A high consistency of 
chromosome gains was noted on both chromosome 18 homologue, 
whereas false positive regions did not display a similar phenomenon. The 
X chromosome was painted with red while the euchromatic part of the Y 
chromosome was painted with green.
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Figure 3.43: Fluorescence ratio profile from male trisomy 18 stained cells 
co-hybridised with normal female DNA. Chromosome gains were noted 
over chromosome 18 (3/2) and the Y chromosome (1/0), while the X 
chromosome (1X/2X) displayed chromosome losses when the threshold 
values were set at 1.4 and 0.6.
131
3.17.2 Trisomy 21
Test DNA was from female trisomy 21 stained cells, and reference DNA 
was from female total genomic DNA. CGH results showed more green 
over chromosome 21 homologues, while the Y chromosome was painted 
with a blue colour (Figure 3.44). Since there were no chromosome gains 
or losses (2X/2X), the X chromosome appeared balanced between green 
and red colour. This status was depicted with a whitish colour in global 
analysis (Figure 3.45). The ratio profile showed 3 false positives over 
chromosome 9 and 11 when the cut-off values were set at 1.2/0. 8  (Figure 
3.46). False positives were eliminated when a stringent value of 1.25 was 
set to represent chromosomal gains (Figure 3.47).
3.18 CGH performance from coded samples of stained cells
3.18.1 Sample 753
This female test DNA was co-hybridised with male reference DNA. 
Qualitative CGH images displayed disparity of green colour over the X 
chromosome (Figure 3.48). The long arm of chromosome X appeared 
unanimously greener than the short arm. To confirm the diagnosis of a 
potential sex chromosome anomaly, test DNA was further co-hybridised 
with female reference DNA. Qualitative CGH images displayed apparent 
red over Xp, while Xq remained a green colour (Figures 3.48; 3.49). The 
euchromatic part of the Y chromosome appeared bright red when test 
DNA was co-hybridised with male DNA, whereas it stained with DAPI 
when both test and reference DNA were from the same sex (i.e. female). 
Combining the results of two CGH experiments, the chromosomal gain 
over Xq and loss over Xp was interpreted, and a diagnosis of 
isochromosome Xq was made. Quantitative ratio profiles were compatible 
with the preliminary qualitative CGH impression (Figures 3.50; 3.51). The 
karyotype result of sample 753 was 46,X, i (X)(q10) (Figure3.52).
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Figure 3.44: CGH karyotyping from female trisomy 21 stained cells. Test 
DNA was from amplified DNA and co-hybridised with normal female total 
genomic DNA. The intersected CGH image demonstrated that both 
chromosome 21 homologues are greenish (3/2). The X chromosome was 
balanced (2X/2X) and the Y chromosome was painted with blue (OY/OY).
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Figure 3.45: Global analysis for trisomy 21 from stained cells. Over­
representation of chromosome regions was noted on both chromosome 21 
homologs (3/2), while other false positive regions did not display a similar 
phenomenon. The X chromosome was painted with white (2X/2X) while the Y 
chromosome was painted with blue.
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Figure 3.46: Fluorescence ratio profile from female trisomy 21 stained cells 
co-hybridised with normal female DNA. Chromosome gains were noted 
over chromosomes 9, 11 and 21 when threshold values were set at 1.2 
and 0.8 to represent chromosome gains and losses, respectively. No 
chromosome gain or loss was seen on the X chromosome (2X/2X).
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Figure 3.47: Fluorescence ratio profile using stringent cut-off values. False 
positives were eliminated when stringent cut-off values were set at 
1.25/0.75 to represent chromosome gains and losses, respectively.
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Figure 3.48: CGH and global analysis for an isochromosome Xq. The upper 
images showed test DNA co-hybridised with normal male DNA. Chromosome 
gain was noted over Xq (3Xq/1Xq) and was shown painted with green, while Xp 
was in balanced status (1Xp/1Xp). The idiogram of the X chromosome showed 
chromosome over-representation (green bar) over Xq arm. The lower images 
showed test DNA co-hybridised with normal female DNA. Chromosome gain was 
noted over Xq (3Xq/2Xq) and was painted a greenish colour, while Xp was under­
represented (1Xp/2Xp) and was painted a reddish colour. The idiogram of the X 
chromosome showed chromosome over-representation (green bar) over the Xq 
arm and under-representation over the Xp arm (red bar).
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Figure 3.49: CGH karyotyping for an isochromosome Xq. A sex chromosome 
anomaly was confirmed when iXq stained cells were co-hybridised with normal 
female total genomic DNA. A1: CGH image displayed a greenish colour over Xq 
while Xp displayed a reddish colour. A2: Global analysis from A1 also displayed 
chromosome gains over Xq and chromosome loss over Xp. B: CGH karyotyping 
from A1. The Y chromosome was painted with blue (OY/OY).
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Figure 3.50: Fluorescence ratio profile from iXq stained cells co-hybridised 
with normal male DNA. Chromosome gains were noted over chromosome 
Xq (3Xq/1 Xq) when threshold values were set at 1.2 and 0.8 to represent 
chromosome gains and losses, respectively. The Y chromosome showed 
chromosome loss (0Y/1Y) and was depicted as a red bar to the left of Y 
idiogram.
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Figure 3.51: Fluorescence ratio profile from iXq stained cells co-hybridised 
with normal female DNA. Chromosome gains were noted over 
chromosome Xq (3Xq/2Xq) when threshold values were set at 1.2/0.8, and 
was depicted as a green bar to the right of chromosome X idiogram. 
Chromosome loss was noted on Xp (1Xp/2Xp) and was depicted as a red 
bar to the left of chromosome X idiogram.
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Fig 3.52: A G-banded karyotype of sample 775 shows 46,X, i (X)(q10).
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3.18.2 Sample 1495
This female DNA was co-hybridised with male reference DNA. Visual 
assessment of digital images did not have a definite conclusion initially. 
Quantitative ratio profiles, using 1.2 and 0.8 as cut-off values, displayed 
chromosomal gains over the X chromosome together with other tiny 
regions over chromosome 12q, 12p, 16p, and 22q (Figure 3.53). When 
more stringent values were adopted (i.e. 1.5), only 12p displayed gains, 
while internal control of the X chromosome was still maintained (i.e. 
2G/1R, 2 copies of X chromosome in test DNA versus 1 copy of X 
chromosome in reference DNA) (Figure 3.54). Global analysis also 
demonstrated that chromosome gains occurred over most of the 
chromosome 12p homologues (Figure 3.55). CGH interpretation was 
partial trisomy 12. The karyotying of the sample 1459 was 46,XX, der (10) 
t (10; 12)(q26.13, p11.23)- a karyotype resulting in trisomy for 12p with an 
effective monosomy of the terminal region of 10q (Figure 3.56).
An additional CGH experiment was carried out using reference DNA from 
normal male amplified DNA. This amplified DNA was prepared from a 
matched number of normal stained cells. The results showed multiple false 
positives even when stringent threshold was set, whereas the internal 
control of X chromosome was still maintained (Figure 3.57). More red was 
noted over chromosome 1 p, 16, 17, 19, 22. Heterchromatic regions of 
chromosomes 1, 9 and acrocentric chromosomes were stained with DAPI 
(Figure 3.58).
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Figure 3.53: Fluorescence ratio profile from female trisomy 12p stained cells. The 
test DNA was co-hybridised with normal male DNA. Chromosome gains were 
noted over chromosomes 1, 12, 16, 22 and X when threshold values were set at 
1.2/0.8 to represent chromosome gains and losses. Chromosome loss was noted 
on the Y chromosome.
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Figure 3.54: Quantitative analysis using stringent cut-off values. Over­
representation of chromosome 12p was maintained when stringent cut-off 
values were set at 1.25 and 0.75 to represent chromosome gains and 
losses, respectively, while false positives were reduced to a minimum.
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Figure 3.55: Global analysis of CGH from a female trisomy 12p co-hybridised 
with normal male DNA. Left column (A1-C1): CGH images. Right column (A2- 
C2): Global analysis of CGH images from the left side. Despite several false 
positives, only chromosome 12p homologues displayed universal chromosomal 
gains.
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Fig 3.56: a: A G-banded karyotype of sample 1495 shows 
46,XX,der(10)t(10;12)(q26.13;p11.23). b\ shows partial G-banded 
karyotype of parent of 1495 carrying balanced translocation
t(10; 12)(q26.13;p11.23).
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Figure 3.57: Fluorescence ratio profile from female trisomy 12p stained 
cells. The test DNA was co-hybridised with amplified normal male DNA. 
Chromosome gains were noted over chromosomes 5, 7, 9, 11, 12, 13 
and X. Chromosome losses were noted over chromosomes 1, 16, 17, 
19, 20 and Y when threshold values were set at 1.2/0.8.
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Figure 3.58: CGH karyotyping from female trisomy 12p stained cells. Test 
DNA was from amplified DNA and co-hybridised with normal male 
amplified DNA. CGH images showed a greenish colour over the X 
chromosome and a reddish colour over euchromatic part of the Y 
chromosome. Under-representation was noted over chromosomes 1 p, 16, 
17, 19, 20 and 22.
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3.18.3 Sample 445
This female DNA was co-hybridised with male reference DNA. No 
apparent diagnosis was made from CGH digital images except for the sex 
(Figure 3.59). When cut-off values were set at 1.2 and 0.8, quantitative 
ratio profiles displayed 5 regions of chromosomal gains and 2 regions of 
chromosomal losses over two different hybridisation areas (Figure 3.60). 
Ratio profiles revealed a normal female when stringent values of 1.3 and 
0.7 were set, while internal control of the X chromosome was still 
maintained. The karyotype of this sample was 46,XX, del (2)(p12-p13) del 
(11)(q25-qter) t (2,11) (Fig 3.61). Chromosome analysis reveals a 
translocation between the short arm of one chromosome 2  and the long 
arm of one chromosome 11. This translocation appears to be unbalanced 
with the region (2)p12->p13 missing from the derivative chromosome 2  
and the region (11 )q25->qter missing from the derivative chromosome 11. 
This is an unbalanced karyotype resulting in monosomy for these regions 
of chromosomes 2 and 11. The CGH results showed that small deletions, 
at band level, might not be detected at a single cell level.
3.19 CGH performance from manufactured mosaics
The results demonstrated that CGH was unable to detect trisomy 18 at 
70% mosaic level using the current protocol (Figure 3.62). Qualitative 
digital images did not display more green over targeted chromosome 18 
and X. The resulting diagnosis would be a normal female under such 
circumstances (Figure 3.63).
3.20 CGH for blastomeres
DNA prepared from single blastomeres was tested with SpectrumRed 
reference DNA from both sexes. CGH images showed uniform 
hybridisation for the majority of the hybridisation area (Figure 3.64). 
Qualitative ratio analysis demonstrated multiple gains/losses when 
threshold values were set at 1.2/0.8 (Figure 3.65).
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Figure 3.59: CGH images obtained from stained cells with tiny chromosomal 
deletions. A1: Qualitative CGH image displayed uniform hybridisation for both 
test and reference DNA. A2: Global analysis showed that the X chromosome was 
painted with a greenish colour (2X/1X) while the Y chromosome was painted with 
a reddish colour (0Y/1Y). B: CGH karyotyping revealed a greenish colour over 
the X chromosome.
150
■u
M
nu—1
a-
<>
>|
>
n = 14
19
□ i t=!«L
n = 16 
20
a
j|W
LJ
m
au
— I
a
u
n =  15
J i
su
u
n = 14 n = 14 n=  15
2L
n = 16 
21
n =  15 
10
n = 16 
16
n = 15 
22
Q
— i
au=aL_!□ua
n = 14
r
u
■y A
n = 12 
11
n = 14 
17
J
a*t_i
Sa
n = 13 
5
*
<
<
n = 14
12
<
n = 15
18
Figure 3.60: Fluorescence ratio profile of small chromosome deletions. 
The test DNA was co-hybridised with normal male DNA. Chromosome 
gains were noted over chromosomes 1 and X. Chromosome losses were 
noted over chromosomes 4, and Y when threshold values were set at 
1.2/0.8 to represent chromosome gains and losses, respectively. For 
single cell CGH, accurate prediction might not be available for small 
chromosome deletions at a single band level.
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Fig 3.61: A G-banded karyotype of sample 445 shows
46lXX,der(2)del(2)(p12-p13),der(11)del(11)(q25),t(2;11)(p13;q25).
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Figure 3.62: CGH images from 70% manufactured mosaics of male 
trisomy 18. Test DNA was from amplified DNA while reference DNA was 
from normal male DNA. CGH karyotyping showed a greenish colour over 
the X chromosome, but chromosome 18 did not show a greenish colour 
change.
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Figure 3.63: Fluorescence ratio profile for 70% manufactured mosaics of 
male trisomy 18. Chromosome gains were noted over the X chromosome 
and chromosome losses were noted over the euchromatic part of the Y 
chromosome when thresholds were set at 1.2/0.8 to represent 
chromosome gains and losses, respectively.
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Figure 3.64: CGFI images from a single blastomere. The test DNA was co­
hybridised with total female genomic DNA. Mixed CGH images were 
pseudocoloured into green, red and blue colour, respectively.
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Figure 3.65: Fluorescence ratio profile from a single blastomere. The test 
DNA was co-hybridised with normal male DNA. Chromosome gains were 
noted over chromosomes 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 18, 19, 21 and 
X, while chromosome losses were noted over the Y chromosome when 
thresholds were set at 1.2/0.8 to represent chromosome gains and losses, 
respectively.
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3.21 Time consideration for CGH
The current described procedure, including retrieval of single amniocytes, 
lysis of cells, and preparation for DOP-PCR, usually took one working day. 
DOP-PCR, which took around 5 hours, was performed as an overnight 
procedure. Subsequent PCR labelling took around 3 hours and was 
carried out on the second day. Preparation for CGH experiments required 
two hours. After this, it took 48-72 hours for two colour hybridisation, and 2 
hours for post-hybridisation washing. Image capture and analysis took 
around 3-4 hours, depending on image quality and complexity of 
diagnosis. Therefore, in total it took some 5-6 days to complete the whole 
process for DOP-PCR-CGH from fresh single amniocytes.
3.21.1 Overnight CGH
To shorten the time requirement, the feasibility of a short protocol involved 
overnight CGH was tried. CGH results were investigated by testing the 
current protocol and a protocol using triple DNA concentration. The 
preliminary results showed that both protocols could produce uniform and 
intense hybridisation signal within 21-23 hours (Figure 3.66). An ultra-short 
protocol using a one-hour hybridisation was tried; however, despite most 
chromosomes being painted under the fluorescent microscope, the 
hybridisation quality was not suitable for ratio profile analysis. All short 
protocol results were tested for visual assessment and not analysed 
quantitatively.
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Figure 3.66: CGH images from an overnight protocol. Test DNA was from 
30 pi labelling probe, which was prepared from a blastomere. Intense 
greenish painting was noted after around 21 hours’ hybridisation.
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3.22 False positives in CGH experiments
False positive findings were a common phenomenon in ratio profile 
analysis in single cell CGH experiments. Depending on the selection of 
cut-off values, the number of false positives could vary even when using 
the same test and reference DNA. Although the theoretical fluorescence 
ratio cut-off values for trisomy and monosomy in CGH analysis are 1.5 and 
0.5 respectively, these values were rarely achieved in real CGH 
experiments (usually resulting in false negatives at such stringent values). 
When less stringent cut-off values were set at 1.2 and 0.8 to represent 
chromosomal gains and losses respectively, smaller copy number 
changes might be detected at the expense of more false positives. On the 
contrary, false negatives might occur if a more stringent cut-off value was 
applied. To minimize false positives, and produce no false negatives, for 
the targeted chromosome and internal control of X chromosome, 
adjustment of the cut-off values were retrospectively manipulated to retain 
the balance between false negative and false positive results (Table 3.5). 
Ratio profiles using stringent cut-off values would reduce the false 
positives. When less stringent cut-off values were set at 1.2 and 0.8 to 
represent chromosomal gains and losses respectively, the average 
number of false positive regions was 5 (inconclusive cases were 
excluded).
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Test DNA Reference DNA FP FR* FP* CGH results
Single amniocyte
47.XX+21 M 8 0.5-1.5 1 Trisomy 21, female
47.XX, +21 PCR*-F 6 0.7-1.3 0 Trisomy 21, female
47,XX, +21 M 17 0.6-1.4 0 Trisomy 21, female
47,XX, +18 M 0 0.8-1.2 0 Trisomy 18, female
Stained cells
47,XY, +18 F 6 0.6-1.4 0 Trisomy 18, male
47.XX, +21 F 3 0.7-1.25 0 Trisomy 21, female
47.XX+21 M 1 0.7-1.3 0 Trisomy 21, female
46,XY F 4 0.8-1.3 0 Male
46,XX M 0 0.8-1.2 0 Female
753, female M 6 0.55-1.45 0 Isochromosome X
753, female F 3 0.7-1.3 1 Isochromosome X
1495, female PCR*-M 22 0.5-1.5 7 ? inconclusive
1495, female M 5 0.8-1.25 0 Trisomy 12p, female
445, female M 5 0.7-1.3 0 Female
445, female M 1 0.7-1.3 0 Female
FP: number of false positives occurring when fluorescence ratio cut-off value was set at 0.8 and 1.2
to represent the chromosomal losses and gains, respectively.
FR*: Retrospective manipulation of stringent cut-off value to result in less false positives and no 
false negative.
FP*: number of false positives occurring when FR* was set as indicated.
M: SpectrumRed normal male DNA 
F: SpectrumRed normal female DNA 
PCR*-F: Amplified female DNA.
PCR*-M: Amplified male DNA.
753: 46,X, i (X)(q10)
1495: 46,XY, der (10) t (10; 12)(q26.13, p11.23)
445: 46,XX, del (2)(p12-p13) del (11)(q25-qter) t (2,11)
Table 3.5: CGH results of single amniocytes and stained cells
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Chapter 4
Discussion
4.1 Manipulation techniques for single cells
To suit various kinds of research purposes, many studies involving single 
cell genetic analyses are carried out by testing simplified methods on 
tissues which are relatively easily available (Beltinger 1997, 1998; Schaaff 
et al 1996). Prior to real preimplantation diagnosis, a number of studies 
have also applied their analytical methods on single cells from different 
sources (Cui et al 1994, Schaaff et al 1996, Wells et al 1999). To retrieve 
single cells, this study applied heat-pulled micropipettes and simple 
needles both on cell suspensions and on archival cytogenetic slides. The 
research aim was to prove the feasibility of single cell genetic analysis 
using PCR and CGH techniques.
Single cell retrieval is an elaborate and tedious process. To validate that 
only one cell was retrieved requires stringent negative controls. In 
comparison, the microdissection used in this study is a relatively simple 
technique. Using this technique, an approximate number of 10-20 cells 
can easily be distinguished and isolated. Despite the efforts to completely 
transfer microdissected cells, small amounts of scraped material may 
remain on the slides. Incomplete transfer of microdissected materials may 
not be problematic for allele detection; however, it can lead to false 
interpretation when global investigation such as CGH technique was 
applied. For this reason areas of slides containing metaphases was 
avoided, because the actual chromosome constitution of a sample may 
not be reflected if only part of a metaphase is included.
In theory, accurate CGH diagnosis is possible only if over 50% of cells 
transferred remain intact. Correct CGH diagnosis of trisomy 18 and 21 in 
this study indicates that the current simplified method has successfully 
transferred at least 5-10 intact cells into the PCR tubes. However, the 
results may not be accurate if fewer cells are transferred. PCR can be 
biased particularly when the starting template is from a single cell. 
Misdiagnosis may occur when part of the genome is damaged by the 
microdissecting procedure.
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Since stained cells are fixed on the slide, microdissection procedures will 
inevitably damage the cells. So far no reliable method is available to 
assess whether single cells have been safely transferred into PCR tubes 
or not. To improve the chance of successful genetic analysis, transfer of 
more than one cell is preferred. However, a less traumatic design may be 
required particularly when only one cell is available (Takabayashi et al
1995). The future prospect of applying CGH techniques to a single cell 
retrieved from a slide is promising if during the transfer the cell genome 
remains intact.
4.2 Lysis protocols and the effect of cell storage for PCR
Single cell genetic diagnosis may fail due to several causes. One of the 
hypotheses is a blockade of a particular genomic site due to incomplete 
lysis. This may explain a proportion of amplification failures and the 
phenomenon of ADO (Wells et al 1998). The selection of any cell type will 
theoretically make no difference if the nuclear genome is fully exposed and 
available for the PCR reaction. However, cell preparation may have an 
impact for subsequent genetic analysis as the current lysis protocol for 
fresh cells could not produce similar results from fixative-treated stained 
cells. Extension of lysis time from 1 hour to one day produced optimal 
CGH results in the stained cell study. It appears that both the reagents 
and the time required for cell lysis can affect the PCR outcome.
In this study, samples were selected from fresh amniocytes, frozen 
amniocytes, buccal cells, fixative-treated lymphocytes, and stained cells. 
Although one-hour lysis was adequate for fresh single amniocytes, 
archival stained cells required a longer time. Fresh amniocytes stored in 
sterile culture medium were the best candidates as they were clean and 
relatively easy to identify. Any potential lysed DNA in the culture medium 
could also be eradicated through repeat washes with PBS. Apart from 
poor PCR performance due to the presence of fixative, cells in fixative 
suspension were not suitable for cell manipulation for technical reasons. 
Despite the advantage of easy identification and retrieval, buccal cells had
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plentiful debris which might increase the chance of contamination in the 
DOP-PCR reaction.
It has been suggested that the use of lysis buffer may play a role in 
decreasing the incidence of ADO. The phenomenon of allele specific 
amplification failure is at least in part dependent on the lysis buffer used 
according to one study. El-Hashemite et al (1997) compared two different 
lysis buffers for PCR performance: KOH/dithiothreitol (DTT) and sodium 
dodecyl sulphate (SDS)/proteinase K (PK). None of the cells lysed by 
SDS/PK showed any evidence of allele-specific amplification failure 
whereas ADO was observed in 4.7% and 17.6% of the HbC and CF cells 
lysed with KOH/DTT respectively (El-Hashemite et al 1997).
SDS is a strong detergent which disrupts membrane lipids, while 
proteinase K digests proteins without interfering with the DNA template 
prior to amplification. In contrast, the contents of alkaline buffer solution 
may interfere with the DNA template, because KOH will denature DNA and 
leave it in a single stranded state. Moreover, DTT does not digest protein 
but breaks the disulphide (S-S) bonds. The denatured DNA and the 
presence of undigested proteins may lie behind the failure of allele specific 
amplification, which is not the case with SDS/PK.
For comprehensive chromosome analysis from a single cell, complete 
removal of DNA-binding protein is necessary as this will help expose the 
DNA template for whole genome amplification. However, the sub-optimal 
performance of allele detection may not be entirely associated with lysis 
buffer. Mechanical damage of the template DNA, the fixative treatment, 
and the analytical methods may all have influences on PCR performance. 
Although successful locus detection of single cells is possible by simple 
boiling (Liu et al 1994), this study prefered inclusion of proteinase K and 
SDS for removal of nuclear protein prior to WGA. Successful CGH in 
diagnosing major chromosome abnormalities in this study indicates that 
inclusion of SDS and proteinase K is an adequate lysis method for current 
single cell CGH protocol.
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It is generally recognised that degraded tissues such as paraffin- 
embedded samples will contain a large proportion of fragmented DNA 
which will jeopardise the PCR performance. Further genetic analysis 
usually fails because of preferential amplification of short products or 
complete failure of amplification. Nevertheless, it was possible to extract 
DNA sequences up to 200 bp from paraffin-embedded samples (Gupta et 
al 1997). The efficiency of single cell PCR from archival pathologic slides 
revealed 11-25% depending on the size of amplified fragments. The 
average degree of DNA disintegration in paraffin-embedded, stained 
tissues gives fragments of around 100 bp (Roehrl et al 1997). For archival 
cytogenetic slides, Choi et al (1999) reported a 100% detection rate of sex 
and exon 46 of the dystrophin gene. However, PCR amplification was 
carried out by scraping all the cells off the slide, and hence this was not 
performed at the single cell level (Choi et al 1999).
For one single cell, Beltinger successfully combined a simple 
microdissection procedure and nested PCR on a cell derived from 
peripheral blood smears (Beltinger et al 1997, 1998). By using ligase- 
mediated PCR/CGH, Klein et al successfully proved the feasibility of whole 
genome screening from a metastatic cancer cell in the bone marrow. 
(Klein et al 1999) This study confirmed that, by using the DOP-PCR/CGH 
technique, detailed chromosome analysis could be achieved from a 
starting template of 10-20 stained cells scraped from G-banding slides. 
Moreover, up to 72% locus detection (i.e. CFTR) was also attained from 
these samples. As DOP-PCR produced a smear ranging from 200-1500 
bp from stained cells, the fragmented sequences encountered from the 
extracted paraffin-embedded tissues are no longer available for G-banding 
slides. Compared with the paraffin-embedded specimens, it appears that 
methanol/acetic acid-treatment causes less damage to the integrity of 
DNA, and therefore results in a higher success rate for molecular genetic 
analysis. As the cells used for non-invasive prenatal diagnosis are usually 
methanol/acetic acid-treated, this will increase the chance of successful
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diagnosis. Further work is needed to prove these techniques before they 
can be incorporated in the field of non-invasive prenatal diagnosis.
4.3 Prevention of contamination
The large number of PCR cycles required for sufficient amplification from a 
single genome intensifies many of the problems encountered in the routine 
PCR of relatively large amounts of DNA. With the starting template DNA of 
one single molecule, the risk of contamination with extraneous DNA 
sequences is the main problem that must be avoided by implementation of 
stringent experimental practices.
For PGD, it is recommended to set up single cell reactions in a room 
designated for this purpose and separated from the laboratory where 
analyses of PCR products take place. (Wells et al 1998). Some sources of 
contamination, however, are intrinsic to specific procedures. Extraneous 
DNA from sperm or maternal cumulus cells is a potential source of 
contamination. Many sperm may be embedded in the zona pellucida after 
IVF and may accidentally be sampled along with the blastomeres during 
embryo biopsy. Based on the poor CGH prediction of manufactured 
mosaicism in this study, reliable CGH diagnosis is unlikely if contamination 
occurs at this stage. Although complex mosaicism seems to be a common 
phenomenon in early embryo development, efforts to screen all the 
chromosomes using CGH techniques required more studies to confirm its 
reliability. Currently, the consistency of single cell CGH is still troubled by 
some technical difficulties such as data interpretations, the problems of 
false positives, and the tolerance of mosaicism (e.g. contamination). To 
overcome the hazard of contamination, a combination of DNA 
fingerprinting prior to single cell CGH may improve the reliability if CGH 
technique is to be used in PGD. (Kuliev et al 1998; Findley et al 1995) 
Precautions to avoid contamination of DOP-PCR protocol have also been 
mentioned in other reports (Telenius et al 1992a; Speicher et al 1993). In 
this study, significant contamination is manifested by an intense smear in 
negative controls, which are indistinguishable from smears derived from
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single cells. Throughout the study period involving single cell analysis, two 
stage DOP-PCR usually resulted in an intense smear which is 
indistinguishable from the negative control. This long protocol was 
abandoned in favour of single stage DOP-PCR. Unfortunately, a certain 
degree of smear was not an uncommon phenomenon in negative controls 
even in single stage DOP-PCR. Nevertheless, subsequent CGH 
experiments prepared from the smear of negative controls did not show 
hybridisation on human metaphases. Based on these experiences, further 
single cell CGH experiments can be carried on if apparent smear strength 
was noted between single cell DOP-PCR and negative controls. As DOP- 
PCR uses degenerate primers to amplify whole genome, certain forms of 
microorganisms can easily be amplified if containers and solutions are not 
totally sterilised.
4.4 Whole genome amplification
DOP-PCR is very efficient in producing a great amount of DNA from 
minute starting quantities. No smear could be detected on an agarose gel 
after 50 cycles of PEP, whereas an obvious smear was produced by use 
of DOP-PCR from a single cell. DOP-PCR yielded 10-20 pg of DNA in 50 
pi after 28 cycles of DOP-PCR. More than 10 separate PCR experiments 
could be carried out after primary DOP-PCR amplification and, in theory, 
limitless experiments could be executed if repeat DOP-PCR using 5 pi of 
primary DOP-PCR product was performed.
Although variation might occur for individual DOP-PCR reactions, the 
smear produced usually ranged from 200-2000 bp. The majority of the 
fragments were less than 1 0 0 0  bp; however, a wide range of sizes might 
be occasionally amplified. DOP-PCR amplification from stained cells 
usually yielded shorter sequences, with the bulk of the smear less than 
1000 bp. This variation might be due to degraded DNA or incomplete lysis. 
All experiments involving two-stage DOP-PCR produced a smear from 
negative controls. The smear strength could not be differentiated from 
positive controls. To prevent false amplification from many PCR cycles,
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two-stage DOP-PCR involving 60 cycles was not recommended. 
Preferential amplification of DOP-PCR evidenced by the presence of 
obvious bands amongst the background smear occurred occasionally. 
Other researchers had also mentioned the similar findings, which might be 
caused by extraneous non-human DNA or mitochondrial DNA (Telenius et 
al 1992; Vollaire et al 2000).
4.5 Genomic coverage and WGA
Several factors may affect the genomic coverage after WGA from a single 
cell: the degree of cell lysis, the method of WGA, and the strategy of 
analytical and detection methods. Zhang et al (1992) studied 12 genetic 
loci and estimated that the probability of amplifying any sequence in the 
genome to a minimum of 30 copies was no less than 78%.
Based on the number and sizes of DOP-PCR products, there were about 
one million fragments generated from the entire genome because 
degenerate primers probably could anneal every 4 kb. It is possible to 
anticipate that an arbitrary stretch of DNA has a one in six chance of being 
included in DOP-PCR product, if the average 500 bp sized product is 
produced in the haploid human genome (i.e. 3 x 109 bp). DOP-PCR 
usually amplified one-third of the genome, and the reaction is 
characterised with:
(1) production of non-specific DNA created by non-specific priming
(2) over-representation of highly repetitive DNA
(3) production of overlapping sets of DNA fragments (Cheung et al 
1996).
Compared with primers flanking long sequences, primers designed for 
short fragments usually produce higher detection rates; however, there are 
significant locus-dependent variations in amplification efficiency for specific 
WGA protocols (Schaaff et al 1996; Roehrl et al 1997; Wells et al 1998). 
Therefore, each locus of interest should be tested independently. Wells 
studied the genomic coverage at various loci (e.g. CFTR, amelogenin, 
APC, R-globin, and DNA markers at chromosome 21 and 18) after several
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versions of WGA (e.g. PEP, Tagged-PCR, DOP-PCR, Alu-PCR) (Wells D 
et al 1998). In their report, the PEP and DOP-PCR methods provided the 
most complete coverage of the genome with 91% and 89% of loci 
successfully amplified, respectively. Alu-PCR performed worst with only 
59% of loci being successfully amplified.
In this study the genomic coverage after DOP-PCR was investigated on 
two different loci by a strategy of nested PCR. Unlike fluorescent PCR, 
nested PCR is a relatively easy and cheap method, while its products can 
be analysed on a simple agarose gel. The results displayed 48% success 
rate for amelogenin locus and 72% success rate for CFTR locus. Instead 
of producing both X and Y bands for male cases, the phenomenon of 
single Y band might indicate that short Y fragments (371 bp) were 
amplified more efficiently than the long X fragments (555 bp) from DOP- 
PCR products. The occurrence of single Y band was not reported in the 
original report in which the sexes were analysed on PEP-amplified-DNA 
from 102 single amniocytes (Schaaff et al 1996). This demonstrated the 
altered detection patterns after different WGA methods. The results also 
indicated that the average size of DOP-PCR products might be too short if 
longer sequences were to be produced at the first round of nested PCR. 
Since DOP-PCR tends to amplify shorter fragments more effectively than 
longer ones, primers preferably aiming at short fragments may yield higher 
success rates than those aiming at longer fragments. This may also 
explain the different performance between the amelogenin locus (555 bp) 
and the CFTR locus (380 bp).
To improve the length of DOP-PCR fragments, an Expanded High Fidelity 
PCR (EHF-PCR) system aiming at longer fragments was tried; however, 
the results did not improve greatly in terms of producing longer fragments. 
Failure to produce longer products by an EHF-PCR system indicates that 
the nature of DOP-PCR or incomplete lysis may be the underlying causes 
which lead to the production of shorter fragments. To improve the success 
rate of locus detection using nested PCR, further study may focus on 
developing WGA protocols which will amplify longer fragments (Dietmaier
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et al 1999). Other improvements may depend on designing primers aiming 
at shorter fragments or on using more sensitive detection methods.
4.6 Optimisation of nested PCR for sex determination
A simple and reliable method of sex determination is important for prenatal 
and preimplantation diagnosis of X-linked recessive diseases. 
Simultaneous amplification of X- and Y-homologous regions is a 
convincing tactic because X-chromosomal fragments serve as an internal 
control for successful amplification. There will be no misdiagnosis due to 
amplification failure as seen in methods relying on amplification of Y- 
specific fragments only. A nested PCR strategy using ZFX/ZFY and 
AMGX/AMGY systems has been successfully applied to the PEP- 
amplified-DNA from single cells (Kristjansson et al 1994; Schaaff et al
1996).
For sex determination, a nested PCR strategy was applied directly to 
single cell or DOP-PCR-derived DNA in this study. The concentration of 
primers and the PCR cycling conditions were performed as the method 
described by Schaaff et al (1996); however, the results displayed extra 
bands. The production of unwanted bands indicated that preferential PCR 
amplification occurred between outer and inner primers during the 
secondary PCR reaction. Not only did the first PCR products remain but 
also extra fragments were produced. This phenomenon disappeared when 
the primer concentration was reduced from 400 nM to 100 nM. Compared 
with the original methodology, both methods transferred 1 pi of the first 
round PCR product into the second round PCR reaction mixture. Schaaffs 
method applied 5 pi (1 tenth volume) PEP products for the first part of 
nested PCR, whereas 5 pi (1 fifth volume) DOP-PCR products were added 
to a total volume of 25 pi in this study. Therefore, an excess of outer 
primer proceeded into the second PCR reaction, and competed with the 
inner primers.
The ADO phenomenon, which involved the failure of one allele being 
amplified during the first several cycles of PCR, might occur in male cases
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with only a Y band or in male cases being diagnosed as females. 
Therefore, this might occur in 17.2% (5/29) in this study. ADO generally 
affected 5-20 % of single cell amplifications (although in some instances 
the frequency was higher) and could be caused by sub-optimal PCR 
conditions and rapid degradation of the target DNA during thermocycling 
(Ray et al 1996; Wells et al 1998).
4.7 Mutation detection on amplified DNA
The advantage of using WGA in single cell genetic analysis is that more 
than one locus can be analysed from the same cell and repeated aliquots 
may be taken for independent tests in the event of ambiguous results (Ao 
et al 1998). This strategy also helps monitor ADO in dominant conditions 
(Ray et al 1996). For a recessive condition ADO will not lead to serious 
misdiagnosis because the affected embryo will still be detected as such. 
However, it may lead to failure to detect the abnormal mutant allele in 
dominant conditions. By analysing the mutation and polymorphism, the 
risk of misdiagnosis resulting from ADO at a single locus is significantly 
reduced.
In this study, the common 3 bp CF A508 deletion could be detected by 
nested PCR after DOP-PCR. Similar results were also achieved by using 
one-stage PCR. The underlying causes for detectable products from one- 
stage PCR might lie on the fact that longer PCR cycles were used and the 
shorter sequences were amplified.
4.8 Optimisation for single cell CGH
4.8.1 Selection of WGA for single cell CGH
Various WGA protocols have been applied in the cloning of 
microdissected chromosomes, single cell genotyping and preimplantation 
multi-locus analyses. These include DOP-PCR, prime-extension 
preamplification (PEP), Alu-PCR, Tagged-PCR, and restriction enzyme 
digestion followed by ligation-mediated PCR.
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To the best of knowledge in 2000, there have been no successful CGH 
results using PEP protocol as the amplification method from minute DNA, 
whereas reverse painting generated by DOP-PCR from chromosome 
microdissection has been reliably established by a number of studies 
(Speicher et al 1993; Meltzer et al 1992; Viersbach et al 1994). In this 
study, WGA using the PEP protocol was abandoned because of its 
inefficiency in producing adequate amount of DNA from single cells. In 
contrast, DOP-PCR proved to be an efficient technique involving multiple 
priming, which allows a more general amplification than other methods. 
Two rounds of DOP-PCR can yield 10 pg probe which allows more than 
five separate CGH experiments. As the current CGH technique is still 
limited by several technical factors, this productivity will help to re-confirm 
the diagnosis if the initial CGH experiments fail or produce equivocal 
results.
Apart from high yields of DOP-PCR, this study also demonstrated that 
uniform signals without any preference for centromeric and telomeric 
regions could be produced from single cell DOP-PCR/CGH protocol. 
However, the centromeric and telomeric regions are mostly stained with 
red colour when amplified DNA is co-hybridised with non-amplified DNA. 
As the experiments use more test DNA than reference DNA, the 
underlying cause due to the disproportion between amounts of test and 
reference DNA is unlikely. The best explanation may indicate DOP-PCR 
does not amplify preferentially over these regions from single cells.
Several other WGA protocols have been investigated in order to compare 
their reliability in producing uniform CGH images. Alu elements are 
preferentially found in the G-light bands of human chromosomes. 
Chromosome paints amplified by Alu-PCR showed a banding pattern 
(Telenius et al 1992). According to Wells’ study, single cell CGH produced 
from Alu-PCR showed extreme bias towards regions rich with Alu repeats 
with low CGH sensitivity in the Alu-deficient areas (Wells et al 1998). 
Tagged-PCR could give accurate single cell CGH results, but displayed a 
disproportionately high level of hybridisation to centromeric and telomeric
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regions and reduced signal intensity elsewhere on the chromosomes 
(Wells et al 1998).
4.8.2 Target metaphases
Selection of high-quality slides is crucial to the success of CGH 
experiments. Although proteinase K can remove nuclear protein, 
cytoplasm and debris, reducing the background and increasing probe 
penetration, this treatment did not significantly improve CGH results in this 
study. In addition, it may also diminish the quality of chromosomal 
morphology and banding patterns. Therefore, it is preferable to select 
metaphase slides containing little or no cytoplasm or debris rather than 
treating the slides with proteinase K.
Kahru et al (1997) developed a rapid denaturation test to identify sub- 
optimal metaphase spreads without having to perform unnecessary, 
lengthy, and expensive hybridisation procedures. Optimal metaphase 
slides have to tolerate denaturation to achieve complete uniform 
hybridisation along all chromosomes. Denaturation may have been 
excessive if a C-banding pattern emerges during the denaturation. 
Unfortunately, failed CGH experiments did still occur in this study despite 
the careful selection of metaphase slides both by morphology and by rapid 
denaturation tests.
Many of the unsuccessful CGH experiments could have been attributed to 
poor metaphase quality when slides were homemade in the early stage of 
this study. It appeared that metaphase preparations ideal for G-banding 
analysis were not necessarily optimal for CGH experiments. Although the 
number of successful CGH experiments increased when commercial 
slides were used, the quality of metaphase slides remained one of major 
obstacles in performing single cell CGH.
Commercial slides were convenient and usually presented with adequate 
numbers of metaphase spreads. However, the same morphological criteria 
and quality assessment should be evaluated prior to CGH experiments 
because some of these batches were not necessarily of uniform standard
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and high quality. Although denaturation at 75°C for 5 minutes was 
generally adequate for these slides, some batches required modification at 
lower temperature for less time (e.g. 73°C for 3-4 minutes). One-colour 
hybridisation might help select appropriate slides prior to real two-colour 
CGH.
So far the only certain criterion for slide quality is through performing an 
actual CGH experiment. The preparation and testing of slides for ideal 
CGH experiments is a labour-intensive process. Commercial slides afford 
a better choice for beginners or a laboratory where metaphase slides are 
not regularly produced. It also shortens both preparation time and the 
learning curve particularly for a difficult procedure such as CGH from 
minute DNA.
4.8.3 Labelling procedures
DNA was labelled indirectly in the early days of CGH development. 
Reporter molecules such as biotin or digoxigenin were detected via 
fluorochrome-coupled reporter binding molecules (Kallioniemi et al 1992). 
The major advantage of the indirect labelling method over the direct one is 
the strong intensity of hybridisation signals obtained by indirect labelling 
through several layers of signal amplification. Compared with indirect 
labelling, deoxynucleotides that have been directly conjugated with 
fluorochromes render a smooth but weak hybridisation signal along the 
chromosomes. This disadvantage can be overcome by the use of a 
sensitive CCD camera and high power illumination such as 100 W 
mercury lamps. The direct labelling method has become more popular 
because the procedure is simpler and requires less time. The accumulated 
experiences in this laboratory also show that direct labelling is a simple 
method and can yield intense hybridisation signals, low background and 
homogeneous coverage of target chromosomes.
One of the main applications of CGH to date has been in the field of 
malignancy. Most studies use tumour DNA as test DNA and normal total 
genomic DNA as reference DNA. These non-amplified DNA sources are
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further labelled by nick translation. Following the guidelines described by 
Kallioniemi et al (1994), the CGH results were usually inconsistent. 
However, the conditions improved when the amount of fluorochrome- 
conjugated nucleotide was raised from 2 pM to 4 pM, and the DNA 
amount was increased from 200 ng to 1 pg. Hybridisation artefacts across 
the genome can be inherent to specific fluorochromes. It may reflect an 
underlying difference in the way green and red molecules bind to DNA, or 
it can be related to a differential affinity of the fluorochromes to certain 
types of DNA families not homogeneously spread throughout the genome 
(Larramendy et al 1998). To produce a hybridisation with signal intensity 
equivalent to both SpectrumGreen and SpectrumRed labelled DNA, the 
commercial guidelines recommend the co-hybridisation of 200 ng 
SpectrumGreen to 100 ng SpectrumRed in a CGH experiment. Although 
the precise mechanism underlying hybridisation and labelling is not clear, 
interchanging the labels between test and reference DNA in CGH has 
been suggested as a method to confirm the CGH results (Kallioniemi et al 
1994; Larramendy et al 1998).
In various conditions involving small amounts of DNA, amplification of the 
starting DNA to a detectable level is a requisite for probe preparation. For 
amplified DNA, further labelling can be achieved either by nick translation 
or using a PCR method. Wells et al (1998) used a PCR method to label 
amplified-DNA and reported accurate diagnosis of major aneuploidies 
from several cell types such as amniocytes, fibroblasts and buccal cells. 
However, Voullaire et al (1998) used nick translation to label amplified- 
DNA and also reported reliable results in predicting common aneuploidies 
such as trisomy 13, 18, and 21 from single amniocytes. The single cell 
CGH results in this study also demonstrated that common aneuploidies 
(e.g. trisomy 21, 18, partial trisomy and sex chromosome aberration) could 
be reliably diagnosed by PCR labelling.
So far these limited reports have demonstrated that both labelling methods 
can produce accurate CGH interpretation from a single cell. However, the 
advantage of the PCR method over nick translation is the feasibility of
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automation. In nick translation, parameters such as reaction time, 
temperature, and probe sizes require close monitoring, whereas PCR 
labelling can be applied automatically in a PCR thermal cycler.
Other reports claimed that amplification of genomic DNA with standard 
Taq DNA polymerase yielded poor amplification (Kuukasjarvi et al 1997). 
By using T7 DNA polymerase in their study, larger DNA fragments could 
be amplified from minute DNA in the primary DOP-PCR reaction. 
Fluorochromes could be added in the subsequent high stringency 
amplification steps. Alternately, if unlabelled DOP-PCR products were 
produced in the primary DOP-PCR reaction, the unlabelled DOP-PCR 
products could be labelled by PCR method or nick translation. However, 
the result of this study and others confirm that appropriate probes could be 
produced by using standard Taq polymerase (Vollaire et al 1999; Wells et 
al 1999). Although an EHF-PCR system aiming at amplifying larger 
fragments was tested in this study, the results were not superior to those 
obtained by standard Taq polymerase. Moreover, the yield tended to 
diminish. Longer DNA fragments might be achieved in PCR labelling using 
an EHF-PCR system; however, similar results were also obtained by using 
Taq polymerase with increased magnesium concentration. 
Fluorochrome-conjugated nucleotides can be added to the primary DOP- 
PCR amplification reaction. However, this will interfere with the capability 
of DOP-PCR amplification from a single cell. Apart from this study, two- 
stage DOP-PCR is preferred by most other researchers so far (Wells et al 
1999; Kuukasjarvi et al 1997). DNA can be labelled with various 
fluorochrome-conjugated nucleotides by nick translation, random priming 
or using temperature cycled amplification methods. In all instances, a 
fraction of input dTTP is substituted with fluorochromes-conjugated-dUTP. 
Instead of using 2.5 pi fluorochrome-conjugated nucleotides as described 
in Wells’ report, a substitution ratio of 20% (2 pi) fluorochromes- 
conjugated-dUTP relative to dTTP also worked reliably in this study (Wells 
et al 1999).
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The distribution of probe size has been stressed in many reports. Similar 
size distribution between test and reference DNA was important because 
this will allow, in theory, an unbiased competition on target chromosomes 
between test and reference DNA. Discrepancy of probe size may lead to 
biased competition between green and red probes and produce false 
results. However, no reliable method can be applied so far in accurately 
quantifying the incorporation rate of fluorochromes. Only a tiny percentage 
of fluorochromes (1-3% of total nucleotide) are incorporated into the 
probes. In addition, the size distribution of probes cannot be accurately 
quantified by current methods. Therefore, the optimal size distribution 
generated by a second DOP-PCR should only be viewed as a requisite to 
carry on further CGH experiments and not a guarantee for successful 
results.
4.9 Homo-hybridisation and hetero-hybridisation
During the optimisation of single cell CGH, reference DNA was prepared 
from either amplified DNA (homo-hybridisation) or non-amplified DNA 
(hetero-hybridisation). Theoretically, reference DNA for single cell CGH 
should be prepared from a matched number of single cells. However, such 
a strategy of homo-hybridisation usually produced high failure rate and 
inconsistent results in this study. The underlying causes might be due to 
the difficulties involved in single cell manipulation or single cell PCR errors. 
Furthermore, incomplete lysis plus preferential amplification through many 
cycles of random priming could also result in part of the genome being 
either over- or under-represented. The situation deteriorated when both 
test and reference DNA were prepared by PCR from single cells. This 
theory was supported by the observation that CGH resulted in unreliable 
prediction when test DNA prepared from 20 aneuploidy stained cells was 
co-hybridised with reference DNA prepared from 20 normal stained cells. 
However, correct CGH interpretation was made when such test DNA was 
co-hybridised with non-amplified reference DNA.
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Since the development of CGH in 1992, the procedure has been plagued 
with technical limitations and difficulties. Among these, DNA copy number 
changes in chromosomes 1 p, 16p, 17p, and in the whole chromosomes 19 
and 22 are considered difficult to interpret, leading to false-positive 
observations (Kallioniemi et al 1994). A similar observation was also noted 
in this study and in other reports when both test and reference DNAs were 
prepared from amplified DNA (Vollaire et al 1999; Wells et al 2000). 
However, when reference DNA was prepared from non-amplified DNA, the 
CGH results did not show this phenomenon. Different DNA preparation 
and complex hybridisation dynamics could have been the factors 
responsible for the hybridisation artefacts. It might also reflect an 
underlying difference in the way FITC and rhodamine molecules bind to 
DNA molecules, or it could be related to a differential affinity of the 
fluorochromes to certain types of DNA families not homogeneously 
distributed in the genome, such as the GC rich areas or small interspersed 
repeated sequence elements (Larramendy et al 1998).
Huang et al (2000) developed a reproducible DOP-PCR-CGH protocol by 
evaluating different labelling methods and different hybridisation mixtures 
(including amplified test DNA vs. amplified reference DNA, termed homo­
hybridisation; and amplified test DNA vs. non-amplified reference DNA or 
vice versa, termed hetero-hybridisation). In their conclusion, a DOP-PCR- 
CGH homo-hybridisation method, especially when combined with labelling 
by nick translation, was reliable and reproducible (Huang et al 2000). 
Although correct single cell CGH interpretation was achieved in a case of 
trisomy 21 using homo-hybridisation, other homo-hybridisation 
experiments usually displayed considerable variations with numerous false 
gains and losses in this study. Compared with homo-hybridisation, hetero­
hybridisation produced higher success rate and reliable single cell CGH 
interpretations in this study. The cause of the different results is not clear, 
although it may be due to different methodology in terms of DNA 
preparation and labelling methods.
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Single cell CGH using hetero-hybridisation produced accurate prediction 
for major chromosome abnormalities (e.g. trisomy 21, 18, partial 
aneuploidy and sex chromosome anomaly) in this study. Apart from 
increased success rate, a reliable non-amplified reference DNA also help 
to identify the underlying causes which might lead to failed single cell CGH 
(e.g. single cell PCR errors, sub-optimal quality of metaphase slides, 
improper temperature or time for chromosome denaturation).
Preparing reference DNA from single cells was a laborious process and 
requires tedious assessment to ensure probe quality. In comparison, 
preparing reference DNA from genomic DNA is relatively straightforward. 
Similar products are also commercially available. Considering the high 
failure rate and poor CGH prediction related to homo-hybridisation, 
preparing reference DNA particularly from a matched number of single 
cells is not recommended.
4.10 Qualitative and quantitative analysis of single cell CGH
Qualitative assessment by inspecting all CGH images is mandatory prior 
to quantitative ratio profile analysis. Guidelines for accepted images have 
been described by a number of studies (Kallioniemi et al 1994; Kallioniemi 
et al 1996). Using the current protocol of hetero-hybridisation, 
pericentromeric regions of chromosome 1, 9, 16 are usually painted with 
red colour. This may suggest these areas tended not to be amplified in the 
DOP-PCR reaction. Lapierre et al (1998) reported the possibility of 
detecting numerical trisomy without the need of digital analysis system. In 
this study obvious colour change of chromosome 18, 21 and sex 
chromosomes can also be differentiated by the naked eye from most 
single cell CGH images involving trisomy 18, 21, and mismatched sex, 
respectively. However, colour intensity cannot be differentiated from 
separated green or red images in trisomy cases. Changes in copy number 
of tiny chromosomal regions however require the utilisation of a CGH 
software programme for detailed analysis. Therefore it is better to rely on
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computer software rather than the naked eye in the interpretation of CGH. 
This would be mandatory in a diagnostic setting.
For quantitative ratio profile analysis, the most widely used thresholds are 
based on fixed cut-off values. Others use statistical concepts to set the 
definition of diagnostic thresholds (Du Manoir et al 1995b, Moore et al
1997). The choice between the two approaches may strongly influence the 
number of gains and losses detected. Barth et al (2000) recommended the 
use of a fixed-threshold procedure because of its higher reliability of 
positive test results, even at the cost of not detecting all possible 
aberrations.
This study manipulated a flexible threshold value to evaluate the risk of 
false positive results in single cell CGH. In the initial stage, when trying to 
test the feasibility of single cell CGH, each experiment was accomplished 
by mismatching sexes between test and reference DNA. Consequently, 
the fluorescent intensity change of the X chromosome and the designated 
chromosome in trisomy cases could be viewed as an internal control for 
optimal CGH results. Although the theoretical fluorescence ratio (FR) cut­
off value for trisomy and monosomy in CGH analysis is 1.5 and 0.5 
respectively, these values were rarely achieved in real CGH experiments, 
which usually resulted in false negatives at such stringent values. To 
minimize false positives, and produce no false negatives, for the targeted 
chromosome and internal control of X chromosome, adjustment of the cut­
off values were manipulated to retain the balance between false negative 
and false positive. Ratio profiles using stringent cut-off values would 
reduce the false positives. When less stringent cut-off values were set at
1.2 and 0.8 to represent chromosomal gains and losses respectively, the 
average number of false positive regions was 5. The problems of false 
positives were not widely reported in the clinical-associated CGH reports. 
Further investigation is required in order to clarify the balance between the 
false positives and the risk of missed detection.
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4.11 Applications and limitations of DOP-PCR/CGH
4.11.1 Detailed chromosome analysis for early embryo development
So far two CGH studies involving blastomeres have demonstrated around 
75% chromosomal aberrations in early embryo cells (Voullaire et al 2000, 
Wells et al 2000). The proportion of totally normal embryos seen in 
Voullaire’s study (25%) is slightly lower than other groups using a FISH 
technique (Delhanty et al 1997, Munne et al 1998b). As CGH allows a 
much more extensive analysis of the karyotype than is possible with 
interphase FISH analysis, this result is to be expected (Voullaire et al 
2000). In Wells’ report, the CGH karyotype of blastomeres also showed a 
high level of mosaic and chaotic results. Only 3 of 12 embryos studied 
showed a normal CGH karyotype (Wells et al 2000).
Numerous chromosome gains and losses were also noted in this study 
involving a single blastomere. Although DOP-PCR/CGH from single 
blastomeres of human cleavage embryos appears to be a reliable 
technique for the determination of whole and partial aneuploidy (Voullaire 
et al 2000), verifying the CGH results of blastomeres with smaller 
duplications or deletions is extremely difficult. Currently, most studies 
report the use of inverse CGH, FISH, microsatellite and LOH analyses to 
validate CGH findings. However, it is impractical to confirm numerous 
gains and losses in early embryo cells. Besides, the accumulated 
experiences in CGH studies show that a number of technical difficulties 
(e.g. the identification of chromosomes, the choice of cut-off threshold, 
and the problem of false positive or false negative findings) will further 
complicate the CGH interpretation of blastomeres, which can have such 
an enormous spectrum of chromosome aberrations. Utilizing ultra 
sensitive charge-coupled device detection of labelled probes in a 
miniaturized format (DNA chip technology) may help to determine the wide 
spectrum of abnormalities currently encountered in the study of early 
embryos.
PGD and transfer of embryos is usually completed within 24 hours. This 
limited time window can be extended if embryos are frozen during the
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PGD process. Technical advances in the culture of human embryos to the 
blastocyst stage will allow an additional two days in which to complete 
CGH. Current single cell DOP-PCR-CGH protocols take around 72 hours 
to perform, with this length of time hampering its application to PGD. By 
increasing the amount of test and reference DNA, an overnight CGH 
protocol produces intense hybridisation signals similar to those from the 
conventional protocols. The preliminary results in this study illustrated that 
a total time of less than 1 Vz days for the DOP-PCR/CGH protocol is 
possible. The implications of an ultra-rapid protocol for whole chromosome 
painting (WCP) probes may indicate further reduction of time requirement 
for CGH is possible (Liu et al 1998b). Combining the advance in 
techniques which allow an extended time window for PGD and a short 
protocol, DOP-PCR/CGH may well be applied in PGD in the future.
4.11.2 Potential application for non-invasive prenatal diagnosis
It has been estimated that around 10-20 fetal erythroblasts can be 
identified from mid-trimester maternal blood, and these cells may provide a 
source for various kinds of genetic analyses (Kuo et al 1999). In order to 
simulate the potentially retrievable fetal cells in maternal blood and prove 
the feasibility of using these cells for multi-purpose diagnosis, this study 
investigated and successfully proved the performance of DOP-PCR/CGH 
on cell clusters containing 10-20 stained cells scraped from G-banded 
slides.
Sex chromosome aneuploidy is among the most common chromosome 
abnormality present at birth. Its incidence at amniocentesis is even greater 
and is estimated to be 1/250 in woman over 35 years of age (Ferguson- 
Smith et al 1984). Therefore, the possibility of sex chromosome 
aneuploidy should always be covered for any modern technique involved 
for prenatal genetic diagnosis. In this study, successful application of 
DOP-PCR/CGH in the diagnosis of isochromosome Xq from stained cells 
demonstrated that these techniques are reliable and could be used as a 
supplement for current prenatal diagnostic procedures (Lapierre et al
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2000) and non-invasive prenatal diagnosis in the future. Compared with 
Xq, the hybridisation over Xp showed less green when test DNA was co- 
hybridised with normal female reference DNA. Although this was indicative 
of deletion on Xp, further hybridisation with normal male reference DNA 
confirmed the diagnosis. The resultant hybridisation showed distinctive red 
colour over Xp; therefore, unequivocal diagnosis of isochromosome Xq 
was made. It is generally recommended that normal female reference 
DNA is used in the CGH experiment as Y chromosome provides less 
genetic information than X chromosome (Weiss et al 1999). However, it is 
worthwhile co-hybridising prenatal test DNA with both sexes as the result 
will provide more information of sex chromosomes and confirm the 
diagnosis of sex chromosome aneuploidies.
Similarly the correct diagnosis of trisomy 21 and 18 from a few stained 
cells in this study also proved that DOP-PCR/CGH is a reliable technique 
for diagnosis of complete aneuploidy. However, the correct diagnosis of 
partial trisomy 12p required a stringent cut-off value because false 
positives occurred if less stringent value was set. In retrospect, a 
consistent greener colour was noted over chromosome 12p using global 
analysis; however, this result was not conclusive during the initial CGH 
evaluation because several other chromosome regions also presented 
with gains. It would be preferable to re-confirm the diagnosis using another 
technique (e.g. FISH) if extra cells are available. The occurrence of false 
positives commonly encountered in the CGH experiments remained an 
issue to be resolved. Although CGH is a powerful tool for universal 
screening of whole genome in various research areas, it can only be 
viewed as supplementary tool for prenatal diagnosis at present.
4.11.3 Limitation of DOP-PCR/CGH
The resolution of CGH from using DOP-PCR-amplified DNA has not been 
well verified in the literature. Successful detection of trisomy 21 in this 
study and other reports shows that resolution power is at least 60 Mb for 
DOP-PCR/CGH techniques involved with single cell genetic analysis
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(Voullaire et al 1998, Wells et al 1997). The results of the current study 
demonstrate that complete or partial aneuploidies can be detected using 
DOP-PCR/CGH techniques. However, further studies are needed to 
confirm the resolution limit of using this technique for single cell genetic 
analysis.
CGH has limitations in detecting genetic abnormalities such as balanced 
translocations, ploidy change, small intragenetic rearrangements and low 
level mosacism. It is also unable to resolve the chromosome sequence 
copy changes smaller than 10 Mb (Bents et al 1998). To increase the 
sensitivity of CGH, a high resolution modification makes it possible to 
detect submicroscopic deletions or duplication but the method does not 
permit precise identification of breakpoints and cannot detect balanced 
rearrangements (Jens Pedersen-Bjergaard 2001). In the future, an array of 
large-insert genomic clones placed in the exact genomic order on a glass 
slide (DNA chips) might replace the metaphase chromosomes as a 
hybridisation target and substantially increase the resolution of the CGH 
technique (Solinas-Toldo et al 1997, Pinkel et al 1998).
It has been generally recognised that CGH can detect copy number 
changes if more than 50% of cells analysed contained chromosomal gains 
or losses (Kallioniemi et al 1994). Although some researchers had 
reported the possibilities of detecting lower mosaics, these studies used 
FISH or conventional cytogenetic counting to decide the mosaic level and 
CGH experiments were not carried out at single cell level (Lesto et al 
1999; Gaffari et al 1998). To simulate the sub-optimal identification of fetal 
cells from maternal blood (i.e. maternal cell contamination), this study 
manufactured 50-70% mosaics by mixing male aneuploidy cells with 
normal female cells. At 70% trisomy 18 mosaic levels, this study was 
unable to detect the trisomy 18 and sex using the current protocols. 
Preferential amplification of normal female cells may be the underlying 
cause; however, incomplete lysis of aneuploidy cells could not be ruled 
out. The CGH tolerance of maternal cell contamination in detecting 
common fetal aneuploidy remains unknown. Failure to detect aneuploidy
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from manufactured mosaicism illustrates that certain prerequisites should 
be met if the strategy of pooling erythroblasts for DOP-PCR/CGH 
diagnosis is to be used in the field of non-invasive prenatal diagnosis. In 
the future, this may necessitate the improvement in a specific antibody for 
fetal erythroblasts detection or the inclusion of DNA fingerprinting prior to 
DOP-PCR /CGH (Wells et al 1998).
4.12 Multi-purpose diagnosis from single cells
There is an increasing demand for fetal karyotyping due to the prevalence 
of maternal serum screening for common aneuploidies, increasing 
ultrasound use in characterising chromosomal anomalies (e.g. nuchal 
translucency thickness) and the tendency for elevated maternal age. It is 
also increasingly common as molecular pathologies are pinpointed for a 
family with a history of a single gene disorders to have a need for genetic 
analysis as well. However, the use of such diverse strategies in the field of 
preimplantation genetic diagnosis and non-invasive prenatal diagnosis has 
not been developed since only one or several single cells are available for 
diagnosis. Current prenatal diagnosis is based mainly on conventional 
cytogenetic karyotyping, polymerase chain reaction (PCR) or fluorescence 
in situ hybridisation (FISH). When analysis is for a specific locus by PCR 
on a single cell, this has the drawback of sacrificing further detection of 
various chromosomal abnormalities.
To date, FISH using centromeric-specific probes, can detect common 
aneuploidies such as trisomy 21, 18, or 13, and abnormal sex 
chromosome constitution simultaneously (Bischoff et al 1998). In addition 
to the possibility of cross hybridisation occurring between some 
chromosomes, simultaneous detection of more than 5 colours is costly and 
technically demanding. To broaden the diagnostic spectrum, various 
strategies including recycling of single cells, multicolour FISH, and whole 
genome amplification followed by specific locus detection have been 
reported (He et al 1999; Marquez et al 1998; Wells et al 1998). This study 
also investigated the feasibility of concomitant diagnosis at both molecular
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and cytogenetic levels using DOP-PCR/CGH and nested PCR (Figure 
4.1). Using this strategy, numerous specific loci and the copy number of 
every chromosome could theoretically be assessed from a single cell.
CGHAliquots for various 
molecular diagnosis 
(e.g. sex, F508)
Whole genome amplification 
(e.g. DOP-PCR)
Normal reference DNA 
labelled with Red 
fluorochrome
Genome wide screening for 
chromosomal gains or losses
Labelling aliquots 
by incorporating 
Fluorescein-dUTP (green)
Single cell / pooling of microdissected 
single cells (e.g. PGD, NPD)
Figure 4.1: Combining WGA and CGH for various loci detection and genome 
wide screening of chromosomes.
4.13 Conclusions
The methods described in this study suggest a novel strategy for diagnosis 
encompassing both molecular and cytogenetic analysis. By using a 
combination of DOP-PCR, nested PCR, and CGH, a wider range of 
genetic analysis is possible from a single cell. Simultaneous detection of 
sex, cystic fibrosis mutation status and diagnosis of chromosomal gains or
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losses across the whole genome from a single cell is possible. This would 
increase the diagnostic scope of current clinical practice.
Although single cell CGH is a lengthy and relatively difficult technique, the 
success rates were optimised when reliable metaphase slides and non- 
amplified reference DNA were used. The results of current studies 
involving single cells, the quantitatively accurate CGH data and the fidelity 
at the specific sequence level, may pave the way for further application of 
this technique in the field of non-invasive prenatal diagnosis and 
preimplantation genetic diagnosis.
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